Sentence,class,file
Available from: http://www.healthycommunitiesinstitute.com/consortiums-and-coalitions-solutions/ 51.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Available from: http://www.holycrosshealth.org/documents/community_involvement/HCH_CommunityBenefitImplementationStrategy_FY13.pdf 53.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Available from:  http://iom.edu/~/media/Files/Report%20Files/2010/For-the-Publics-Health-The-Role-of-Measurement-in-Action- and-Accountability/For%20the%20Publics%20Health%202010%20Report%20Brief.pdf 55.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Available from: http://www.computerworld.com/s/arti- cle/9238593/How_big_data_will_save_your_life 56.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Available from: http://www.improvingpopula- tionhealth.org/PopHealthPhaseIICommissionedPaper.pdf59.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Available from: http://www.qualityforum.org/Publica-tions/2008/12/National_Voluntary_Consensus_Standards_for_Influenza_and_Pneumococcal_Immunizations.aspx  63.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Available  from: http://uwphi.pophealth.wisc.edu/publications/other/ blog-collection-final-2014-04-05.pdf 70.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
"Avail-able from: http://www.dignityhealth.org/Who_We_Are/Community_Health/212401 25Stoto: Population Health Measurement Produced by The Berkeley Electronic Press, 2014",Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Available from: http://www.iom.edu/Reports/2008/State-of-the-USA-Health-Indicators-Letter-Re-port.aspx 72.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Available from: http://healthaffairs.org/blog/2013/05/09/a-framework-for-account- able-care-measures/ 73.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Available  from: http://healthpolicyohio.org/groups/health-measure-ment/ 74.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Available from: http://www.ihi.org/resources/Pages/IHIWhitePapers/AGuidetoMeasur-ingTripleAim.aspx 75.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Available from: http://www.countyhealthrankings.org/ 77.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Available from: http://iom.edu/~/media/Files/Report%20Files/2010/For-the-Publics-Health-The-Role-of-Measurement-in-Action-and-Accountability/For%20the%20Publics%20Health%202010%20Report%20Brief.pdf 78.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Available from: http://iom.edu/~/media/Files/Report%20Files/2010/For-the-Publics-Health-The-Role-of-Measurement-in-Action-and-Accountability/For%20the%20Publics%20Health%202010%20Report%20Brief.pdf 79.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Available from: http://www.improvingpopula-tionhealth.org/PopHealthPhaseIICommissionedPaper.pdf80.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Available from: http://apps.nccd.cdc.gov/sammec/about_sammec.asp 82.,OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Available from: http://iom.edu/~/media/Files/Report%20Files/2010/For- the-Publics-Health-The-Role-of-Measurement-in-Action- and-Accountability/For%20the%20Publics%20Health%20 2010%20Report%20Brief.pdf 84.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Available from: http://www.qualityforum.org/docs/measure_evalua- tion_criteria.aspx 85.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Available from: http://www.qualityforum.org/docs/measure_evalua- tion_criteria.aspx 86.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Available from: http://www.healthleadersmedia.com/intelligence/detail/cfm?con-tent_id=296742&year=2013 90.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Available from: http://www.iom.edu/Global/Perspectives/2013/Makingthe-CaseforContinuousLearning.aspx 91.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
6 http://repository.academyhealth.org/egems/vol2/iss4/6 DOI: 10.13063/2327-9214.1132,Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Available  from: http://www.communitycommons.org/chna/ 94.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Available from: http://www.healthycommunitiesinstitute.com/consortiums-and-coalitions-solutions/ 95.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Available from: http://stacks.cdc.gov/view/cdc/20707 96.,OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Available from: http://www.countyhealthrankings.org/ 97.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Available from: http://www.countyhealthrankings.org/ 98.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Available from: http://www.nyc.gov/html/doh/html/data/nycmacroscope.shtml 100.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Available  from: http://www.qualityforum.org/docs/measure_evalua- tion_criteria.aspx 104.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Avail-able from: http://www.rand.org/publications/WR/WR106/ 107.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Available from: http://www.qualityforum.org/Publi- cations/2014/08/Risk_Adjustment_for_Socioeconomic_Sta-tus_or_Other_Sociodemographic_Factors.aspx  113.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
Available from: http://www.qualityindi-cators.ahrq.gov/modules/pqi_resources.aspx 114.,OADS,/arxiv_data1/oa_pdf/50/eb/egems1132.PMC4438103.pdf
8 http://repository.academyhealth.org/egems/vol2/iss4/8 DOI: 10.13063/2327-9214.1172,Non-OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
8 http://repository.academyhealth.org/egems/vol2/iss4/8 DOI: 10.13063/2327-9214.1172,Non-OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
8 http://repository.academyhealth.org/egems/vol2/iss4/8 DOI: 10.13063/2327-9214.1172,Non-OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
8 http://repository.academyhealth.org/egems/vol2/iss4/8 DOI: 10.13063/2327-9214.1172,Non-OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
2009; http://www.healthit.gov/sites/default/files/hitech_act_excerpt_from_arra_with_index.pdf.,Non-OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
http://georgewbush-white-house.archives.gov/infocus/technology/economic_poli-cy200404/chap3.html.,Non-OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
2014; http://www.healthit.gov/FACAS/sites/faca/files/HITPC_Feb2014_HITPC.pdf.,OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
http://effectivehealthcare.ahrq.gov/index.cfm/what-is-comparative-effectiveness-re-search1/.,Non-OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
http://www.pcori.org/content/establishing-definition-patient-cen-tered-outcomes-research.,Non-OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
New Requirements for 501(c)(3)  Hospitals Under the Affordable Care Act http://www.irs.gov/Charities-&-Non-Profits/Charitable-Organizations/New-Requirements-for-501(c)(3)-Hospit als-Under-the-Afford- able-Care-Act.,Non-OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
http://www.cms.gov/Medi-care/Medicare-Fee-for-Service-Payment/sharedsavingspro-gram/Quality_Measures_Standards.html.,Non-OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
http://www.phaboard.,Non-OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
8 http://repository.academyhealth.org/egems/vol2/iss4/8 DOI: 10.13063/2327-9214.1172,Non-OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
Inventory of  Standards Relevant to Cloud Computing http://collaborate.nist.gov/twiki-cloud-computing/bin/view/CloudComputing/StandardsInventory.,OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
http://www.cdc.gov/biosense/com-munity.html.,Non-OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
http://www.popmednet.org/.,Non-OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
http://www.hmoresearchnetwork.,Non-OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
http://www.healthit.gov/poli-cy-researchers-implementers/federal-health-architecture-fha.,Non-OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
2012; http://www.cdc.gov/vaccines/programs/iis/techni-cal-guidance/downloads/h l7guide-1-4-2012-08.pdf.,Non-OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
2013; http://www.hl7.org/implement/standards/prod-uct_brief.cfm?product_id=98.,OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
2014; http://www.hl7.org/implement/stan- dards/fhir/overview.html.,Non-OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
http://www.nyc.gov/html/doh/html/data/nycmacroscope.shtml.,Non-OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
2013; http://www.nyc.gov/html/doh/down-loads/pdf/data/nyc-macro-report.pdf.,OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
2009; http://www.cdc.gov/InformaticsCompetencies.58.,OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
2014; http://www.healthit.gov/policy-researchers-implement-ers/health-it-strategic-planning.,Non-OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
2013; https://www.networkforphl.org/_asset/lwp1wv/PPT-PH-and-LHS-Lessons-from-Tw o-Networks-J-Brown.pdf.,OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
2014; http://wiki.siframework.org/file/view/Public+Health+Community+Plat-form+Briefing+Document+April+25+2014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
org/10.13063/12327-19214.11010 http://repository.academy-health.org/egems/vol13061/iss13061/13015 63.,Non-OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
"1980; http://www.oecd.org/docu-ment/18/0,2340,en_2649_34255_1815186_1_1_1_1,00.html.",Non-OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
8 http://repository.academyhealth.org/egems/vol2/iss4/8 DOI: 10.13063/2327-9214.1172,Non-OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
"http://healthit.gov/policy-researchers-implement-ers/federal-health-architecture-fha Accessed May 18, 2014.",Non-OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
2014; http://www.phdsc.org/about/pdfs/AHIMA-PHDSC_%20Press_Release_10022014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
http://jphit.org/.,Non-OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
"IHE Quality, Research, and Public Health 5 Technical Framework Supplement  2014; http://ihe.net/uploadedFiles/ Documents/QRPH/IHE_QRPH_Suppl_SDC.pdf.",OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
2014; http://www.ihe.net/uploadedFiles/Documents/PCC/IHE_PCC_White_Paper_DAF_Rev1.0_2014-03-28.pdf.,Non-OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
2014; http://www.medicaid.gov/Medicaid-CHIP-Program-Information/By-Top-ics/Data-and-Systems/Medicaid-Information-Technology-Ar-chitecture-MITA.html.,OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
2013; http://www.mini-sentinel.org/methods/methods_development/details.aspx?ID=1041.,Non-OADS,/arxiv_data1/oa_pdf/86/bb/egems1172.PMC4438104.pdf
7 http://repository.academyhealth.org/egems/vol2/iss4/7 DOI: 10.13063/2327-9214.1175,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/egems1175.PMC4438105.pdf
7 http://repository.academyhealth.org/egems/vol2/iss4/7 DOI: 10.13063/2327-9214.1175,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/egems1175.PMC4438105.pdf
7 http://repository.academyhealth.org/egems/vol2/iss4/7 DOI: 10.13063/2327-9214.1175,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/egems1175.PMC4438105.pdf
7 http://repository.academyhealth.org/egems/vol2/iss4/7 DOI: 10.13063/2327-9214.1175,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/egems1175.PMC4438105.pdf
7 http://repository.academyhealth.org/egems/vol2/iss4/7 DOI: 10.13063/2327-9214.1175,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/egems1175.PMC4438105.pdf
[cited 2014 January 16] Available from http://www.phf.org/programs/AHDLC/Pages/Academic_Health_Depart-ment_Learning_Communi ty.aspx 3.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/egems1175.PMC4438105.pdf
March 2014. http://www.cdc.gov/nphpsp/documents/essential-phs.pdf 9.,OADS,/arxiv_data1/oa_pdf/4d/3a/egems1175.PMC4438105.pdf
[cited 2014 January 16] Available from http://www.phf.org/programs/AHDLC/Pages/Academic_Health_Depart-ment_Learning_Communi ty.aspx 12.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/egems1175.PMC4438105.pdf
[cited 2014 January 16] Available from http://www.phf.org/programs/AHDLC/Pages/Academic_Health_Depart-ment_Learning_Communi ty.aspx 37.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/egems1175.PMC4438105.pdf
Available from  http://www.naccho.org/topics/infrastructure/informatics/resources/upload/top-8-with-NACCHO-letterhead-2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/egems1175.PMC4438105.pdf
(http://www.hibeacon.org/images/BeaconNation/Beacon_Nation_Learn-ing_Guide_Population_H ealth_LG6.pdf).,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/egems1175.PMC4438105.pdf
Health IT Gov [cited  2014 April 3] Health Adoption Programs (http://www.health- it.gov/policy-researchers-implementers/beacon-community- program) 40.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/egems1175.PMC4438105.pdf
Available at http://www.shadac.org 41.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/egems1175.PMC4438105.pdf
eGEMs: 1(2) Article 5: 2013 Available http://repository.academyhealth.org/egems/vol1/iss2/5.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/egems1175.PMC4438105.pdf
Available at http://www.thecom-munityguide.org.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/egems1175.PMC4438105.pdf
Available at http://www.ahrq.gov/workingforquality/about.htm.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/egems1175.PMC4438105.pdf
Avail-able at http://www.hhs.gov/ash/initiatives/quality/quality/phqf-consensus-statement.pdf48.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/egems1175.PMC4438105.pdf
Available at  http://www.healthypeople.gov/2020/faqs.aspx.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/egems1175.PMC4438105.pdf
Available at http://www.ahrq.gov/workingforquality/about.htm.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/egems1175.PMC4438105.pdf
7 http://repository.academyhealth.org/egems/vol2/iss4/7 DOI: 10.13063/2327-9214.1175,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/egems1175.PMC4438105.pdf
"review Korean J Intern Med 2015;30:271-278 http://dx.doi.org/10.3904/kjim.2015.30.3.271 Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgRecent trends in diagnostic techniques for    inflammatory bowel disease Makoto Naganuma1, Naoki Hosoe1, Takanori Kanai2, and Haruhiko Ogata1 1Center for Diagnostic and  Therapeutic Endoscopy,  2Department of Gastroenterology  and Hepatology, Keio University  School of Medicine, Tokyo, Japan Received : March 26, 2015 Accepted : April 16, 2015 Correspondence to  Haruhiko Ogata, M.D.",Non-OADS,/arxiv_data1/oa_pdf/e0/1d/kjim-30-271.PMC4438281.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.271ULCerATive  COLi TiS Usefulness and clinical impact of endoscopic proce - dures in UC UC is characterized by continuous colonic mucosal in - flammation that typically presents in the second and  third decades of life.",Non-OADS,/arxiv_data1/oa_pdf/e0/1d/kjim-30-271.PMC4438281.pdf
"New diagnostic devices in IBD www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.271by enabling > 1,000-fold magnification of the mucosa.",Non-OADS,/arxiv_data1/oa_pdf/e0/1d/kjim-30-271.PMC4438281.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.271have been developed, such as capsule endoscopy (CE)  and balloon-assisted enteroscopy (BAE).",Non-OADS,/arxiv_data1/oa_pdf/e0/1d/kjim-30-271.PMC4438281.pdf
New diagnostic devices in IBD www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.271ly less sensitive for the detection of strictures that can  be identified by single-balloon assisted enteroscopy.,Non-OADS,/arxiv_data1/oa_pdf/e0/1d/kjim-30-271.PMC4438281.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.271[46].",Non-OADS,/arxiv_data1/oa_pdf/e0/1d/kjim-30-271.PMC4438281.pdf
New diagnostic devices in IBD www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.271eration colon capsule endoscopy compared with colo - noscopy.,Non-OADS,/arxiv_data1/oa_pdf/e0/1d/kjim-30-271.PMC4438281.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.271small bowel: comparison of CT enterography, MR en - terography, and small-bowel follow-through as diag - nostic techniques.",Non-OADS,/arxiv_data1/oa_pdf/e0/1d/kjim-30-271.PMC4438281.pdf
"review Korean J Intern Med 2015;30:279-293 http://dx.doi.org/10.3904/kjim.2015.30.3.279 Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgHard tissue regeneration using bone substitutes:  an update on innovations in materials  Swapan Kumar Sarkar1 and Byong Taek Lee1,2 1Institute of Tissue Regeneration,  2Department of Regenerative  Medicine, Soonchunhyang University College of Medicine, Cheonan, Korea Received : January 21, 2015 Accepted : March 5, 2015 Correspondence to Byong Taek Lee, Ph.D. Department of Regenerative  Medicine, Soonchunhyang University College of Medi - cine, 31 Suncheonhyang 6-gil, Dongnam-gu, Cheonan 330-930, KoreaTel: +82-41- 570 -2427E-mail: lbt@sch.ac.krBone is a unique organ composed of mineralized hard tissue, unlike any other  body part.",Non-OADS,/arxiv_data1/oa_pdf/d3/47/kjim-30-279.PMC4438282.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.279herent limitations in terms of strength, osteoconduc - tion, osteoinduction, osseointegration, and biodegra- dation.",OADS,/arxiv_data1/oa_pdf/d3/47/kjim-30-279.PMC4438282.pdf
Materials for hard tissue regeneration www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.279and allow easy fabrication into the final preforms [13-15].,Non-OADS,/arxiv_data1/oa_pdf/d3/47/kjim-30-279.PMC4438282.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.279by incorporating Si, Sr, and Zn [28-35].",OADS,/arxiv_data1/oa_pdf/d3/47/kjim-30-279.PMC4438282.pdf
Materials for hard tissue regeneration www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.279ramic is a crystallized glass (the crystalline phase is  created during thermal treatment) with a residual glass phase.,Non-OADS,/arxiv_data1/oa_pdf/d3/47/kjim-30-279.PMC4438282.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.279manufacture porous scaffolds.",OADS,/arxiv_data1/oa_pdf/d3/47/kjim-30-279.PMC4438282.pdf
"Materials for hard tissue regeneration www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.279for tissue engineering, mimicing the topology of the  extracellular matrix, thus improving cellular adhesion and proliferation [83].",Non-OADS,/arxiv_data1/oa_pdf/d3/47/kjim-30-279.PMC4438282.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.279OPTi MiZiNG TH e MiCrOSTrUCTU re AND  MOrPHOLOGY OF B iOCer AMiC-BAS eD  BONe  SUBST iTUTe S Scaffold mechanical properties, such as compressive  and bending strength, sharply decrease as porosity increases.",Non-OADS,/arxiv_data1/oa_pdf/d3/47/kjim-30-279.PMC4438282.pdf
"Materials for hard tissue regeneration www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.279CLiNiCALLY A vAiLABL e BON e SUBST iTUTeS  AND CLi NiCAL i NveSTiGATi ONS Many commercial products are available, with specific  applications, such as filling of bone voids, craniofacial bone voids; and facilitation of spinal fusion.",Non-OADS,/arxiv_data1/oa_pdf/d3/47/kjim-30-279.PMC4438282.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.279our basic understanding of the underlying principles.",Non-OADS,/arxiv_data1/oa_pdf/d3/47/kjim-30-279.PMC4438282.pdf
"Materials for hard tissue regeneration www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.279pore architecture, excellent mechanical strength and  mineralization ability.",Non-OADS,/arxiv_data1/oa_pdf/d3/47/kjim-30-279.PMC4438282.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.279with BCP and RGD containing peptide for improved os - teogenic differentiation.",OADS,/arxiv_data1/oa_pdf/d3/47/kjim-30-279.PMC4438282.pdf
Materials for hard tissue regeneration www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.279tents.,Non-OADS,/arxiv_data1/oa_pdf/d3/47/kjim-30-279.PMC4438282.pdf
http://dx.doi.org/10.1002/ app.41241.,Non-OADS,/arxiv_data1/oa_pdf/d3/47/kjim-30-279.PMC4438282.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.279calvarial defects with customised tissue-engineered  bone grafts II: evaluation of cellular efficiency and effi - cacy in vivo.",Non-OADS,/arxiv_data1/oa_pdf/d3/47/kjim-30-279.PMC4438282.pdf
Materials for hard tissue regeneration www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.2792014;97:47-56.,Non-OADS,/arxiv_data1/oa_pdf/d3/47/kjim-30-279.PMC4438282.pdf
"review Korean J Intern Med 2015;30:294-304 http://dx.doi.org/10.3904/kjim.2015.30.3.294 Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgClinical implications of copy number variations in  autoimmune disorders Seon-Hee Yim1, Seung-Hyun Jung2,3, Boram Chung2,3, and Yeun-Jun Chung2,3 1Department of Medical  Education, 2Integrated  Research Center for Genome Polymorphism,  3Department  of Microbiology, College of Medicine, The Catholic University of Korea, Seoul, Korea Received  : March 25, 2015 Accepted : March 30, 2015 Correspondence toYeun-Jun Chung, M.D.",Non-OADS,/arxiv_data1/oa_pdf/ab/cd/kjim-30-294.PMC4438283.pdf
CNVs in autoimmune diseases www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.294bypassing these tolerance checkpoints.,Non-OADS,/arxiv_data1/oa_pdf/ab/cd/kjim-30-294.PMC4438283.pdf
"In total, 353,126 CNVs have been reported in the Database of Genomic Variants (http://dgv.tcag.ca/dgv/app/home) as of October 2014.",OADS,/arxiv_data1/oa_pdf/ab/cd/kjim-30-294.PMC4438283.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.294consequences of CNVs include changes in protein ex - pression levels and truncation or alterations in protein  sequences.",Non-OADS,/arxiv_data1/oa_pdf/ab/cd/kjim-30-294.PMC4438283.pdf
CNVs in autoimmune diseases www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.294smaller CNVs and define CNV breakpoints more pre- cisely.,Non-OADS,/arxiv_data1/oa_pdf/ab/cd/kjim-30-294.PMC4438283.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.294COPY NUMBer  vAriATiONS iN AUTO iMMUN e  DiSOrDerS  Genetic variation and human autoimmune disease Autoimmune disorders can be caused by several differ- ent mechanisms, including continuous stimulation of autoreactive lymphocytes by diverse self-antigens or in - hibiting negative regulatory mechanisms for autoim - mune lymphocyte growth.",Non-OADS,/arxiv_data1/oa_pdf/ab/cd/kjim-30-294.PMC4438283.pdf
CNVs in autoimmune diseases www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.2942 to 6 [35].,Non-OADS,/arxiv_data1/oa_pdf/ab/cd/kjim-30-294.PMC4438283.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.294significantly correlated with psoriasis in 190 Dutch  cases and 303 controls.",Non-OADS,/arxiv_data1/oa_pdf/ab/cd/kjim-30-294.PMC4438283.pdf
"CNVs in autoimmune diseases www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.294ciated with the risk for SLE, with ORs of 1.0 to 1.3.",Non-OADS,/arxiv_data1/oa_pdf/ab/cd/kjim-30-294.PMC4438283.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.2949.",Non-OADS,/arxiv_data1/oa_pdf/ab/cd/kjim-30-294.PMC4438283.pdf
Available from: http://dgv.tcag.ca/dgv/app/statistics?ref=.,OADS,/arxiv_data1/oa_pdf/ab/cd/kjim-30-294.PMC4438283.pdf
CNVs in autoimmune diseases www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.29436.,Non-OADS,/arxiv_data1/oa_pdf/ab/cd/kjim-30-294.PMC4438283.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.2942010;19:4930-4938.",Non-OADS,/arxiv_data1/oa_pdf/ab/cd/kjim-30-294.PMC4438283.pdf
"EDITORIAL Korean J Intern Med 2015;30:305-307 http://dx.doi.org/10.3904/kjim.2015.30.3.305 Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgNeutrophil gelatinase-associated lipocalin as a  predictor of adverse renal outcomes in immuno - globulin A nephropathy Seong Kwon Ma Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea Received : April 1, 2015 Accepted: April 16, 2015 Correspondence to  Seong Kwon Ma, M.D.",Non-OADS,/arxiv_data1/oa_pdf/25/4e/kjim-30-305.PMC4438284.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.305dicted renal progression (hazard ratio [HR], 5.56; 95%  confidence interval [CI], 1.42 to 21.73; p  = 0.014) along  with tubular damage (HR, 8.79; 95% CI, 2.01 to 38.51; p   = 0.004).",Non-OADS,/arxiv_data1/oa_pdf/25/4e/kjim-30-305.PMC4438284.pdf
NGAL in IgA nephropathy http://dx.doi.org/10.3904/kjim.2015.30.3.305trophil gelatinase-associated lipocalin (NGAL) is associ - ated with severity of renal disease in proteinuric patients.,Non-OADS,/arxiv_data1/oa_pdf/25/4e/kjim-30-305.PMC4438284.pdf
"ORIGINAL ARTICLE Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:308-315 http://dx.doi.org/10.3904/kjim.2015.30.3.308INTRODUCTION 18F-Fluorodeoxyglucose positron-emission tomography (18F-FDG PET) is well established as a valuable imaging  tool for detecting various types of malignancy, such as  head and neck, pancreas, brain, lung, colon, and meta-1Digestive Disease Center and  Research Institute, Department of  Internal Medicine, Departments of  2Nuclear Medicine, and  3Radiology, Soonchunhyang  University Bucheon Hospital, Bucheon;  4Department of  Radiology, Soonchunhyang University Hospital, Seoul, Korea Received : May 25 , 201 4 Revised : June 27, 2014 Accepted : August 25, 2014 Correspondence to Young Seok Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/a7/a5/kjim-30-308.PMC4438285.pdf
"The prediction for HCC using 18F-FDG PET www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.308static liver tumors [1,2].",Non-OADS,/arxiv_data1/oa_pdf/a7/a5/kjim-30-308.PMC4438285.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.308the liver mean (Lmean) SUV, and the ratio of the Tmax  SUV to the Lmean SUV (Tmax/Lmean).",OADS,/arxiv_data1/oa_pdf/a7/a5/kjim-30-308.PMC4438285.pdf
"The prediction for HCC using 18F-FDG PET www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.308RESULTS Baseline characteristics Seventy-seven patients (52 males, 25 females) with a  mean age of 63.3 ± 11.0 years were included in this study.",OADS,/arxiv_data1/oa_pdf/a7/a5/kjim-30-308.PMC4438285.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.308ered to be primary treatment modalities for intermedi- ate-stage HCC.",Non-OADS,/arxiv_data1/oa_pdf/a7/a5/kjim-30-308.PMC4438285.pdf
The prediction for HCC using 18F-FDG PET www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.308for accurate measurement of Tmax [23].,OADS,/arxiv_data1/oa_pdf/a7/a5/kjim-30-308.PMC4438285.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.308Acknowledgments This work was supported by the Soonchunhyang Uni- versity Research Fund.",Non-OADS,/arxiv_data1/oa_pdf/a7/a5/kjim-30-308.PMC4438285.pdf
The prediction for HCC using 18F-FDG PET www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.308orodeoxyglucose PET/CT for transarterial chemolipiodol - ization of hepatocellular carcinoma.,Non-OADS,/arxiv_data1/oa_pdf/a7/a5/kjim-30-308.PMC4438285.pdf
"ORIGINAL ARTICLE Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:316-324 http://dx.doi.org/10.3904/kjim.2015.30.3.3161Department of Cardiology,  Meram School of Medicine  Hospital, Necmettin Erbakan University, Konya;  2Cardiology  Clinic, Kahramanmaras Necip Fazil City Hospital, Kahramanmaras;  3Cardiology Clinic, Lokman Hekim  Van Hospital, Van; 4Department  of Cardiology, Ercis Government Hospital, Van;  5Department  of Biochemistry, Dr Faruk Sükan Maternity and Children’s Hospital, Konya;  6Department of  Biochemistry, Selcuk University School of Medicine, Konya, Turkey Received : May 28 , 201 4 Revised : June 23, 2014 Accepted : November 14, 2014 Correspondence to Alpay Aribas, M.D.",Non-OADS,/arxiv_data1/oa_pdf/18/67/kjim-30-316.PMC4438286.pdf
ADMA and sleep quality in diabetes www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.316INTRODUCTION Sleep quality (SQ) is an important factor in the quality  of life.,Non-OADS,/arxiv_data1/oa_pdf/18/67/kjim-30-316.PMC4438286.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.316Study protocol Type 2 diabetes mellitus subjects were questioned re- garding a history of hypertension.",Non-OADS,/arxiv_data1/oa_pdf/18/67/kjim-30-316.PMC4438286.pdf
ADMA and sleep quality in diabetes www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.316The differences between the categorical variables were  determined using the chi-square test.,OADS,/arxiv_data1/oa_pdf/18/67/kjim-30-316.PMC4438286.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.316tive, and positive predictive values of ADMA on poor SQ.",OADS,/arxiv_data1/oa_pdf/18/67/kjim-30-316.PMC4438286.pdf
"ADMA and sleep quality in diabetes www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.316DISCUSSION We determined that serum ADMA levels were signifi- cantly increased in patients considered poor sleepers, and that ADMA levels can serve as an independent factor associated with poor SQ in normotensive patients with type 2 diabetes mellitus.",Non-OADS,/arxiv_data1/oa_pdf/18/67/kjim-30-316.PMC4438286.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.316[18] showed a negative association between HbA1c and  ADMA in young people with type 1 diabetes due to the down-regulation of ADMA production or stimulation of its metabolism.",Non-OADS,/arxiv_data1/oa_pdf/18/67/kjim-30-316.PMC4438286.pdf
ADMA and sleep quality in diabetes www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.316Limitations An important limitation of the present study was the  unavailability of polysomnographic data.,Non-OADS,/arxiv_data1/oa_pdf/18/67/kjim-30-316.PMC4438286.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.316inflammation is associated with poorer sleep quality in  stable haemodialysis patients.",Non-OADS,/arxiv_data1/oa_pdf/18/67/kjim-30-316.PMC4438286.pdf
"ORIGINAL ARTICLE Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:325-334 http://dx.doi.org/10.3904/kjim.2015.30.3.325INTRODUCTION Drug-resistant tuberculosis (TB) is a global concern.",Non-OADS,/arxiv_data1/oa_pdf/c2/5c/kjim-30-325.PMC4438287.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.325ing, despite this global effort [2].",Non-OADS,/arxiv_data1/oa_pdf/c2/5c/kjim-30-325.PMC4438287.pdf
"Drug-resistance  pattern of Mycobacterium  tuberculosis  www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.325(TAF), and treatment after interruption (TAI).",Non-OADS,/arxiv_data1/oa_pdf/c2/5c/kjim-30-325.PMC4438287.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.325PZA, CPM, KM, and Ofx was observed during the 8-year  study period.",OADS,/arxiv_data1/oa_pdf/c2/5c/kjim-30-325.PMC4438287.pdf
"Drug-resistance  pattern of Mycobacterium  tuberculosis  www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.325Prevention of 2012, 1,212 MDR TB cases were reported  via the national TB monitoring system, which is a large burden in Korea despite a national effort [15].",Non-OADS,/arxiv_data1/oa_pdf/c2/5c/kjim-30-325.PMC4438287.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.325According to previous studies performed in the pri- vate sector based on TB strains identified before 2009  [3,6,17-21], the any-drug-resistant TB rate was 15.0% to 20.4%, the monodrug-resistant TB rate was 6.4% to 17.6%, the MDR TB rate was 4.4% to 13.2%, and the XDR TB rate was 0.5% to 1.4%.",Non-OADS,/arxiv_data1/oa_pdf/c2/5c/kjim-30-325.PMC4438287.pdf
Drug-resistance  pattern of Mycobacterium  tuberculosis  www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.325Table 4.,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/kjim-30-325.PMC4438287.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.325cases than it does in PTB cases [9,10,22].",Non-OADS,/arxiv_data1/oa_pdf/c2/5c/kjim-30-325.PMC4438287.pdf
Drug-resistance  pattern of Mycobacterium  tuberculosis  www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.325many drug-sensitive EPTB cases were excluded.,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/kjim-30-325.PMC4438287.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.325Conflict of interest No potential conflict of interest relevant to this article  was reported.",Non-OADS,/arxiv_data1/oa_pdf/c2/5c/kjim-30-325.PMC4438287.pdf
"ORIGINAL ARTICLE Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:335-344 http://dx.doi.org/10.3904/kjim.2015.30.3.335INTRODUCTION  The diagnostic accuracy of thyroid dysfunctions is pri- marily affected by the validity of the reference interval for serum thyroid-stimulating hormone (TSH) [1].",Non-OADS,/arxiv_data1/oa_pdf/04/29/kjim-30-335.PMC4438288.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.335(TPOAbs), or anti-thyroglobulin antibodies (TgAbs) as  measured by sensitive immunoassays; (2) no personal or family history of thyroid dysfunction; (3) no visible or palpable goiter; and (4) no medications (except estrogen) [2].",Non-OADS,/arxiv_data1/oa_pdf/04/29/kjim-30-335.PMC4438288.pdf
Normal reference interval for TSH www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.335from RG1.,OADS,/arxiv_data1/oa_pdf/04/29/kjim-30-335.PMC4438288.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.335which was very close to the 2.5th percentile TSH value of  0.73 mIU/L in RG3.",OADS,/arxiv_data1/oa_pdf/04/29/kjim-30-335.PMC4438288.pdf
"Normal reference interval for TSH www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.335of the TSH level in AG1 was 2.86 mIU/L (male, 2.57 mI- U/L; female, 3.09 mIU/L) and the 97.5th percentile of the TSH level was 13.05 mIU/L (male, 12.40 mIU/L; female, 14.31 mIU/L).",OADS,/arxiv_data1/oa_pdf/04/29/kjim-30-335.PMC4438288.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.335Distribution of serum TSH levels according to age The distribution of serum TSH levels in the normal ref- erence population was also assessed according to age: 10% of the subjects were 20 to 39 years of age, 28% were 40 to 49 years of age, 43% were 50 to 59 years of age, 16% were 60 to 69 years, and 3% were 70 to 79 years of age.",Non-OADS,/arxiv_data1/oa_pdf/04/29/kjim-30-335.PMC4438288.pdf
"Normal reference interval for TSH www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.335(2.29 and 7.70 mIU/L, respectively).",OADS,/arxiv_data1/oa_pdf/04/29/kjim-30-335.PMC4438288.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.335[1,5-7].",Non-OADS,/arxiv_data1/oa_pdf/04/29/kjim-30-335.PMC4438288.pdf
Normal reference interval for TSH www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.3354.,OADS,/arxiv_data1/oa_pdf/04/29/kjim-30-335.PMC4438288.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.33527.",Non-OADS,/arxiv_data1/oa_pdf/04/29/kjim-30-335.PMC4438288.pdf
"ORIGINAL ARTICLE Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:345-353 http://dx.doi.org/10.3904/kjim.2015.30.3.345INTRODUCTION Immunoglobulin A nephropathy (IgAN) is the most  common cause of primary glomerulonephritis world-wide and a frequent cause of end-stage renal disease (ESRD) in patients with primary glomerular disease [1].",Non-OADS,/arxiv_data1/oa_pdf/88/34/kjim-30-345.PMC4438289.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.345time of an infectious episode.",Non-OADS,/arxiv_data1/oa_pdf/88/34/kjim-30-345.PMC4438289.pdf
"pNGAL as a predictor of outcome in IgAN www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.345Statistical analysis  Data are reported as means ± standard deviation, medi- an and interquartile range, or percentage frequency, as appropriate, and t  tests or one-way analysis of variance  was used for comparisons among groups.",OADS,/arxiv_data1/oa_pdf/88/34/kjim-30-345.PMC4438289.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.345500 400 300 200 100 0 10 20 30 40 50 60 70pNGAL (ng/mL) Age (yr)r = 0.332, p = 0.001 500 400 300 200100 0 50 100 150 200 250pNGAL (ng/mL) Initial eGFR (mL/min/1.73 m2)       r = -0.397, p < 0.001500400 300 200 100 0 0.4 0.6 0.8 1.0 1.2 1.4pNGAL (ng/mL) Initial creatinine (mg/dL)r = 0.336, p = 0.001 500400 300 200 100 0 2 4 6 8 10 12pNGAL (ng/mL) Initial uric acid (mg/dL)r = 0.289, p = 0.006     500400300200100 0 0 2 4 6pNGAL (ng/mL) Initial PCR (mg/g)r = 0.288, p = 0.006500400300200100 0 –6 –4 –2 0 2 4pNGAL (ng/mL) eGFR sloper = 0.032, p = 0.760 500400300200100 0 –0.05 0.00 0.05 0.10 0.15 0.20pNGAL (ng/mL) Creatinine sloper = 0.186, p = 0.077500400300200100 0 0 100 200 300 400pNGAL (ng/mL) Initial total cholesterol (mg/dL)r = 0.167, p = 0.115 Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/88/34/kjim-30-345.PMC4438289.pdf
"pNGAL as a predictor of outcome in IgAN www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.345cholesterol (r = 0.167, p = 0.115), eGFR slope (r = 0.032, p  =  0.760), and creatinine slope (r = 0.186, p = 0.077) showed  no correlation with pNGAL.",OADS,/arxiv_data1/oa_pdf/88/34/kjim-30-345.PMC4438289.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.345stitial fibrosis in renal biopsy (HR, 3.943; 95% CI, 1.132  to 13.731; p  = 0.031), documented proteinuria (> 1 g/day;  HR, 7.128; 95% CI, 1.937 to 26.232; p  = 0.003), pNGAL (HR,  1.011; 95% CI, 1.004 to 1.017; p = 0.001), and lower baseline  eGFR (HR, 0.914; 95% CI, 0.869 to 0.961; p < 0.001).",Non-OADS,/arxiv_data1/oa_pdf/88/34/kjim-30-345.PMC4438289.pdf
pNGAL as a predictor of outcome in IgAN www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.345Indications for immunosuppressive therapy are based  on the perceived risk factors for progressive kidney dis-ease.,Non-OADS,/arxiv_data1/oa_pdf/88/34/kjim-30-345.PMC4438289.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.345was significantly higher in patients with adverse renal  outcomes and showed strong correlations with tubular atrophy/interstitial fibrosis and other clinical variables.",Non-OADS,/arxiv_data1/oa_pdf/88/34/kjim-30-345.PMC4438289.pdf
pNGAL as a predictor of outcome in IgAN www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.34517.,OADS,/arxiv_data1/oa_pdf/88/34/kjim-30-345.PMC4438289.pdf
"ORIGINAL ARTICLE Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:354-361 http://dx.doi.org/10.3904/kjim.2015.30.3.354INTRODUCTION Immunoglobulin A nephropathy (IgAN) is the most prevalent glomerular disease in most countries, and  shows a diverse clinical course.",Non-OADS,/arxiv_data1/oa_pdf/57/a9/kjim-30-354.PMC4438290.pdf
"NGAL and the prognosis of IgAN www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.354renal disease (ESRD) 20 years after diagnosis, and an ad- ditional 20% will have progressive impairment of renal function [1].",Non-OADS,/arxiv_data1/oa_pdf/57/a9/kjim-30-354.PMC4438290.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.354Definition of serum and urine NGAL levels High serum NGAL was defined as a level > 150 ng/mL, in  accordance with the reference value of serum NGAL at our clinic.",Non-OADS,/arxiv_data1/oa_pdf/57/a9/kjim-30-354.PMC4438290.pdf
"NGAL and the prognosis of IgAN www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.354rum albumin (r  = –0.243, p = 0.007), but not with baseline  eGFR.",OADS,/arxiv_data1/oa_pdf/57/a9/kjim-30-354.PMC4438290.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.354rum albumin (hazard ratio [HR], 0.32; 95% confidence  interval [CI], 0.12 to 0.86; p  = 0.024), the high NGAL group  (HR, 1.72; 95% CI, 1.25 to 17.79; p  = 0.022) and T2 lesions  (HR, 9.71; 95% CI, 2.30 to 40.96; p  = 0.002) were associated  with renal progression.",Non-OADS,/arxiv_data1/oa_pdf/57/a9/kjim-30-354.PMC4438290.pdf
NGAL and the prognosis of IgAN www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.354tients in the high NGAL group comprised 14.0% of the  cohort.,OADS,/arxiv_data1/oa_pdf/57/a9/kjim-30-354.PMC4438290.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.354renal dysfunction at presentation has consistently been  related to the risk of ESRD.",Non-OADS,/arxiv_data1/oa_pdf/57/a9/kjim-30-354.PMC4438290.pdf
NGAL and the prognosis of IgAN www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.354study.,OADS,/arxiv_data1/oa_pdf/57/a9/kjim-30-354.PMC4438290.pdf
"ORIGINAL ARTICLE Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:362-371 http://dx.doi.org/10.3904/kjim.2015.30.3.362INTRODUCTION Despite recent advances in the treatment of non-Hod-gkin’s lymphoma (NHL), some patients with advanced  stage diffuse large B-cell lymphoma (DLBCL) are not cured by conventional chemotherapy alone, resulting in Department of Hematology,  Catholic Blood and Marrow Transplantation Center, Seoul St. Mary’s Hospital, College of  Medicine, The Catholic University  of Korea, Seoul, Korea Received : April 20 , 201 4 Revised : May 22, 2014 Accepted : July 8, 2014 Correspondence to Seok-Goo Cho, M.D.",Non-OADS,/arxiv_data1/oa_pdf/bf/5f/kjim-30-362.PMC4438291.pdf
Frontline autologous-HSCT for high-risk DLBCL www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.362poor survival outcomes.,Non-OADS,/arxiv_data1/oa_pdf/bf/5f/kjim-30-362.PMC4438291.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.362a reduction of at least 50% in the sum of the products of  the dimensions on CT with positive FDG-PET without a newly developed lesion.",Non-OADS,/arxiv_data1/oa_pdf/bf/5f/kjim-30-362.PMC4438291.pdf
Frontline autologous-HSCT for high-risk DLBCL www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.362and Wilcoxon rank-sum test.,OADS,/arxiv_data1/oa_pdf/bf/5f/kjim-30-362.PMC4438291.pdf
"All of the statistical analyses were performed using SAS version 9.2 (SAS Institute Inc., Cary, NC, USA) and R software version 2.15.1 (The R Foundation for Statistical Computing, 2012; http://www.r-project.org/).",OADS,/arxiv_data1/oa_pdf/bf/5f/kjim-30-362.PMC4438291.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.362frontline auto-HSCT showed 3-year OS and PFS rates of  75% and 66%, respectively, whereas the R-CHOP alone group showed 3-year OS and PFS rates of 49% and 39%, respectively.",OADS,/arxiv_data1/oa_pdf/bf/5f/kjim-30-362.PMC4438291.pdf
Frontline autologous-HSCT for high-risk DLBCL www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.362motherapy.,Non-OADS,/arxiv_data1/oa_pdf/bf/5f/kjim-30-362.PMC4438291.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.362auto-HSCT group compared to 78% in the chemother- apy alone group; the difference not statistically signifi-cant between the two treatment arms (p = 0.556) [9].",Non-OADS,/arxiv_data1/oa_pdf/bf/5f/kjim-30-362.PMC4438291.pdf
"Frontline autologous-HSCT for high-risk DLBCL www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.362study showed that only FDG-PET was significantly pre- dictive of survival outcome, and another showed that both aaIPI and FDG-PET were independent predic-tors of failure-free survival [30,31].",OADS,/arxiv_data1/oa_pdf/bf/5f/kjim-30-362.PMC4438291.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.3625.",Non-OADS,/arxiv_data1/oa_pdf/bf/5f/kjim-30-362.PMC4438291.pdf
Frontline autologous-HSCT for high-risk DLBCL www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.362sive toxicity of once daily i.v.,Non-OADS,/arxiv_data1/oa_pdf/bf/5f/kjim-30-362.PMC4438291.pdf
"ORIGINAL ARTICLE Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:372-383 http://dx.doi.org/10.3904/kjim.2015.30.3.372INTRODUCTION The proportion of people age 65 and older is expected  to increase in the Republic of Korea (ROK), and the in-creasing proportion of elderly persons will have a great impact on the healthcare system.",Non-OADS,/arxiv_data1/oa_pdf/7e/f8/kjim-30-372.PMC4438292.pdf
Elderly and non-elderly women with APN www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.372decreased immune and physiologic functions can make  the elderly susceptible to UTIs.,Non-OADS,/arxiv_data1/oa_pdf/7e/f8/kjim-30-372.PMC4438292.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.372ic characteristics, medical history, underlying diseases,  urinary tract symptoms, physical examination findings, laboratory findings, the duration of antibiotic therapy, microbiological data, defervescent time, duration of hospital stay, and mortality by reviewing the electron-ic medical records of the study participants.",Non-OADS,/arxiv_data1/oa_pdf/7e/f8/kjim-30-372.PMC4438292.pdf
"Elderly and non-elderly women with APN www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.372comorbid conditions, and laboratory findings in the el- derly and non-elderly groups.",Non-OADS,/arxiv_data1/oa_pdf/7e/f8/kjim-30-372.PMC4438292.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.372Table 1.",Non-OADS,/arxiv_data1/oa_pdf/7e/f8/kjim-30-372.PMC4438292.pdf
"Elderly and non-elderly women with APN www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.372versus 95.8% (662/691) at 120 hours after the initial an- timicrobial agents were started in the elderly versus non-elderly groups, respectively, and these differences were not significantly different between the two groups (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/7e/f8/kjim-30-372.PMC4438292.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.372the EOT in the ESBL-positive group were significant- ly lower than those in the ESBL-negative group (92.5% [62/67] vs. 98.1% [795/810], p = 0.005; and 77.8% [42/54] vs.  91.6% [457/499], p = 0.001).Clinical significance and risk factors of early clinical  failure in women with APN  We classified the women with APN into two groups: the  early clinical success group (939 patients, 82.8%) and the early failure group (195 patients, 17.2%) according to the presence of defervescence after 72 hours of antimicro-Table 3.",Non-OADS,/arxiv_data1/oa_pdf/7e/f8/kjim-30-372.PMC4438292.pdf
Elderly and non-elderly women with APN www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.372bial therapy.,Non-OADS,/arxiv_data1/oa_pdf/7e/f8/kjim-30-372.PMC4438292.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.372also significantly lower in the early clinical success  group.",Non-OADS,/arxiv_data1/oa_pdf/7e/f8/kjim-30-372.PMC4438292.pdf
Elderly and non-elderly women with APN www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.372early clinical success and early clinical failure groups.,Non-OADS,/arxiv_data1/oa_pdf/7e/f8/kjim-30-372.PMC4438292.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.372While diabetes mellitus has been shown to be an inde- pendent predictor of longer hospitalizations in a previ- ous study [19], diabetes mellitus was not an independent risk factor contributing to longer hospitalization (≥  10  days) in the elderly in this study.",Non-OADS,/arxiv_data1/oa_pdf/7e/f8/kjim-30-372.PMC4438292.pdf
Elderly and non-elderly women with APN www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.372ment of complicated urinary tract infection.,Non-OADS,/arxiv_data1/oa_pdf/7e/f8/kjim-30-372.PMC4438292.pdf
"ORIGINAL ARTICLE Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:384-390 http://dx.doi.org/10.3904/kjim.2015.30.3.384INTRODUCTION Rheumatoid arthritis (RA) is a chronic, progressive auto - immune disease characterized by joint pain, joint swell - ing, fatigue, sleep disturbance, and functional disability  [1-3].",Non-OADS,/arxiv_data1/oa_pdf/da/cd/kjim-30-384.PMC4438293.pdf
Sleep quality in rheumatoid arthritis www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.384between disease activity and sleep quality [6].,Non-OADS,/arxiv_data1/oa_pdf/da/cd/kjim-30-384.PMC4438293.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.384for qualitative variables to compare RA patients with  healthy controls.",Non-OADS,/arxiv_data1/oa_pdf/da/cd/kjim-30-384.PMC4438293.pdf
"Sleep quality in rheumatoid arthritis www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.384variables except pain VAS, BDI-II, and PSQI (data not  shown).",Non-OADS,/arxiv_data1/oa_pdf/da/cd/kjim-30-384.PMC4438293.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.384DISCUSSION Similar to Western populations, the prevalence of in - somnia disorder is 5% in the general population of  South Korea [18].",Non-OADS,/arxiv_data1/oa_pdf/da/cd/kjim-30-384.PMC4438293.pdf
Sleep quality in rheumatoid arthritis www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.384ed from the use of different questionnaires [13].,Non-OADS,/arxiv_data1/oa_pdf/da/cd/kjim-30-384.PMC4438293.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.38412.",Non-OADS,/arxiv_data1/oa_pdf/da/cd/kjim-30-384.PMC4438293.pdf
"ORIGINAL ARTICLE Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:391-397 http://dx.doi.org/10.3904/kjim.2015.30.3.391INTRO duCTION Ankylosing spondylitis (AS) is a common chronic in- flammatory rheumatic disease that mainly affects the spine and sacroiliac (SI) joints [1].",Non-OADS,/arxiv_data1/oa_pdf/c2/5b/kjim-30-391.PMC4438294.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.391The emphasis in AS management is on early diagnosis  and prevention of bony ankylosis.",Non-OADS,/arxiv_data1/oa_pdf/c2/5b/kjim-30-391.PMC4438294.pdf
Predictive factors of progression in AS www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.391REsuLT s  Patients had a mean disease duration of 9.25 ± 4.3 years.,Non-OADS,/arxiv_data1/oa_pdf/c2/5b/kjim-30-391.PMC4438294.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.391AS is highly variable and unpredictable.",OADS,/arxiv_data1/oa_pdf/c2/5b/kjim-30-391.PMC4438294.pdf
"Predictive factors of progression in AS www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.391ous studies, which have shown that both acute-phase  reactants and Bath AS Disease Activity Index scores are higher in patients with peripheral joint involvement than in patients with purely axial disease [4,12-14].",Non-OADS,/arxiv_data1/oa_pdf/c2/5b/kjim-30-391.PMC4438294.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.391This study suggests that hip arthritis at the time of  diagnosis is a useful clinical predictor of radiographic  progression in the SI and hip joints.",Non-OADS,/arxiv_data1/oa_pdf/c2/5b/kjim-30-391.PMC4438294.pdf
Predictive factors of progression in AS www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.391patients with peripheral joint disease (PJD) have less se - vere spinal disease course than those without PJD.,Non-OADS,/arxiv_data1/oa_pdf/c2/5b/kjim-30-391.PMC4438294.pdf
"LETTER TO THE EDITOR Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:398-401 http://dx.doi.org/10.3904/kjim.2015.30.3.398Departments of 1Internal Medicine  and 2Pathology, Korea University  Guro Hospital, Seoul, KoreaPancreatic mucinous cystadenoma of borderline  malignancy associated with Clonorchis sinensis Jong Hwan Choi1, Ji Hoon Kim1, Chung Ho Kim1, Young Kul Jung1, Jong Eun Yeon1, Kwan Soo Byun1,  and Insun Kim2 Received : October 22, 2008 Revised : December 4, 2008 Accepted : December 22, 2008 Correspondence to Ji Hoon Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/d1/e6/kjim-30-398.PMC4438295.pdf
Pancreatic mucinous cystadenoma associated with clonorchiasis399 www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.3981 month.,Non-OADS,/arxiv_data1/oa_pdf/d1/e6/kjim-30-398.PMC4438295.pdf
"3, May 2015400 www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.398enhancement in the posterior wall of the distal rectum.",Non-OADS,/arxiv_data1/oa_pdf/d1/e6/kjim-30-398.PMC4438295.pdf
Pancreatic mucinous cystadenoma associated with clonorchiasis401 www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.398back-current of bile into the pancreatic duct [5].,Non-OADS,/arxiv_data1/oa_pdf/d1/e6/kjim-30-398.PMC4438295.pdf
"LETTER TO THE EDITOR Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:402-405 http://dx.doi.org/10.3904/kjim.2015.30.3.4021Department of Internal Medicine,  Seoul National University Hospital,  Seoul; 2Department of Pathology,  Seoul National University College of  Medicine, Seoul; 3Research Institute  of Salt and Health, Seoul K-Clinic,  Seoul, KoreaCutaneous vasculitis and renal involvement in Mycoplasma pneumoniae  infection Hajeong Lee1, Kyung Chul Moon2, and Suhnggwon Kim3 Received : January 13, 2009 Revised : April 6, 2009 Accepted : May 29, 2009 Correspondence toSuhnggwon Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/58/14/kjim-30-402.PMC4438296.pdf
"403 www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.402Lee H, et al.",OADS,/arxiv_data1/oa_pdf/58/14/kjim-30-402.PMC4438296.pdf
404 www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.402The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/58/14/kjim-30-402.PMC4438296.pdf
"405 www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.402Lee H, et al.",OADS,/arxiv_data1/oa_pdf/58/14/kjim-30-402.PMC4438296.pdf
"LETTER TO THE EDITOR Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:406-410 http://dx.doi.org/10.3904/kjim.2015.30.3.4061Department of Internal Medicine,  2Divison of Nephrology, Department  of Internal Medicine, College of  Medicine, The Catholic University of Korea, Seoul, KoreaHenoch-Schönlein purpura secondary to infective endocarditis in a patient with pulmonary valve stenosis and a ventricular septal defect Sung Eun Ha1, Tae Hyun Ban1, Sung Min Jung1, Kang Nam Bae1, Byung Ha Chung2, Cheol Whee Park2,  and Bum-Soon Choi2 Received : October 2, 2014 Revised : October 6, 2014 Accepted : October 13, 2014 Correspondence toBum-Soon Choi, M.D.",Non-OADS,/arxiv_data1/oa_pdf/34/24/kjim-30-406.PMC4438297.pdf
"HSP secondary to IE with PV and VSD407 www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.406immunoglobulins, and urine chemistry.",OADS,/arxiv_data1/oa_pdf/34/24/kjim-30-406.PMC4438297.pdf
"3, May 2015408 www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.406tricuspid valve, suggesting a perimembranous ventric - ular septal defect (VSD) (defect size, 4.1 mm).",Non-OADS,/arxiv_data1/oa_pdf/34/24/kjim-30-406.PMC4438297.pdf
HSP secondary to IE with PV and VSD409 www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.406infective endocarditis.,Non-OADS,/arxiv_data1/oa_pdf/34/24/kjim-30-406.PMC4438297.pdf
"3, May 2015410 www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.4063.",Non-OADS,/arxiv_data1/oa_pdf/34/24/kjim-30-406.PMC4438297.pdf
"LETTER TO THE EDITOR Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:411-414 http://dx.doi.org/10.3904/kjim.2015.30.3.411Department of Internal Medicine,  Uijeongbu St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, KoreaTriple-negative breast cancer that progressed as estrogen receptor-positive skin metastases Sang Min Lee, Eun Jin Kang, Ju Hee Kim, Jong Min Yun, Der Sheng Sun, Yoon Ho Ko,    and Hye Sung Won Received : December 18, 2013 Revised : April 23, 2014 Accepted : November 3, 2014 Correspondence toHye Sung Won, M.D.",Non-OADS,/arxiv_data1/oa_pdf/15/fe/kjim-30-411.PMC4438298.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.411chemotherapy with docetaxel and epirubicin, and ad - juvant radiotherapy of the right chest wall and regional  lymphatics.",Non-OADS,/arxiv_data1/oa_pdf/15/fe/kjim-30-411.PMC4438298.pdf
"ER-positive skin metastases from TNBC www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.411PR, or HER2; it accounts for 15% to 20% of all breast  cancers.",Non-OADS,/arxiv_data1/oa_pdf/15/fe/kjim-30-411.PMC4438298.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.411a switch in tumor biology during progression [1,2].",Non-OADS,/arxiv_data1/oa_pdf/15/fe/kjim-30-411.PMC4438298.pdf
"LETTER TO THE EDITOR Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:415-417 http://dx.doi.org/10.3904/kjim.2015.30.3.415Department of Internal Medicine,  College of Medicine, The Catholic University of Korea, Seoul, KoreaPolymyalgia rheumatica following paraspinal muscle inflammation and sacroiliitis Taeseok Lim, Seokyung Woo, Yoon Gwon Mun, Eunjung Yim, Jung Hee Koh, and Kyung-Su Park Received : September 9, 2014 Revised : September 23, 2014 Accepted : October 8, 2014 Correspondence to Kyung-Su Park, M.D.",Non-OADS,/arxiv_data1/oa_pdf/11/ac/kjim-30-415.PMC4438299.pdf
"3, May 2015 http://dx.doi.org/10.3904/kjim.2015.30.3.415sence of rheumatoid factor, development of subacromi - al bursitis, aggravation of lower back stiffness and pain  despite improvement of the initial inflammation on MRI, and the absence of other joint involvement sug - gested the possibility of PMR [2] and we added pred - nisolone 15 mg.",Non-OADS,/arxiv_data1/oa_pdf/11/ac/kjim-30-415.PMC4438299.pdf
Polymyalgia rheumatica www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.3.415the sacroiliac joint.,Non-OADS,/arxiv_data1/oa_pdf/11/ac/kjim-30-415.PMC4438299.pdf
"Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org IMAGE OF INTERESTKorean J Intern Med 2015;30:418-419http://dx.doi.org/10.3904/kjim.2015.30.3.418A 49-year-old male with a 10-year his - tory of Behcet’s disease (BD) presented  with sudden visual field defects in both eyes the first occurred when walking.",Non-OADS,/arxiv_data1/oa_pdf/4a/41/kjim-30-418.PMC4438300.pdf
Homonymous hemianopia in BD http://dx.doi.org/10.3904/kjim.2015.30.3.418inflammation.,Non-OADS,/arxiv_data1/oa_pdf/4a/41/kjim-30-418.PMC4438300.pdf
"Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org IMAGE OF INTERESTKorean J Intern Med 2015;30:420http://dx.doi.org/10.3904/kjim.2015.30.3.420A 72-year-old female bladder cancer  patient presented with a history of ileal conduit urinary diversion; a urethral bal - loon catheter was inserted to control her urinary tract stoma.",Non-OADS,/arxiv_data1/oa_pdf/41/d6/kjim-30-420.PMC4438301.pdf
"Erratum Korean J Intern Med 2015;30:421 http://dx.doi.org/10.3904/kjim.2015.30.3.421Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/0b/kjim-30-421.PMC4438302.pdf
"pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:267-268 http://dx.doi.org/10.3904/kjim.2015.30.2.267 In the article cited above, upper part page in title page has an error.",Non-OADS,/arxiv_data1/oa_pdf/5a/0b/kjim-30-421.PMC4438302.pdf
"In addition, bacterial communities of seep sites were analyzedby 454 MPTS of the V4–V6 region of the 16 S rRNA gene (10-cm sediment depth) from the same DNA extracts, using the 518 F and 1064R primers, and following the protocols published on http://vamps.mbl.edu.",OADS,/arxiv_data1/oa_pdf/39/27/ismej2014217a.PMC4438319.pdf
"ARISA peaks were binned (2-bp bin size; Interactive Binner function, http://www.ecology-research.com; Ramette, 2009),and ARISA PCR triplicates were merged into a consensus profile by keeping only operational taxonomic units (OTU) that appeared in at least two of the PCR replicates and by averaging thecorresponding relative peak intensities.",OADS,/arxiv_data1/oa_pdf/39/27/ismej2014217a.PMC4438319.pdf
R package version 2.0-2. http://CRAN.R-project.org/package=vegan.,Non-OADS,/arxiv_data1/oa_pdf/39/27/ismej2014217a.PMC4438319.pdf
R package version 1.6-1. http://CRAN.R-project.org/package=labdsv.,Non-OADS,/arxiv_data1/oa_pdf/39/27/ismej2014217a.PMC4438319.pdf
http://www.isa.org.jm/ files/documents/EN/Pub s/TS9/index.html#/.,OADS,/arxiv_data1/oa_pdf/39/27/ismej2014217a.PMC4438319.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on The ISME Journal website (http://www.nature.com/ismej)Bacterial diversity at cold seeps P Pop Ristova et al 1318 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/39/27/ismej2014217a.PMC4438319.pdf
454 sequences have been submitted to theEuropean Nucleotide Archive (ENA) database(http://www.ebi.ac.uk/ena; study accession number ERP008543).,OADS,/arxiv_data1/oa_pdf/dd/f4/ismej2014221a.PMC4438323.pdf
", 2009) and 72 513 from CCMP1516 down- loaded from http://genomeportal.jgi.doe.gov) were represented by 84 881 60-mer probes (2–3 probes/ cluster) on 105K microarrays (Amadid: 022065) fortwo-color (Cy3 and Cy5) competitive array hybridi- zations (Agilent, Santa Clara, CA, USA).",OADS,/arxiv_data1/oa_pdf/dd/f4/ismej2014221a.PMC4438323.pdf
MODIS/Aqua satellite 2002–presentlevel 3 data were downloaded from the Goddard Space Flight Center Ocean Biology Processing Group’s OceanColor website (http://oceancolor.gsfc.-nasa.gov) and ocean water depth from the ETOPO5digital elevation database available at http:// www.ngdc.noaa.gov/mgg/global/relief/ETOPO5.,OADS,/arxiv_data1/oa_pdf/dd/f4/ismej2014221a.PMC4438323.pdf
"Only parts of each scaffold are indicated (numbers indicate nucleotide positions in the JGI assembly), yet the entire Scaffold_529 was identified by JGI as a ‘diploid allele’ of Scaffold_68 (http://genome.jgi.doe.gov and Read et al.",OADS,/arxiv_data1/oa_pdf/dd/f4/ismej2014221a.PMC4438323.pdf
Most of the DHC loci in the JGI genome assembly of CCMP1516 occurred on pairs of highly homologous and syntenic scaffolds that JGI identi-fied as probably representing alternate structures of homologous chromosome pairs (‘diploid alleles’ in the terminology on the JGI genome portal at http://genome.jgi.doe.gov/).,OADS,/arxiv_data1/oa_pdf/dd/f4/ismej2014221a.PMC4438323.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on The ISME Journal website (http://www.nature.com/ismej)Life cycle and genome evolution in Emiliania P von Dassow et al 1377 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/dd/f4/ismej2014221a.PMC4438323.pdf
"For example, the Fungenedatabase (http://fungene.cme.msu.edu/index.spr) (Fish et al., 2013) has over 500 sequences with 499% identity to intI1 .T h e s ea r em o s t l yf r o m clinical isolates, although a few are from environ- mental strains.Using intI1 gene as a proxy for anthropogenic pollution MR Gillings et al 1272 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/5f/25/ismej2014226a.PMC4438328.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on The ISME Journal website (http://www.nature.com/ismej)Using intI1 gene as a proxy for anthropogenic pollution MR Gillings et al 1279 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/5f/25/ismej2014226a.PMC4438328.pdf
"http://informahealthcare.com/dep ISSN: 0968-7637 (print), 1465-3370 (electronic) Drugs Educ Prev Pol, 2015; 22(1): 66–76 !2015 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/aa/c7/cdep22_66.PMC4438351.pdf
"Since 2005, its UK-licence has permitted naloxone to be administered by anyone in anemergency to save the person’s life for whom naloxone wasprescribed (Strang, Kelleher, Best, Mayet, & Manning, 2006).As of 2011, under new guidelines on immunity-for-prescriber-and-authorised-persons from Scotland’s Lord Advocate,naloxone can also be administered in Scotland by authorisedpersons, namely: those who come in contact with vulnerableThis is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License(http://creativecommons.org/licenses/by-nc-nd/4.0/), which permitsnon-commercial re-use, distribution, and reproduction in any medium,provided the original work is properly cited, and is not altered,transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/aa/c7/cdep22_66.PMC4438351.pdf
Retrieved from http://forthvalleysat.co.uk/v2/index2.php?,Non-OADS,/arxiv_data1/oa_pdf/aa/c7/cdep22_66.PMC4438351.pdf
"Welsh Assembly Government Social Research, Retrieved from http://wales.gov.uk/about/aboutresearch/ social/latestresearch/naloxoneproject/;jsessionid ¼c1bTTNVQlhfz 0b29xxcqT1mDR9hTdT1hQmjghYm6LN4ynxv7CTnR!-505488680?lang ¼en.",Non-OADS,/arxiv_data1/oa_pdf/aa/c7/cdep22_66.PMC4438351.pdf
Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6106a1.htm?s_cid¼mm6106a1_e.,OADS,/arxiv_data1/oa_pdf/aa/c7/cdep22_66.PMC4438351.pdf
Retrieved from http://www.scotland.gov.uk/ News/Releases/2010/08/17095105.,Non-OADS,/arxiv_data1/oa_pdf/aa/c7/cdep22_66.PMC4438351.pdf
Retrieved from http://www.dailyre-cord.co.uk/news/scottish-news/daily-record-methadone-campaign- 1304584.,Non-OADS,/arxiv_data1/oa_pdf/aa/c7/cdep22_66.PMC4438351.pdf
Retrieved from http://www.isdscotland.org/Health-Topics/ Drugs-and-Alcohol-Misuse/Publications/2012-07-31/2012-07-31- naloxone-monitoring-report.pdf?,Non-OADS,/arxiv_data1/oa_pdf/aa/c7/cdep22_66.PMC4438351.pdf
Retrieved from https://isdscotland.scot.nhs.uk/Health-Topics/Drugs-and-Alcohol-Misuse/Publications/2013-07-30/2013-07-30-naloxone- report.pdf?30587404967.,Non-OADS,/arxiv_data1/oa_pdf/aa/c7/cdep22_66.PMC4438351.pdf
Retrieved from https://isdscotland.scot.nhs.uk/Health-Topics/Drugs- and-Alcohol-Misuse/Publications/.,Non-OADS,/arxiv_data1/oa_pdf/aa/c7/cdep22_66.PMC4438351.pdf
Retrieved from http://www.nta.nhs.uk/uploads/appendices-final.pdf and http://www.nta.nhs.uk/news-2011-naloxone-report.aspx.,Non-OADS,/arxiv_data1/oa_pdf/aa/c7/cdep22_66.PMC4438351.pdf
"*See http://www.ons.gov.uk/ons/rel/pop-estimate/population-estimates-for-uk–england-and-wales–scotland-and-northern-ireland/mid- 2011-and-mid-2012/stb—mid-2011—mid-2012-uk-population- estimates.html Link to latest data for 2011 and 2012, which were provided in early September 2014 at our request: www.ons.gov.uk/ons/about-ons/business-transpar ency/freedom-of-information/what-can-i-request/published- ad-hoc-data/health/september-2014/index.html **See https://www.rss.org.uk/site/cms/newsarticle.asp?chapter ¼15&nid ¼7976 S. M. Bird et al.",Non-OADS,/arxiv_data1/oa_pdf/aa/c7/cdep22_66.PMC4438351.pdf
"http://informahealthcare.com/dep ISSN: 0968-7637 (print), 1465-3370 (electronic) Drugs Educ Prev Pol, 2015; 22(2): 125–134 !2014 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/6f/87/cdep22_125.PMC4438355.pdf
"Furthermore,the mass media do not just act as a conduit to policy actors, This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License(http://creativecommons.org/licenses/by-nc-nd/4.0/), which permitsnon-commercial re-use, distribution, and reproduction in any medium,provided the original work is properly cited, and is not altered,transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/6f/87/cdep22_125.PMC4438355.pdf
"http://informahealthcare.com/dep ISSN: 0968-7637 (print), 1465-3370 (electronic) Drugs Educ Prev Pol, 2015; 22(2): 143–149 !2014 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/90/87/cdep22_143.PMC4438356.pdf
"Other academic work has drawn attention to ways in This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License(http://creativecommons.org/licenses/by-nc-nd/4.0/), which permitsnon-commercial re-use, distribution, and reproduction in any medium,provided the original work is properly cited, and is not altered,transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/90/87/cdep22_143.PMC4438356.pdf
Government’s response to the alcohol strategy consultation Retrieved from https://www.gov.uk/government/ speeches/governments-response-to-the-alcohol-strategy-consultation.,Non-OADS,/arxiv_data1/oa_pdf/90/87/cdep22_143.PMC4438356.pdf
Retrieved from http://www.homeoffice.gov.uk/drugs/alcohol/drinking-banning-orders/.,Non-OADS,/arxiv_data1/oa_pdf/90/87/cdep22_143.PMC4438356.pdf
Retrieved from http://www.alcoholstakeholders.nh- s.uk/pdf/Newsletter.pdf.,Non-OADS,/arxiv_data1/oa_pdf/90/87/cdep22_143.PMC4438356.pdf
Retrieved from http://www.telegraph.co.uk/news/politics/david-cameron/9746352/Families-like-mine-pay-more-for-food-to-subsid-ise-binge-drinking-says-David-Cameron.html.,Non-OADS,/arxiv_data1/oa_pdf/90/87/cdep22_143.PMC4438356.pdf
Retrieved from http://www.jsad.com/jsad/static/binge.html.,OADS,/arxiv_data1/oa_pdf/90/87/cdep22_143.PMC4438356.pdf
Retrieved from http://www.alcoholstakeholders.nhs.uk/media/ Alcohol_Harm_Reduction_Girl.mpg.,Non-OADS,/arxiv_data1/oa_pdf/90/87/cdep22_143.PMC4438356.pdf
Retrieved from http://www.alcoholstakeholders.nhs.uk/media/ Alcohol_Harm_Reduction_Boy.mpg.,Non-OADS,/arxiv_data1/oa_pdf/90/87/cdep22_143.PMC4438356.pdf
Retrieved from http://www.socre- sonline.org.uk/14/2/6.html.,Non-OADS,/arxiv_data1/oa_pdf/90/87/cdep22_143.PMC4438356.pdf
"UNAIDS Report on the global AIDS epidemic 2012 (November 2012) http://www.unaids.org/en/ (7 December 2012, date last accessed) 12.",Non-OADS,/arxiv_data1/oa_pdf/34/93/sft128.PMC4438376.pdf
"Th  is is an Open Access article distributed under the terms of the Creative Commons Attribution- NonCommercial-NoDerivs License (http://creativecommons.org/lic enses/by-nc-nd/4.0/), which permits non-commercial re-use, distri bution, and  reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any  way.",Non-OADS,/arxiv_data1/oa_pdf/47/63/sann47_150.PMC4438385.pdf
"[Internet] Madrid, ac- cessed June 20th, 2013 in http://www.msc.es/profesionales/ formacion/docs/progNefrologia.pdf 7.",Non-OADS,/arxiv_data1/oa_pdf/09/de/sft080.PMC4438395.pdf
"Fisher ’s exact test for independence was used to test whether the proportion of anti-Xa activities within the reference range varied across guideline adherence, since six cells (67%) had an expected frequency of <5 ( http://in-silico.net/tools/ statistics/ ﬁsher_exact_test , consulted on 15 May 2013).",OADS,/arxiv_data1/oa_pdf/13/4c/sft083.PMC4438398.pdf
"2009. http://www.ema.europa.eu/docs/ en_GB/document_library/Presentation/2009/11/ WC500011064.pdf (22 May 2013, date last accessed) 17.",Non-OADS,/arxiv_data1/oa_pdf/8b/dc/sft085.PMC4438400.pdf
Supplementary data Supplementary data is available online at http://ndt.ox- fordjournals.org.,OADS,/arxiv_data1/oa_pdf/d3/3e/sft093.PMC4438407.pdf
The process for potassium is similar (obtained from https://en.wikipedia.org/wiki/Polystyrene_sulfonate ).,Non-OADS,/arxiv_data1/oa_pdf/33/df/sft108.PMC4438418.pdf
"Again, PubMed was not helpful, but an Internet website was informative (http://clinicaltrials.gov/ct2/show/NCT01737697?term=hy perkalemia&rank=4 ).",Non-OADS,/arxiv_data1/oa_pdf/33/df/sft108.PMC4438418.pdf
"Published by Oxford University Press on behalf of CINP.International Journal of Neuropsychopharmacology, 2015, 1–9 doi:10.1093/ijnp/pyu058 Research Article 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9b/f0/pyu058.PMC4438538.pdf
"Briefly,  the brain tissue was extracted using the brain extraction tool (BET) and, subsequently, segmentation into white matter (WM), gray mat-ter (GM) and cerebrospinal fluid (CSF) was achieved using the auto-mated brain segmentation tool FAST (Zhang et al., 2001); both BET and FAST are part of the FSL suite (http://www.fmrib.ox.ac.uk/fsl).",OADS,/arxiv_data1/oa_pdf/9b/f0/pyu058.PMC4438538.pdf
"Published by Oxford University Press on behalf of CINP.International Journal of Neuropsychopharmacology, 2015, 1–8 doi:10.1093/ijnp/pyu089 Research Article 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/39/9a/pyu089.PMC4438539.pdf
"The 24th hour postfertiliza- tion represents the end of the segmentation and the begin-ning of the pharyngula stage of zebrafish development, which corresponds approximately to the late first trimester or early second trimester of human fetal development (Kimmel et al., 1995; also see http://zfin.org/zf_info/zfbook/stages/ and http://www.ehd.org/virtual-human-embryo/).",Non-OADS,/arxiv_data1/oa_pdf/39/9a/pyu089.PMC4438539.pdf
"Published by Oxford University Press on behalf of CINP.International Journal of Neuropsychopharmacology, 2015, 1–9 doi:10.1093/ijnp/pyu094 Research Article 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/49/07/pyu094.PMC4438540.pdf
"Published by Oxford University Press on behalf of CINP.International Journal of Neuropsychopharmacology, 2015, 1–13 doi:10.1093/ijnp/pyu096 Research Article 1 Copyedited by: OUP This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/60/cb/pyu096.PMC4438541.pdf
"Received: June 8, 2014; Revised: November 13, 2014; Accepted: November 14, 2014International Journal of Neuropsychopharmacology, 2015, 1–17 doi:10.1093/ijnp/pyu097 Research Article 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/1b/pyu097.PMC4438542.pdf
"Published by Oxford University Press on behalf of CINP.International Journal of Neuropsychopharmacology, 2015, 1–11 doi:10.1093/ijnp/pyu103 Research Article 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/ac/pyu103.PMC4438545.pdf
"Immunoblot band intensity was quantified with ImageJ Analysis Software (National Institutes of Health, http://imagej.nih.gov/ij).",OADS,/arxiv_data1/oa_pdf/50/ac/pyu103.PMC4438545.pdf
"Published by Oxford University Press on behalf of CINP.International Journal of Neuropsychopharmacology, 2015, 1–14 doi:10.1093/ijnp/pyu105 Research Article 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/12/b1/pyu105.PMC4438546.pdf
"For a certif-icate, please see: http://www.textcheck.com/certificate/T0FYvX.",Non-OADS,/arxiv_data1/oa_pdf/12/b1/pyu105.PMC4438546.pdf
"Published by Oxford University Press on behalf of CINP.International Journal of Neuropsychopharmacology, 2015, 1–9 doi:10.1093/ijnp/pyu106 Research Article 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/1d/pyu106.PMC4438547.pdf
Retrieved 16 Oct 2014. http://www.unodc.org/docu-ments/ATS/ATS_Global_Assessment_2011.pdf.,OADS,/arxiv_data1/oa_pdf/6f/1d/pyu106.PMC4438547.pdf
"Published by Oxford University Press on behalf of CINP.International Journal of Neuropsychopharmacology, 2015, 1–9 doi:10.1093/ijnp/pyu113 Research Article 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/d0/pyu113.PMC4438551.pdf
"Published by Oxford University Press on behalf of CINP.International Journal of Neuropsychopharmacology, 2015, 1–9 doi:10.1093/ijnp/pyu117 Research Article 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/d1/pyu117.PMC4438552.pdf
"Published by Oxford University Press on behalf of CINP.International Journal of Neuropsychopharmacology, 2015, 1–13 doi:10.1093/ijnp/pyv017 Research Article 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6d/59/pyv017.PMC4438553.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/15/pyv026.PMC4438555.pdf
"International Journal of Neuropsychopharmacology, 2015, 1–1 doi:10.1093/ijnp/pyv033 Erratum 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/3c/pyv033.PMC4438556.pdf
"2009 ), cyanase is nearly ubiqui- tous in the Basidiomycota, the Ascomycota (other than the yeasts, where it is absent), as well as in other fungal phyla(http://supfam.cs.bris.ac.uk/SUPERFAMILY/cgi-bin/taxviz.cgi?sf= 55234 , last accessed February 23, 2014; Wilson et al.",Non-OADS,/arxiv_data1/oa_pdf/a2/06/evv025.PMC4438557.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a2/06/evv025.PMC4438557.pdf
"lycopersici 4287 (NRRL 34936) ( http://www.broadinstitute.org/ , second anno- tation, last accessed March 1, 2012), O. maius Zn version 1.0 (http://www.jgi.doe.gov/ , last updated May 24, 2011, last accessed March 1, 2012), and C. lunatus m118 version 2.0 (http://www.jgi.doe.gov/ , last updated February 13, 2012, last accessed March 1, 2012) and other Pezizomycotina cyanase sequences of EC 4.2.1.104 ( Kanehisa et al.",Non-OADS,/arxiv_data1/oa_pdf/a2/06/evv025.PMC4438557.pdf
"Identifying CCA Gene Clusters in FOSC Genomes Cluster sequences were identiﬁed in the ten FOSC genomes available through the BROAD Institute Fusarium Comparative Database ( http://www.broadinstitute.org/annotation/genome/ fusarium_group/MultiHome.html , last accessed May 30, 2012; Ma et al.",OADS,/arxiv_data1/oa_pdf/a2/06/evv025.PMC4438557.pdf
"2009 ).EF1-/C11sequences for all of the isolates included in the alignment were downloaded from theFUSARIUM-ID version 1.0 database ( http://isolate.fusar iumdb.org/ , last accessed February 23, 2015; Geiser et al.",OADS,/arxiv_data1/oa_pdf/a2/06/evv025.PMC4438557.pdf
"best ML trees were compared visually using the MirrorTree MTSERVER ( http://csbg.cnb.csic.es/mtserver/ , last accessed February 23, 2015; Ochoa and Pazos 2010) .",OADS,/arxiv_data1/oa_pdf/a2/06/evv025.PMC4438557.pdf
Available from: http://www.amvac-chemical.,Non-OADS,/arxiv_data1/oa_pdf/a2/06/evv025.PMC4438557.pdf
Available from: http://www.agrisk.umn.edu/cache/ arl01681.htm .,OADS,/arxiv_data1/oa_pdf/a2/06/evv025.PMC4438557.pdf
"This reprog-ramming of cell metabolism in breast cancer is facilitated byoncogenes and tumor suppressor genes and both catalytic and© Prachi Mishra and Stefan Ambs *Correspondence to: Stefan Ambs; Email: ambss@mail.nih.gov Submitted: 10/10/2014; Revised: 11/21/2014; Accepted: 11/24/2014http://dx.doi.org/10.4161/23723556.2014.992217 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
J Proteomics 2013; 94:279-88; PMID:24125731; http://dx.doi.org/ 10.1016/j.jprot.2013.10.002 2.,OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
J Clin Invest 2014; 124:398-412;PMID:24316975; http://dx.doi.org/10.1172/ JCI71180 3.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
PMID:25091696; http://dx.doi.org/ 10.1186/s13058-014-0415-9 4.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
PMID:25155347; http://dx.doi.org/ 10.1002/ijc.29152 5.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Nature 2011; 477:54-60; PMID:21886157; http://dx.doi.org/10.1038/nature10354 6.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Nat Genet 2014; 46:543-50; PMID:24816252; http://dx.doi.org/10.1038/ng.2982 Figure 2.,OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Breast Cancer Res 2008; 10:R106; PMID:19087284;http://dx.doi.org/10.1186/bcr2211 8.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Nat Rev Drug Discov 2011; 10:671-84; PMID:21878982; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
BMC Cancer 2010; 10:626; PMID:21078168; http://dx.doi.org/ 10.1186/1471-2407-10-626 12.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Science 2013; 342:1094-98; PMID: 24288332; http://dx.doi.org/10.1126/science.1241908 14.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Cancer Cell 2009; 15:539- 50; PMID:19477432; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Nature2011; 478:197-203; PMID:21976023; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Breast Cancer Res 2014; 16:410; PMID:25060643; http://dx.doi.org/10.1186/s13058- 014-0410-1 18.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Nature 2009; 462:739-44; PMID:19935646; http://dx.doi.org/10.1038/nature08617 19.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Cancer Cell 2010; 18:553-67;PMID:21130701; http://dx.doi.org/10.1016/j.ccr.,OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Cancer Cell 2011; 19:17-30; PMID:21251613; http://dx.doi.org/ 10.1016/j.ccr.2010.12.014 21.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Nature 2012; 483:474-78; PMID:22343901; http://dx.doi.org/10.1038/nature10860 22.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
BMC Cancer 2010; 10:433;PMID:20716336; http://dx.doi.org/10.1186/1471- 2407-10-433 23.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Cancer Res 2011; 71:3236-45; PMID:21415164; http://dx.doi.org/10.1158/0008-5472.CAN-10-3894 25.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Clin Cancer Res 2013; 19:571-85; PMID:23236214; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
BMC Genomics 2012; 13:334; PMID:22823888; http://dx.doi.org/10.1186/1471- 2164-13-334 27.,OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Science 2009; 324:1029-33; PMID:19460998; http://dx.doi.org/ 10.1126/science.1160809 28.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
J Clin Invest 2013; 123:3678-84;PMID:23999442; http://dx.doi.org/10.1172/JCI69600 29.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
MolCancer Ther 2014; 13:890-901; PMID:24523301; http://dx.doi.org/10.1158/1535-7163.MCT-13-0870 30.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Mol Cell 2011; 42:426-37; PMID:21596309; http://dx.doi.org/ 10.1016/j.molcel.2011.05.004 31.,OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
J Clin Invest 2013; 123:3685-92; PMID:23999443; http://dx.doi.org/ 10.1172/JCI69741 32.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Proc Natl Acad Sci U S A 2011; 108:19611- 16; PMID:22106302; http://dx.doi.org/10.1073/ pnas.1117773108 33.,OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Cancer Cell 2010; 18:207-19; PMID:20832749; http://dx.doi.org/10.1016/j.ccr.2010.08.009 35.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
PLoS Genet 2011; 7:e1002229; PMID:21852960; http://dx.doi.org/ 10.1371/journal.pgen.1002229 36.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Cancer Cell2013; 24:450-65; PMID:24094812; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Nat Genet 2011; 43:869-74; PMID:21804546; http://dx.doi.org/10.1038/ng.890 39.,OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Science 2012; 336:1040-44; PMID:22628656;http://dx.doi.org/10.1126/science.1218595 40.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Nature 2012; 491:458-62; PMID:23064226; http://dx.doi.org/10.1038/nature11540 41.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Nature 2013; 493:542-46;PMID:23242140; http://dx.doi.org/10.1038/nature 11743 42.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Nature 2008; 452:230-33; PMID:18337823; http://dx.doi.org/10.1038/nature06734 43.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Science 2011; 334:1278-83; PMID:22052977; http://dx.doi.org/10.1126/science.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Cell 2013; 155:397-409; PMID:24120138; http://dx.doi.org/10.1016/j.cell.2013.09.025 45.,OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Cell 2011; 145:732-44; PMID:21620138; http://dx.doi.org/10.1016/j.cell.,OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Br J Cancer 2010; 102:941-46; PMID:20234370; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Biochim Biophys Acta 2013; 1831:1566-72.; PMID:23872477; http://dx.doi.org/ 10.1016/j.bbalip.2013.07.008 49.,OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Mol Cancer Ther 2011; 10:427-36.;PMID:21282354; http://dx.doi.org/10.1158/1535- 7163.MCT-10-0802 50.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Cancer Res 2004; 64:4270-76; PMID:15205341; http://dx.doi.org/10.1158/0008-5472.CAN-03-3829 55.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
J Prote- ome Res 2012; 11:850-60; PMID:22070544; http://dx.doi.org/10.1021/pr200685r 56.,OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Cancer Res 2010; 70:5507-17; PMID:20551061; http://dx.doi.org/10.1158/0008-5472.CAN-09-4476 57.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
BMC Cancer 2012; 12:39; PMID:22277092; http://dx.doi.org/10.1186/1471-2407-12-3958.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Breast Cancer Res 2014; 16:R5; PMID:24447408; http://dx.doi.org/10.1186/bcr3597 59.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Nat Rev Cancer 2010; 10:489-503; PMID:20555359; http://dx.doi.org/10.1038/nrc2875 60.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Cancer Res 2012; 72:726-35; PMID:22298596; http://dx.doi.org/10.1158/0008- 5472.CAN-11-2167 61.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Nature 2000; 406:747-52;PMID:10963602; http://dx.doi.org/10.1038/ 35021093 62.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Nature2012; 490:61-70; PMID:23000897; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Breast Cancer Res 2010; 12:R36; PMID:20565864; http://dx.doi.org/ 10.1186/bcr2590 65.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Clin Cancer Res 2004;10:5367-74; PMID:15328174; http://dx.doi.org/ 10.1158/1078-0432.CCR-04-0220 66.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Lancet Oncol 2007; 8:235-44; PMID:17329194; http://dx.doi.org/10.1016/S1470-2045(07)70074-8 68.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Cancer Res 2010; 70:8309-18; PMID:20959483; http://dx.doi.org/10.1158/0008-5472.CAN-10-1319 69.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Isocitrate dehydrogenase 1 (IDH1) mutation in breast adenocarcinoma is associated with elevated levels of serum and urine 2-hydroxyglutarate.Oncologist 2014; 19:602-07; PMID:24760710; http://dx.doi.org/10.1634/theoncologist.2013-0417 70.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Science 2006;312:1650-53; PMID:16728594; http://dx.doi.org/ 10.1126/science.1126863 71.,OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Cell 2006; 126:107-20; PMID:16839880; http://dx.doi.org/10.1016/j.cell.2006.05.03672.,OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
EMBO J 2009; 28:3015-26; PMID:19713938; http://dx.doi.org/10.1038/emboj.2009.242 73.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Cell 2012; 148:244-58; PMID:22265415;http://dx.doi.org/10.1016/j.cell.2011.12.017 74.,OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Nat Cell Biol 2014; 16:357-66; PMID:24658687; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
PLoS ONE 2009; 4:e6772; PMID:19714244; http://dx.doi.org/10.1371/journal.pone.0006772 76.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Cell Metab 2013; 18:617-33; PMID:23954639; http://dx.doi.org/10.1016/j.cmet.,OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Clin Cancer Res 2009; 15:5049-59; PMID:19671852; http://dx.doi.org/10.1158/1078-0432.CCR-09-0632 78.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Cancer Res 2004; 64:3892-99;PMID:15172999; http://dx.doi.org/10.1158/0008- 5472.CAN-03-2904 80.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Cell 2007; 129:1261-74; PMID:17604717; http://dx.doi.org/10.1016/j.cell.,OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Cancer Cell 2006;10:269-80; PMID:17045205; http://dx.doi.org/ 10.1016/j.ccr.2006.08.022 82.,OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Cancer Cell 2009; 16:21-32; PMID:19573809; http://dx.doi.org/10.1016/j.ccr.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
PLoS ONE 2009; 4:e6693; PMID:19690609; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Mol Cell Biol2005; 25:6225-34; PMID:15988031; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Clin Cancer Res 2013;19:5835-41; PMID:23897900; http://dx.doi.org/ 10.1158/1078-0432.CCR-12-3629 87.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Nature 2013; 496:101-05; PMID:23535601;http://dx.doi.org/10.1038/nature12040 89.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Free Radic Res 2010; 44:479-96; PMID:20370557; http://dx.doi.org/10.3109/10715761003667554 90.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Nature 2012; 485:661-65; PMID:22660331; http://dx.doi.org/10.1038/nature11066 91.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Cancer Res 2012;15;72:5712-20;PMID:22986741; http://dx.doi.org/10.1158/0008- 5472.CAN-12-2215 92.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Cancer Res 2007; 67:1472-86; PMID:17308085; http://dx.doi.org/10.1158/0008- 5472.CAN-06-313793.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Cell 2001; 107:1-3; PMID:11595178; http://dx.doi.org/ 10.1016/S0092-8674(01)00518-9 94.,OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Clin Cancer Res 2013; 19:5158-69; PMID:23833310; http://dx.doi.org/ 10.1158/1078-0432.CCR-12-3300 96.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Cancer Res 2012; 72:5812-23;PMID:23139210; http://dx.doi.org/10.1158/0008- 5472.CAN-12-1098 99.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Cancer Res 2011; 71:2550-60; PMID:21300765; http://dx.doi.org/10.1158/0008-5472.CAN-10-2828100.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Br J Cancer 2010;102:1-7; PMID:19935796; http://dx.doi.org/ 10.1038/sj.bjc.6605457 101.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Mol Oncol 2013; 7:130-42; PMID:23142657;http://dx.doi.org/10.1016/j.molonc.2012.10.005 102.,OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Mol Cancer 2010; 9:33; PMID:20144215; http://dx.doi.org/10.1186/1476- 4598-9-33 103.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
Neoplasia 2014; 16:390-402; PMID:25016594; http://dx.doi.org/10.1016/j.neo.2014.05.007 104.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/kmco-02-03-992217.PMC4438683.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/57/a7/gfu401.PMC4438741.pdf
"Hospital Episode Statistics, 2014;http://www.hscic.gov.uk/hes .",Non-OADS,/arxiv_data1/oa_pdf/57/a7/gfu401.PMC4438741.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.For commercial re-use, please contact journals.permissions@oup.com1037",Non-OADS,/arxiv_data1/oa_pdf/a7/50/gfv006.PMC4438742.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/27/main.PMC4438786.pdf
E-mail address: richard.lipton@einstein.yu.edu http://dx.doi.org/10.1016/j.dadm.2014.12.002 2352-8729/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/07/27/main.PMC4438786.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/27/main.PMC4438786.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2014.12.002 .,OADS,/arxiv_data1/oa_pdf/07/27/main.PMC4438786.pdf
http://dx.doi.org/10.1053/j.ajkd.,OADS,/arxiv_data1/oa_pdf/07/27/main.PMC4438786.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/01/58/ofu120.PMC4438881.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/49/ofv003.PMC4438884.pdf
Available at: http://www.cdc.gov/parasites/ schistosomiasis/health_professionals .,Non-OADS,/arxiv_data1/oa_pdf/3f/49/ofv003.PMC4438884.pdf
Available at: http://www.cdc.gov/parasites/ strongyloides/health_professionals/ .,Non-OADS,/arxiv_data1/oa_pdf/3f/49/ofv003.PMC4438884.pdf
Available at: http://www.ibge.gov.br/english/ geociencias/geogra ﬁa/default_div_int.shtm .,Non-OADS,/arxiv_data1/oa_pdf/3f/49/ofv003.PMC4438884.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/16/ofv004.PMC4438885.pdf
"This isan Open Access article distributed under the terms of theCreative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution ofthework, in any medium, provided the original work is not alteredor transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/8d/ofv005.PMC4438886.pdf
Available at: http://www.cumc.columbia.,Non-OADS,/arxiv_data1/oa_pdf/e0/b5/ofv009.PMC4438890.pdf
"analyses were conducted using WinBUGS version 1.4 (Medical Research Council Biostatistics Unit, Cambridge, Massachu-setts), R version 3.0 ( http://www.r-project.org/ ) and Stats Direct version 9.1 ( www.statsdirect.com/ ).",OADS,/arxiv_data1/oa_pdf/46/d9/ofv010.PMC4438891.pdf
Available at: http://apps.who.int/medicine docs/documents/s18693en/s18693en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/46/d9/ofv010.PMC4438891.pdf
Available at http://www.who.int/malaria/publications/world_malaria_report_2013/ report/en .,Non-OADS,/arxiv_data1/oa_pdf/f2/b0/ofv012.PMC4438893.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/ac/ofv016.PMC4438896.pdf
Supplementary Material Supplementary material is available online at Open Forum Infectious Diseases (http://OpenForumInfectiousDiseases.oxford journals.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/21/ac/ofv016.PMC4438896.pdf
Available at: http://www.cdc.gov/hiv/topics/surveillance/resources/ reports/ .,Non-OADS,/arxiv_data1/oa_pdf/21/ac/ofv016.PMC4438896.pdf
Available at: http://projectreporter.nih.gov/ .,Non-OADS,/arxiv_data1/oa_pdf/21/ac/ofv016.PMC4438896.pdf
Available at: http://projectreporter.nih.,Non-OADS,/arxiv_data1/oa_pdf/21/ac/ofv016.PMC4438896.pdf
Available at:http://www.who.int/mediacentre/factsheets/fs164/en/ .,Non-OADS,/arxiv_data1/oa_pdf/75/db/ofv017.PMC4438897.pdf
IDU HIV Prevention 2004 .http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/75/db/ofv017.PMC4438897.pdf
Available at: http://www.sante.gouv.fr/IMG/ pdf/Rapport_Morlat_2013_Mise_en_ligne.pdf .,Non-OADS,/arxiv_data1/oa_pdf/cd/55/ofv018.PMC4438898.pdf
Avail- able at: http://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent- arv-guidelines/0/ .,Non-OADS,/arxiv_data1/oa_pdf/cd/55/ofv018.PMC4438898.pdf
Available at:http://www.hivfrenchresistance.org/2013/Algo-sep-2013.pdf .A c - cessed 14 October 2014.,Non-OADS,/arxiv_data1/oa_pdf/cd/55/ofv018.PMC4438898.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/74/ofv022.PMC4438901.pdf
Available at: http://www.cdc.gov/nhsn/PDFs/ pscManual/4PSC_CLABScurrent.pdf .,OADS,/arxiv_data1/oa_pdf/76/72/ofv023.PMC4438902.pdf
Available at: http://www.eucast.,Non-OADS,/arxiv_data1/oa_pdf/76/72/ofv023.PMC4438902.pdf
Avail- able at: http://ictvonline.org/codeOfVirusClassi ﬁcation_2012.asp .,Non-OADS,/arxiv_data1/oa_pdf/7a/14/ofv024.PMC4438903.pdf
Available at: http://emmahodcroft.com/ TreeCollapseCL.html .,Non-OADS,/arxiv_data1/oa_pdf/7a/14/ofv024.PMC4438903.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/98/ofv025.PMC4438904.pdf
"All statistical analyses were performed using Stata 12.0 (Stata Corp, College Station, TX) and R version 3.0.2 with the survival and ggplot2 ( http://cran.r-project.org/web/ packages/ggplot2/index.html )a n ds u r v i v a l( http://cran.r- project.org/web/packages/survival/index.html ) special packages.",OADS,/arxiv_data1/oa_pdf/09/90/ofv026.PMC4438905.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/47/ofv027.PMC4438906.pdf
Available at: http://www.openepi.com .,Non-OADS,/arxiv_data1/oa_pdf/56/1c/ofv028.PMC4438907.pdf
Avail- able at: http://www.who.int/tb/publications/global_report/en/ .A c - cessed 19 March 2015.,Non-OADS,/arxiv_data1/oa_pdf/cc/36/ofv030.PMC4438908.pdf
Available at: http://www.who.int/healthsystems/ TTR-TaskShifting.pdf .,Non-OADS,/arxiv_data1/oa_pdf/cc/36/ofv030.PMC4438908.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2e/57/ofv037.PMC4438909.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/38/45/ofv041.PMC4438910.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/ .,Non-OADS,/arxiv_data1/oa_pdf/4d/e3/nihms688412.PMC4438995.pdf
Data from http://clinicaltrials.gov .,OADS,/arxiv_data1/oa_pdf/4d/e3/nihms688412.PMC4438995.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Pathobiology of Aging & Age-related Diseases 2015, 5: 27743 - http://dx.doi.org/10.3402/pba.v5.27743 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/00/81/PBA-5-27743.PMC4439419.pdf
"The Rb family of proteins is also important for the induction and maintenance of senescence.Kaoru Tominaga 2 (page number not for citation purpose)Citation: Pathobiology of Aging & Age-related Diseases 2015, 5: 27743 - http://dx.doi.org/10.3402/pba.v5.27743",Non-OADS,/arxiv_data1/oa_pdf/00/81/PBA-5-27743.PMC4439419.pdf
"Cellular senescence: beneficial effects Tumor suppression Although tumor-derived or virally transformed cells proliferate indefinitely in culture, normal cells entersenescence after reaching a typical number of divisions.Genetic studies using cell fusion technology by which normal human cells were fused with various immortal cell lines demonstrated that the resulting hybrids could notRole of cellular senescence in vivo Citation: Pathobiology of Aging & Age-related Diseases 2015, 5: 27743 - http://dx.doi.org/10.3402/pba.v5.27743 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/00/81/PBA-5-27743.PMC4439419.pdf
"The clearance of senescent cells by immune cells attracted by SASP factors, which aresecreted by senescent cells, also seems to be an importantstep in halting tissue repair when the process is completed.In mice deficient in the p53/p21 or p16/Rb pathways, stellate cells continue to proliferate and do not enter senescence, and fibrosis in the liver is markedly increased.Kaoru Tominaga 4 (page number not for citation purpose)Citation: Pathobiology of Aging & Age-related Diseases 2015, 5: 27743 - http://dx.doi.org/10.3402/pba.v5.27743",Non-OADS,/arxiv_data1/oa_pdf/00/81/PBA-5-27743.PMC4439419.pdf
"Obesity ismost commonly caused by excessive food intake and/or low physical activity, leading to the accumulation ofRole of cellular senescence in vivo Citation: Pathobiology of Aging & Age-related Diseases 2015, 5: 27743 - http://dx.doi.org/10.3402/pba.v5.27743 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/00/81/PBA-5-27743.PMC4439419.pdf
"This work was supported by Grants-in-Aid for Scientiﬁc Research (KAKENHI Grant Number 24613006).Kaoru Tominaga 6 (page number not for citation purpose)Citation: Pathobiology of Aging & Age-related Diseases 2015, 5: 27743 - http://dx.doi.org/10.3402/pba.v5.27743",Non-OADS,/arxiv_data1/oa_pdf/00/81/PBA-5-27743.PMC4439419.pdf
"1990; 247: 205 /C19.Role of cellular senescence in vivo Citation: Pathobiology of Aging & Age-related Diseases 2015, 5: 27743 - http://dx.doi.org/10.3402/pba.v5.27743 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/00/81/PBA-5-27743.PMC4439419.pdf
"2011; 30: 1536 /C148.Kaoru Tominaga 8 (page number not for citation purpose)Citation: Pathobiology of Aging & Age-related Diseases 2015, 5: 27743 - http://dx.doi.org/10.3402/pba.v5.27743",Non-OADS,/arxiv_data1/oa_pdf/00/81/PBA-5-27743.PMC4439419.pdf
"1993; 259: 87 /C191.Role of cellular senescence in vivo Citation: Pathobiology of Aging & Age-related Diseases 2015, 5: 27743 - http://dx.doi.org/10.3402/pba.v5.27743 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/00/81/PBA-5-27743.PMC4439419.pdf
"2013; 273: 429 /C136.Kaoru Tominaga 10 (page number not for citation purpose)Citation: Pathobiology of Aging & Age-related Diseases 2015, 5: 27743 - http://dx.doi.org/10.3402/pba.v5.27743",Non-OADS,/arxiv_data1/oa_pdf/00/81/PBA-5-27743.PMC4439419.pdf
Available from: http://www.hc - sc.gc.ca/ewh -semt/pubs/contaminants/psl2 - lsp2/nonylphenol/index -eng.php.,Non-OADS,/arxiv_data1/oa_pdf/15/7d/IJBMS-18-317.PMC4439445.pdf
"(http://europa.eu.int), CAS Nos: 84852 -15-3 and  25154 -52-3, volume 10.",Non-OADS,/arxiv_data1/oa_pdf/15/7d/IJBMS-18-317.PMC4439445.pdf
2002.   http://www.bfr.bund.de/cm/343/4_nonylphenol_un d_nonylphenol.pdf   3.,Non-OADS,/arxiv_data1/oa_pdf/15/7d/IJBMS-18-317.PMC4439445.pdf
"Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d8/34/aps-42-265.PMC4439583.pdf
"Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4e/cc/aps-42-267.PMC4439584.pdf
"278Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/cb/aps-42-278.PMC4439585.pdf
"282Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/32/4f/aps-42-282.PMC4439586.pdf
"288Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/e3/aps-42-288.PMC4439587.pdf
"Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/f8/aps-42-295.PMC4439588.pdf
"302Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a8/69/aps-42-302.PMC4439589.pdf
"Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/05/aps-42-309.PMC4439590.pdf
Available  from: http://www.plasticsurgery.org/news-and-resources/  2012-plastic-surgery-statistics.html.,Non-OADS,/arxiv_data1/oa_pdf/a7/05/aps-42-309.PMC4439590.pdf
"316Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7e/21/aps-42-316.PMC4439591.pdf
"Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/73/0d/aps-42-321.PMC4439592.pdf
"Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c2/1c/aps-42-327.PMC4439593.pdf
"334Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/4c/aps-42-334.PMC4439594.pdf
"Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/07/aps-42-341.PMC4439595.pdf
"346Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8c/72/aps-42-346.PMC4439596.pdf
"Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/cc/aps-42-351.PMC4439597.pdf
"356Copyright © 2015  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/76/32/aps-42-356.PMC4439598.pdf
"Received: 25 Jun 2014 • Revised: 29 Jul 2014 • Accepted: 1 Aug 2014   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.3.361 • Arch Plast Surg 2015;42:361-362 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.IMAGESImagesSeromas and hematomas are relatively common  complications of a variety of surgical procedures.",Non-OADS,/arxiv_data1/oa_pdf/a9/5f/aps-42-361.PMC4439599.pdf
"Received: 1 Dec 2014 • Revised: 10 Jan 2015 • Accepted: 14 Jan 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.3.362 • Arch Plast Surg 2015;42:362-364 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a9/5f/aps-42-361.PMC4439599.pdf
"Received: 1 Dec 2014 • Revised: 10 Jan 2015 • Accepted: 14 Jan 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.3.362 • Arch Plast Surg 2015;42:362-364 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/0a/aps-42-362.PMC4439600.pdf
"Received: 20 Dec 2014 • Revised: 3 Jan 2015 • Accepted: 19 Jan 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.3.365 • Arch Plast Surg 2015;42:365-367 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cc/1c/aps-42-365.PMC4439601.pdf
"Received: 19 Jan 2015 • Revised: 9 Feb 2015  • Accepted: 10 Feb 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.3.368 • Arch Plast Surg 2015;42:368-370 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b4/f9/aps-42-368.PMC4439602.pdf
http://dx.doi.org/10.1097/ SAP .0000000000000248.,OADS,/arxiv_data1/oa_pdf/b4/f9/aps-42-368.PMC4439602.pdf
"Received: 7 Feb 2014 • Revised: 11 Aug 2014 • Accepted: 12 Aug 2014   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.3.370 • Arch Plast Surg 2015;42:370-372 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.in its size is usually a consequence of malignant  change, or inflammation.",Non-OADS,/arxiv_data1/oa_pdf/b4/f9/aps-42-368.PMC4439602.pdf
http://dx.doi.org/10.1097/ SAP .0000000000000248.,OADS,/arxiv_data1/oa_pdf/0a/f0/aps-42-370.PMC4439603.pdf
"Received: 7 Feb 2014 • Revised: 11 Aug 2014 • Accepted: 12 Aug 2014   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.3.370 • Arch Plast Surg 2015;42:370-372 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.in its size is usually a consequence of malignant  change, or inflammation.",Non-OADS,/arxiv_data1/oa_pdf/0a/f0/aps-42-370.PMC4439603.pdf
"Received: 7 May 2014 • Revised: 31 May 2014 • Accepted: 31 May 2014   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.3.373 • Arch Plast Surg 2015;42:373-375 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/39/52/aps-42-373.PMC4439604.pdf
"Received: 27 Mar 2014 • Revised: 1 Jun 2014 • Accepted: 9 Jun 2014   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.3.375 • Arch Plast Surg 2015;42:375-377 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.surrounding the central nervous system.",Non-OADS,/arxiv_data1/oa_pdf/39/52/aps-42-373.PMC4439604.pdf
"Received: 27 Mar 2014 • Revised: 1 Jun 2014 • Accepted: 9 Jun 2014   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.3.375 • Arch Plast Surg 2015;42:375-377 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.surrounding the central nervous system.",Non-OADS,/arxiv_data1/oa_pdf/53/2c/aps-42-375.PMC4439605.pdf
"Received: 24 Jul 2014 • Revised: 5 Aug 2014 • Accepted: 23 Aug 2014   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.3.378 • Arch Plast Surg 2015;42:378-380 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/4e/aps-42-378.PMC4439606.pdf
"Received: 30 Mar 2014 • Revised: 24 Jun 2014 • Accepted: 25 Jun 2014   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.3.380 • Arch Plast Surg 2015;42:380-383 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/4e/aps-42-378.PMC4439606.pdf
"Received: 30 Mar 2014 • Revised: 24 Jun 2014 • Accepted: 25 Jun 2014   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.3.380 • Arch Plast Surg 2015;42:380-383 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cb/81/aps-42-380.PMC4439607.pdf
"Received: 2 Aug 2014 • Revised: 12 Sep 2014 • Accepted: 22 Sep 2014   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.3.383 • Arch Plast Surg 2015;42:383-385 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cb/81/aps-42-380.PMC4439607.pdf
"Received: 2 Aug 2014 • Revised: 12 Sep 2014 • Accepted: 22 Sep 2014   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2015.42.3.383 • Arch Plast Surg 2015;42:383-385 Copyright  2015 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/59/aps-42-383.PMC4439608.pdf
Heterozygous muta- tions of CASR cause familial hypocalciuric hypercalcemia Open AccessK Taki and others De novo S591C CASR mutation in FHHID: 15-0016; May 2015 DOI: 10.1530/EDM-15-0016 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0Unported License .q2015 The authors http://www.edmcasereports.com Published by Bioscientiﬁca Ltd,Non-OADS,/arxiv_data1/oa_pdf/b8/b8/edmcr-2015-150016.PMC4439728.pdf
"Biochemical tests ResultReference range Serum albumin (g/dl) 3.9 3.9–4.9 Serum calcium (mg/dl) 12.2 8.8–10.8 Serum phosphate (mg/dl) 2.6 2.7–4.4Serum magnesium (mg/dl) 2.5 1.9–2.5 Serum creatinine (mg/dl) 0.58 0.4–0.8 Urinary calcium (mg/gCre) 225FECa (%) 1.07 % TRP (%) 81.72 Intact PTH (pg/ml) 34 10–651,25-(OH) 2vitamin D (pg/ml) 44.7 20–60 K Taki and others De novo S591C CASR mutation in FHHID: 15-0016; May 2015 DOI: 10.1530/EDM-15-0016 http://www.edmcasereports.com 2",Non-OADS,/arxiv_data1/oa_pdf/b8/b8/edmcr-2015-150016.PMC4439728.pdf
K Taki and others De novo S591C CASR mutation in FHHID: 15-0016; May 2015 DOI: 10.1530/EDM-15-0016 http://www.edmcasereports.com 3,Non-OADS,/arxiv_data1/oa_pdf/b8/b8/edmcr-2015-150016.PMC4439728.pdf
"(doi:10.1542/peds.2006-3209 ) 8 D’Souza-Li L, Yang B, Canaff L, Bai M, Hanley DA, Bastepe M, Salisbury SR, Brown EM, Cole DE & Hendy GN 2002 Identiﬁcation and functional characterization of novel calcium-sensing receptor mutations in K Taki and others De novo S591C CASR mutation in FHHID: 15-0016; May 2015 DOI: 10.1530/EDM-15-0016 http://www.edmcasereports.com 4",OADS,/arxiv_data1/oa_pdf/b8/b8/edmcr-2015-150016.PMC4439728.pdf
( doi:10.1111/j.1582-4934.2007.00096.x ) Received in ﬁnal form 12 February 2015 Accepted 21 April 2015 K Taki and others De novo S591C CASR mutation in FHHID: 15-0016; May 2015 DOI: 10.1530/EDM-15-0016 http://www.edmcasereports.com 5,Non-OADS,/arxiv_data1/oa_pdf/b8/b8/edmcr-2015-150016.PMC4439728.pdf
"Monthly temperature and precipitation from 2001 to 2099 were downloaded from theIPCC data distribution centre ( http://www.ipcc-data.org ) of five different GCMs: (i) the CGCM3.1(T47) model of the Canadian Centre for Climate Modelling and Analysis(CCMA-CGCM3), the CM2.0 model of the Geophysical Fluid Dynamics Laboratory inthe USA (GFDL-CM2), the ECHAM5 mo del of the Max Planck Institute for Meteorology in Germany (MPIM-ECHAM5) , the high resolution version of the MIROC3.2 model of the National Institute for Environmental Studies in Japan (NIES- MIROC3) and the HADGEM1 model of the Had ley Centre for Climate Prediction and Research in the United Kingdom (UKMO-HAD GEM1).",OADS,/arxiv_data1/oa_pdf/cc/6f/10584_2011_Article_143.PMC4439731.pdf
212921) as part of the CEOP- AEGIS project ( http://www.ceop-aegis.org/ ) coordinated by the Université de Strasbourg.,Non-OADS,/arxiv_data1/oa_pdf/cc/6f/10584_2011_Article_143.PMC4439731.pdf
"InterAcademy Council, p113, http://reviewipcc.interacademycouncil.net/report.html IPCC (2008) Procedures for the preparation, review, acceptance, adoption, approval and publication of IPCC reports.",Non-OADS,/arxiv_data1/oa_pdf/db/4a/10584_2011_Article_350.PMC4439732.pdf
"http://www.unutki.org/ default.php?doc_id=187 van der Sluijs JP, van Est R, Riphagen M (2010) Beyond consensus: reflections from a democratic perspective on the interaction between climate politics and science.",Non-OADS,/arxiv_data1/oa_pdf/db/4a/10584_2011_Article_350.PMC4439732.pdf
Details	are	 available at: http://myappworx.com/rxphoto • PicSafeMedi is an app for secure sharing of medical images  among doctors.,Non-OADS,/arxiv_data1/oa_pdf/0a/11/IDOJ-6-158.PMC4439742.pdf
Details are available at: https://picsafe.com/ medi • Camera + and Camera awesome [Figure 6]: These apps  enhance the feature set of a smartphone camera by  providing advanced settings such as splitting the focus and  exposure.,Non-OADS,/arxiv_data1/oa_pdf/0a/11/IDOJ-6-158.PMC4439742.pdf
"Details are available at: https://itunes.apple.com/ in/app/camera+/id329670577?mt = 8 • Snapseed and Photoshop Express are editing apps that  can be useful for advanced editing such as changing  the exposure, white balance, sharpness, cropping,  and so forth.",Non-OADS,/arxiv_data1/oa_pdf/0a/11/IDOJ-6-158.PMC4439742.pdf
snapseedandhl = en and https://itunes.apple.com/in/app/ snapseed/id439438619?mt = 8 • Magnifier app [Figure 7].,Non-OADS,/arxiv_data1/oa_pdf/0a/11/IDOJ-6-158.PMC4439742.pdf
Details are available at: https://itunes.apple.com/in/app/ magnifying-glass-light-digital/id406048120?mt = 8.,Non-OADS,/arxiv_data1/oa_pdf/0a/11/IDOJ-6-158.PMC4439742.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Minimally invasive tubular access for posterior cervical  foraminotomy Byron C. Branch1, Donald L. Hilton Jr.1,2, Clark Watts2,3 1Departments of Neurosurgery, University of T exas Health Science Center, 2Neurosurgical Associates of San Antonio PA, San Antonio, T exas, 3University of  T exas  School of Law , Austin, T exas, USA E‑mail: *Byron C. Branch ‑ branch@uthscsa.edu;   Donald L. Hilton Jr.  ‑ dhiltonjr@sbcglobal.net; Clark Watts ‑ cwatts@mindspring.com   *Corresponding Author: Received: 20 November 14  Accepted: 04 March 15  Published: 19 May 15 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.157308  Quick Response Code: Videos available at   www.surgicalneurologyint.comAbstract Background: Minimally invasive tubular access for posterior cervical foraminotomy  can be an effective and safe technique for decompression of the nerve root  utilizing minimally invasive muscle splitting with routine outpatient discharge.",Non-OADS,/arxiv_data1/oa_pdf/0a/d1/SNI-6-81.PMC4439784.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/81/157308 Copyright: © 2015 Branch BC.,Non-OADS,/arxiv_data1/oa_pdf/0a/d1/SNI-6-81.PMC4439784.pdf
"Surgical Neurology International 2015, 6:81  http://www.surgicalneurologyint.com/content/6/1/81stenosis or soft disc herniation.",Non-OADS,/arxiv_data1/oa_pdf/0a/d1/SNI-6-81.PMC4439784.pdf
"Surgical Neurology International 2015, 6:81  http://www.surgicalneurologyint.com/content/6/1/81grew an organism; however, the specimens were sent  after the initiation of antibiotics.",Non-OADS,/arxiv_data1/oa_pdf/0a/d1/SNI-6-81.PMC4439784.pdf
"Surgical Neurology International 2015, 6:81  http://www.surgicalneurologyint.com/content/6/1/81provides a path of light to enhance visualization.",Non-OADS,/arxiv_data1/oa_pdf/0a/d1/SNI-6-81.PMC4439784.pdf
"Surgical Neurology International 2015, 6:81  http://www.surgicalneurologyint.com/content/6/1/81procedures among 183 patients to an average inpatient  length of stay of 7 days among 89 patients.",Non-OADS,/arxiv_data1/oa_pdf/0a/d1/SNI-6-81.PMC4439784.pdf
"Surgical Neurology International 2015, 6:81  http://www.surgicalneurologyint.com/content/6/1/81vs.",Non-OADS,/arxiv_data1/oa_pdf/0a/d1/SNI-6-81.PMC4439784.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Nontraumatic aneurysm rupture following an endoscopic third  ventriculostomy and ventricular drainage: Case report of a rare  complication Naohisa Miyagi, Hisaaki Uchikado1, Takachika Aoki2, Kiyohiko Sakata2, Masaru Hirohata2,   Motohiro Morioka2 Department of Neurosurgery, Nakagami Hospital, Okinawa, 1Uchikado Neuro‑Spine Clinic, 2Department of Neurosurgery, Kurume University School of Medicine,  Fukuoka, Japan E‑mail: *Naohisa Miyagi ‑ miyanao@med.kurume‑u.ac.jp; Hisaaki Uchikado ‑ uchikado@med.kurume‑u.ac.jp; Takachika Aoki ‑ takachi@med.kurume‑u.ac.jp;  Kiyohiko Sakata ‑ kiyo@med.kurume‑u.ac.jp; Masaru Hirohata ‑ hiroha@med.kurume‑u.ac.jp; Motohiro Morioka ‑ mmorioka@med.kurume‑u.ac.jp   *Corresponding author Received: 11 September 14  Accepted: 19 December 14  Published: 19 May 15 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.157303  Quick Response Code: Abstract Background:  Although endoscopic third ventriculostomy is a safe procedure, the  authors report a case of aneurysmal subarachnoid hemorrhage as an unusual  and serious complication of an endoscopic third ventriculostomy and ventricular  drainage.",Non-OADS,/arxiv_data1/oa_pdf/2e/f7/SNI-6-80.PMC4439787.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/80/157303 Copyright: © 2015 Miyagi  N.  This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/2e/f7/SNI-6-80.PMC4439787.pdf
"Surgical Neurology International 2015, 6:80  http://www.surgicalneurologyint.com/content/6/1/80CASE REPORT A 60‑year‑old male presented with slowly progressive  drowsiness was admitted to our hospital.",Non-OADS,/arxiv_data1/oa_pdf/2e/f7/SNI-6-80.PMC4439787.pdf
"Surgical Neurology International 2015, 6:80  http://www.surgicalneurologyint.com/content/6/1/80perforation of the anterior cerebral artery branch,  massive intraventricular hemorrhage, and contusions  of the thalamus and hypothalamus.",Non-OADS,/arxiv_data1/oa_pdf/2e/f7/SNI-6-80.PMC4439787.pdf
http://www.nber.org/chapters/c2387.,Non-OADS,/arxiv_data1/oa_pdf/99/f6/ecoj0125-0403.PMC4439835.pdf
http://www.stiglitz-sen-ﬁtoussi.fr/ (last accessed: 11 December 2014).,Non-OADS,/arxiv_data1/oa_pdf/99/f6/ecoj0125-0403.PMC4439835.pdf
http://www.fao.org/do- crep/016/i3027e/i3027e00.htm.,Non-OADS,/arxiv_data1/oa_pdf/1f/99/CEJI-39-47723.PMC4439950.pdf
http://seer.cancer.gov/csr/1975_2010.,Non-OADS,/arxiv_data1/oa_pdf/1f/c7/CEJI-39-47727.PMC4439954.pdf
The results were identified by comparing the obtained sequences with the registered sequences in GenBank through BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi ).,OADS,/arxiv_data1/oa_pdf/28/5a/CEJI-39-47732.PMC4439959.pdf
Blasting was performed at the National Cen- ter for Biotechnology Information (http://www.ncbi.nlm.nih.gov/).,OADS,/arxiv_data1/oa_pdf/28/5a/CEJI-39-47732.PMC4439959.pdf
"Virion/Serion GmbH, SERION ELISA classic, Adenovirus IgA/IgG,http://www.virion-serion.de/download/gebrauchsan-weisung/adenovirus/IFU-Adenovirus-SL.pdf 16.",Non-OADS,/arxiv_data1/oa_pdf/40/41/CEJI-39-42131.PMC4439974.pdf
Anon.http://www.nauka.gov.pl/g2/oryginal/2013_05/ 91344c98ee12f19a3735d49716e9f643.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8f/4e/CEJI-39-42114.PMC4439981.pdf
2008. http://www.uroweb.org/fileadmin/user_upload/Guidelines/Urolithiasis.pdf.,OADS,/arxiv_data1/oa_pdf/7a/94/CEJI-39-45952.PMC4440001.pdf
Internet: http://www.who.int/dietphysicalactivity/ publications/facts/obesity/en/ (accessed 5 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/74/e2/CEJI-39-45949.PMC4440003.pdf
"Faurschou M, Dreyer L, Kamper AL, http://www.ncbi.nlm.",OADS,/arxiv_data1/oa_pdf/80/c6/CEJI-39-43730.PMC4440014.pdf
http://apps.who.int/medicinedocs/en/d/ Js2200e/6.html.,OADS,/arxiv_data1/oa_pdf/b2/8b/CEJI-39-43711.PMC4440021.pdf
Available at: http://scielo.sld.cu/scielo.php?script=sci_issuetoc&pid=0864-028920070002 &lng= es& nrm=iso.,OADS,/arxiv_data1/oa_pdf/d4/37/CEJI-39-43727.PMC4440032.pdf
"Centers for Disease Control and Prevention; http://www.cdc.gov/dh-dsp/data_statistics/fact_sheets/fs_women_heart.htm, Kochanek KD,  Xu JQ, Murphy SL, Miniño AM, Kung HC.",Non-OADS,/arxiv_data1/oa_pdf/28/ca/MR-14-24884.PMC4440193.pdf
22. http://apps.who.int/bmi/index.jsp?introPage=intro_3.html.,Non-OADS,/arxiv_data1/oa_pdf/28/ca/MR-14-24884.PMC4440193.pdf
23. http://www.cdc.gov/healthyplaces/healthtopics/physactivity.htm.,Non-OADS,/arxiv_data1/oa_pdf/28/ca/MR-14-24884.PMC4440193.pdf
Updated May 2014; http://www.who.int/mediacentre/factsheets/ fs311/en/ 2.,Non-OADS,/arxiv_data1/oa_pdf/9e/1d/MR-14-24888.PMC4440197.pdf
World Health Organization Global Infobase; https://apps.who.int/in-fobase/Indicators.aspx 4.,Non-OADS,/arxiv_data1/oa_pdf/9e/1d/MR-14-24888.PMC4440197.pdf
26. http://www.aagbi.org/sites/default/files/la_toxicity_2010_0.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b8/50/MR-14-24891.PMC4440200.pdf
References 1. http://www.rcog.org.uk/what-we-do/campaigning-and-opinions/state- ment/rcog-statement-later-maternal-age.,Non-OADS,/arxiv_data1/oa_pdf/12/bf/MR-14-24892.PMC4440201.pdf
2. http://www.rcog.org.uk/what-we-do/campaigning-and-opinions/state-ment/rcog-statement-updated-nice-guidance-treating-people-f.3.,Non-OADS,/arxiv_data1/oa_pdf/12/bf/MR-14-24892.PMC4440201.pdf
11.2 Female Age; http://www.ncbi.nlm.nih.gov/books/NBK45935/pdf/TOC.pdf.,Non-OADS,/arxiv_data1/oa_pdf/12/bf/MR-14-24892.PMC4440201.pdf
5.1 Maternal Age; http://www.rcog.org.uk/files/rcog-corp/060612SAC8.pdf.,Non-OADS,/arxiv_data1/oa_pdf/12/bf/MR-14-24892.PMC4440201.pdf
"For lysosomal tracking experiments, particle detection was per- formed using a custom-written MATLAB algorithm (available uponrequest) and tracking was performed using u-track 2.0 software (http://lccb.hms.harvard.edu/software.html) (84).",OADS,/arxiv_data1/oa_pdf/ce/98/tra0016-0572.PMC4440230.pdf
Graphical Abstract ©2015 The Authors This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/fb/nihms-672933.PMC4440329.pdf
"Box 9104, Morgantown,  WV 26506-9104, USA SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, two figures, and one table and can be found with this  article online at http://dx.doi.org/10.1016/j.celrep.2015.03.032 .",OADS,/arxiv_data1/oa_pdf/9b/fb/nihms-672933.PMC4440329.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b8/8f/btt-9-035.PMC4440355.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pBiologics: Targets and Therapy 2015:9 35–43Biologics: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  35Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BTT .S5336 1Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/b8/8f/btt-9-035.PMC4440355.pdf
"Or use: http://youtu.be/i6cwbAwEXR gBiologic monotherapy in the treatment   of rheumatoid arthritis Jacqueline Detert Pascal Klaus Department of Rheumatology and  Clinical immunology, Charité –  Universitätsmedizin Berlin, Berlin,   Germany Correspondence: Jacqueline Detert   Department of Rheumatology and  Clinical immunology, Charité –  Universitätsmedizin Berlin, Charitéplatz 1,   Berlin 10117, Germany   Tel +49 30 4505 13133   Fax +49 30 4505 13982   email jacqueline.detert@charite.d eAbstract:  Biologics, possibly in combination with a conventional disease-modifying antirheu - matic drug (DMARD) – preferably methotrexate (MTX), are used in accordance with the rec - ommendations of the international rheumatological societies.",Non-OADS,/arxiv_data1/oa_pdf/b8/8f/btt-9-035.PMC4440355.pdf
"For this review article, PubMed, MEDLINE,  EMBASE, and Cochrane Library databases literature and  clinical trial register ( http://www.clinicaltrial.go v) were  searched for clinical studies with the aim of analyzing  biological monotherapy in RA.",OADS,/arxiv_data1/oa_pdf/b8/8f/btt-9-035.PMC4440355.pdf
"Biologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/b8/8f/btt-9-035.PMC4440355.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/b8/8f/btt-9-035.PMC4440355.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2f/ae/rmhp-8-081.PMC4440357.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pRisk Management and Healthcare Policy 2015:8 81–89Risk Management and Healthcare Policy Dove press submit your manuscript | www.dovepress.co m Dove press  81ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/RMHP .S8300 8Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/2f/ae/rmhp-8-081.PMC4440357.pdf
"Or use: http://youtu.be/qaYv5Gd4fq 8Older people’s perspectives on an elderly-friendly  hospital environment: an exploratory study sushmita Karki1 Dharma nand Bhatta1,2 Umesh Raj aryal3 1Department of Public Health,   nobel college, Pokhara University,   Kathmandu, nepal; 2Faculty of  Medicine, epidemiology Unit, Prince  of songkla University, songkhla,   Thailand; 3Department of community  Medicine, Kathmandu Medical college,   Kathmandu, nepal correspondence: Dharma nand Bhatta   Department of Public Health, nobel  college, Pokhara University, sinamangal,  Kathmandu, nepal   Tel +977 98 4148 5128   email dnbhatta@yahoo.co mBackground:  Many older people are vulnerable with multiple health problems and need of  extensive care and support for quality of life.",Non-OADS,/arxiv_data1/oa_pdf/2f/ae/rmhp-8-081.PMC4440357.pdf
Available from: http://www.lawcommission.gov.np/site/sites/default/ files/Documents/Senior%2BCitizens%2BRules.pd f.  26.,OADS,/arxiv_data1/oa_pdf/2f/ae/rmhp-8-081.PMC4440357.pdf
"Available at http://www.who.int/ageing/publications/Global_age_ friendly_cities_Guide_English.pd f. Accessed April 15, 2015.",Non-OADS,/arxiv_data1/oa_pdf/2f/ae/rmhp-8-081.PMC4440357.pdf
"Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/risk-management-and-healthcare-policy-journa lRisk Management and Healthcare Policy is an international, peer- reviewed, open access journal focusing on all aspects of public health,  policy, and preventative measures to promote good health and improve  morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/2f/ae/rmhp-8-081.PMC4440357.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/ae/rmhp-8-081.PMC4440357.pdf
"RefSeq genes which have been detected next to the IS were analysed for their presence within three different cancer gene databases: CGC (Cancer Gene Census Database; http://www.sanger.ac.uk/genetics/CGP/Census/), RTCGD (Ret-rovirus and Transposon tagged Cancer Gene Database; http://variation.osu.edu/rtcgd/index.html and CBioPortal (cBio  Cancer Genomics Portal; http://www.cbioportal.org/public- portal/).",OADS,/arxiv_data1/oa_pdf/27/fe/CGT-15-64.PMC4440358.pdf
Preliminary clinical results showing  the advantage of the new Lentiglobin BB305 lentiviral vec-tor over the previous HPV569 vector in two  -thalassemia  patients were reported at the 2014 annual meeting of the European Hematology Association and the 2014 annual  meeting of the American Society of Hematology and can be  read at http://investor.bluebirdbio.com/ phoenix.zhtml?,Non-OADS,/arxiv_data1/oa_pdf/27/fe/CGT-15-64.PMC4440358.pdf
"c=251820&p=irol-newsArticle&ID=1939867 and at http://investor.bluebirdbio.com/phoenix.zhtml?c=251820&p=irol-newsArticle&ID=1995913, respectively.",Non-OADS,/arxiv_data1/oa_pdf/27/fe/CGT-15-64.PMC4440358.pdf
The annotated SNP ﬁles were analyzed with HomozygosityMap- per (http://www.homozygositymapper.org/) to identify the region ofhomozygosity in the proband.,OADS,/arxiv_data1/oa_pdf/88/a9/odi0021-0456.PMC4440386.pdf
"Remaining variants were ana-lyzed in silico with Align GVGD (http://agvgd.iarc.fr/) (Tavtigian et al, 2006), SIFT (http://sift.jcvi.org/) (Ng and Henikoff, 2003), MutationTaster (http://www.mutationtaster.org/) (Schwarz et al, 2010), and Poly- Phen-2 (http://genetics.bwh.harvard.edu/pph2/) (Adzhubei et al, 2010).",Non-OADS,/arxiv_data1/oa_pdf/88/a9/odi0021-0456.PMC4440386.pdf
"jcvi.org/) (Choi et al, 2012) and MutPred (http://mutpred.mutdb.org/) (Li et al, 2009) programs.",OADS,/arxiv_data1/oa_pdf/88/a9/odi0021-0456.PMC4440386.pdf
"Additionally, this variant was not found in the NHLBI exome variant server (http://evs.gs.washing-ton.edu/EVS/) and the 1000 Genome database (http:// www.ncbi.nlm.nih.gov/variation/tools/1000genomes/).",OADS,/arxiv_data1/oa_pdf/88/a9/odi0021-0456.PMC4440386.pdf
"Table 1 In silico analysis of the ﬁltered variants Chr Gene ChangesAlign GVGD SIFTMutation Taster PolyPhen-2 chr15 ATP10A NM_024490:c.T2977G:p.F993V Class C0 Tolerated (score: 0.53)Polymorphism Benign (score =0.003) chr2 MARCH7 NM_001282806:c.A959G: p.E320GClass C0 Tolerated (score: 0.06)Disease causing Possibly damaging (score =0.953) chr2 ITGB6 NM_000888:c.G517C:p.G173R Class C65 Deleterious (score: 0) Disease causing Probably damaging (score =1.000) chr20 TAF4 NM_003185:c.A397T:p.S133C Class C0 Tolerated (score: 0.11)Polymorphism Possibly damaging (score =0.953) chr20 LAMA5 NM_005560:c.C1957T:p.R653C Class C0 Tolerated (score: 0.07)Disease causing Benign (score =0.238) chr8 CSPP1 NM_024790:c.A3463G:p.S1155G Class C0 Tolerated (score: 0.3) Polymorphism Benign (score =0.000) Table 2 In silico analysis of the ITGB6 variant Mutation PolyPhen2 MutationTaster SIFT PROVEAN MutPred c.G517C Score =1.000 Probability =0.999 Score =0 Score =/C07.731 Score =0.931 p.Gly173Arg Probably damaging Disease causing Damaging Deleterious Gain of methylation at G173 ( P=0.0136) URLs: Align GVGD, http://agvgd.iarc.fr/ (Tavtigian et al, 2006); PolyPhen2, http://genetics.bwh.harvard.edu/pph2/ (Adzhubei et al, 2010); Mutationtas- ter, http://www.mutationtaster.org/ (Schwarz et al, 2010); SIFT, http://sift.jcvi.org/ (Ng and Henikoff, 2003); PROVEAN, http://provean.jcvi.org/ (Choi et al, 2012); MutPred, http://mutpred.mutdb.org/ (Li et al, 2009).",Non-OADS,/arxiv_data1/oa_pdf/88/a9/odi0021-0456.PMC4440386.pdf
Retrieved from http://www.skybrary.aero/index.php/Pilots_and_Air_Trafﬁc_Controllers_Phraseology_Study International Maritime Organization (2005).,Non-OADS,/arxiv_data1/oa_pdf/96/98/joop0088-0273.PMC4440387.pdf
"Retrieved from http://www.imo.org/blast/blastDataHelper.asp?data_ id=24571&ﬁlename=A918%2822%29.pdf Jones, D. G., & Endsley, M. R. (1996).",OADS,/arxiv_data1/oa_pdf/96/98/joop0088-0273.PMC4440387.pdf
Retrieved from http://www.asrs.arc.nasa.gov/ publications/directline/dl4_sterile.htm The North West European Area Guidelines (2009).,Non-OADS,/arxiv_data1/oa_pdf/96/98/joop0088-0273.PMC4440387.pdf
"Retrieved from http://www.nwea.info/ Van Maanen, J.",Non-OADS,/arxiv_data1/oa_pdf/96/98/joop0088-0273.PMC4440387.pdf
"[47] The Bush Research Group http://depts.washington.edu/bushlab/ (accessed Dec 17, 2014).",Non-OADS,/arxiv_data1/oa_pdf/e6/c7/jms0050-0711.PMC4440389.pdf
"[101] The Martin Jarrold Research Group http://www.indiana.edu/~nano/ software.html (accessed Dec 10, 2014).",OADS,/arxiv_data1/oa_pdf/e6/c7/jms0050-0711.PMC4440389.pdf
"[103] The Bowers Research Group http://bowers.chem.ucsb.edu/theory_ analysis/cross-sections/sigma.shtml (accessed Dec 10, 2014).",OADS,/arxiv_data1/oa_pdf/e6/c7/jms0050-0711.PMC4440389.pdf
"[104] WebPSA http://luschka.bic.ucsb.edu:8080/WebPSA/index.jsp (accessed Dec 10, 2014).",OADS,/arxiv_data1/oa_pdf/e6/c7/jms0050-0711.PMC4440389.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/32/8e/opth-9-865.PMC4440420.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 865–872Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  865Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S6948 6Clinical utility of 3% diquafosol ophthalmic  solution in the treatment of dry eyes Shizuka Koh Department of Ophthalmology,   Osaka University Graduate School  of Medicine, Suita, Osaka, JapanAbstract:  Diquafosol is a drug used for dry eye treatment with a novel mechanism of action.",Non-OADS,/arxiv_data1/oa_pdf/32/8e/opth-9-865.PMC4440420.pdf
"These new eye drops have enabled us to selectively treat the tear film layer Correspondence: Shizuka Koh Department of Ophthalmology, Osaka  University Graduate School of Medicine,  Room e7, 2-2 Yamadaoka, Suita, Osaka  565-0871, Japan Tel +81 6 6879 3456 Fax +81 6 6879 3458 email skoh@ophthal.med.osaka-u.ac.j pJournal name: Clinical Ophthalmology Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Koh Running head recto: Diquafosol ophthalmic solution for dry eye treatment DOI: http://dx.doi.org/10.2147/OPTH.S69486",Non-OADS,/arxiv_data1/oa_pdf/32/8e/opth-9-865.PMC4440420.pdf
Available from: http://www.dryeye.ne.jp/en/tfot/index.html .,Non-OADS,/arxiv_data1/oa_pdf/32/8e/opth-9-865.PMC4440420.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/32/8e/opth-9-865.PMC4440420.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/32/8e/opth-9-865.PMC4440420.pdf
Available from: http://www.dryeye.ne.jp/en/tfot/ index.html.,Non-OADS,/arxiv_data1/oa_pdf/32/8e/opth-9-865.PMC4440420.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b2/c4/amep-6-367.PMC4440421.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2015:6 367–372Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  367OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S8264 5Diversity of United states medical students   by region compared to Us census data Mark M smith1 steven h rose1 Darrell r schroeder2 Timothy r long1 1Department of Anesthesiology,  Mayo clinic college of Medicine,  rochester, M n, UsA;  2Division of  Biomedical statistics and informatics,  Mayo clinic college of Medicine,  rochester, M n, UsA correspondence: Timothy r long   Department of Anesthesiology, Mayo  clinic college of Medicine,   200 First street sW, rochester,   Mn 55905, UsA   Tel +1 507 255 3298   Email long.timothy14@mayo.ed uPurpose:  Increasing the diversity of the United States (US) physician workforce to better  represent the general population has received considerable attention.",Non-OADS,/arxiv_data1/oa_pdf/b2/c4/amep-6-367.PMC4440421.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/b2/c4/amep-6-367.PMC4440421.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b2/c4/amep-6-367.PMC4440421.pdf
"Available from: https://www.census.gov/popest/data/ historical/2010s/vintage_2012/datasets.htm l. Accessed June  24,   2014.",OADS,/arxiv_data1/oa_pdf/b2/c4/amep-6-367.PMC4440421.pdf
"Available from: https://www.census.gov/popest/about/ geo/codes.htm l. Accessed June  30, 2014.",OADS,/arxiv_data1/oa_pdf/b2/c4/amep-6-367.PMC4440421.pdf
Available from: https://www.aamc.org/data/facts/enrollmentgraduate /.,Non-OADS,/arxiv_data1/oa_pdf/b2/c4/amep-6-367.PMC4440421.pdf
Available from: https://www.aamc.org/data/facts/ applicantmatriculant /.,OADS,/arxiv_data1/oa_pdf/b2/c4/amep-6-367.PMC4440421.pdf
Available from: https://supreme.justia.,Non-OADS,/arxiv_data1/oa_pdf/b2/c4/amep-6-367.PMC4440421.pdf
Available  from: https://www.aamc.org/initiatives/holisticreview /.,Non-OADS,/arxiv_data1/oa_pdf/b2/c4/amep-6-367.PMC4440421.pdf
"Available from:  http://nces.ed.gov/programs/coe/indicator_coi.as p. Accessed March  6,  2015.",OADS,/arxiv_data1/oa_pdf/b2/c4/amep-6-367.PMC4440421.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6c/6a/dddt-9-2663.PMC4440422.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 2663–2675Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2663PersPecTivesopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S8443 7DNA stabilization by the upregulation of estrogen  signaling in BRCA  gene mutation carriers Zsuzsanna suba surgical and Molecular T umor  Pathology centre, National institute  of Oncology, Budapest, HungaryAbstract:  Currently available scientific evidence erroneously suggests that mutagenic  weakness or loss of the BRCA1/2  genes may liberate the proliferative effects of estrogen sig - naling, which provokes DNA damage and genomic instability.",Non-OADS,/arxiv_data1/oa_pdf/6c/6a/dddt-9-2663.PMC4440422.pdf
"Their ubiquitously expressed BRCA protein products control DNA replication, including  transcriptional processes and recombination, as well as the repair of DNA damages.4correspondence: Zsuzsanna suba surgical and Molecular Tumor Pathology  centre, National institute of Oncology,  H-1122, ráth György street 7-9,  Budapest, Hungary Tel +36 1 224 8600 Fax +36 1 224 8620 email subazdr@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Perspectives Y ear: 2015 Volume: 9 Running head verso: Suba Running head recto: DNA stabilization by the upregulation of estrogen signaling DOI: http://dx.doi.org/10.2147/DDDT.S84437",Non-OADS,/arxiv_data1/oa_pdf/6c/6a/dddt-9-2663.PMC4440422.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/6c/6a/dddt-9-2663.PMC4440422.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/6a/dddt-9-2663.PMC4440422.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6b/3c/idr-8-119.PMC4440423.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInfection and Drug Resistance 2015:8 119–128Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  119RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S6673 9Chronic Lyme disease: misconceptions   and challenges for patient management John J Halperin Department of Neurosciences,  Overlook Medical Center,   Summit, NJ, USA Correspondence: John J Halperin   Department of Neurosciences,   Overlook Medical Center,  99 Beauvoir  Avenue, Summit, NJ  07902, USA   Tel +1 908 522 3510  email john.halperin@atlantichealth.or gAbstract:  Lyme disease, infection with the tick-borne spirochete Borrelia burgdorferi , causes  both specific and nonspecific symptoms.",Non-OADS,/arxiv_data1/oa_pdf/6b/3c/idr-8-119.PMC4440423.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/6b/3c/idr-8-119.PMC4440423.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6b/3c/idr-8-119.PMC4440423.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/13/f9/bctt-7-111.PMC4440424.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.ph pBreast Cancer: Targets and Therapy 2015:7 111–123Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  111Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S6069 6Pi3K mutations in breast cancer: prognostic   and therapeutic implications T oru Mukohara Cancer Center and Division of  Medical Oncology/Hematology, Kobe  University Hospital, Kobe, Japan Correspondence: Toru Mukohara   Cancer Center and Division of Medical  Oncology/Hematology, Kobe University  Hospital, 7-5-2 Kusunoki-cho, Chuo-ku,  Kobe, Hyogo 650-0017, Japan   Tel +81 78 382 5820   Fax +81 78 382 5821   email mukohara@med.kobe-u.ac.j pAbstract:  The PI3K pathway is the most frequently enhanced oncogenic pathway in breast can - cer.",Non-OADS,/arxiv_data1/oa_pdf/13/f9/bctt-7-111.PMC4440424.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/13/f9/bctt-7-111.PMC4440424.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/be/0a/amep-6-359.PMC4440425.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2015:6 359–366Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  359OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S2776 2Understanding and perceptions of final-year  Doctor of Pharmacy students about generic  medicines in Karachi, Pakistan: a quantitative insight shazia Qasim Jamshed1 Mohamad izham Mohamad  Ibrahim2 Mohamad Azmi hassali3 Adheed Khalid sharrad4 Asrul Akmal shafie3 Zaheer-Ud-Din Babar5 1Pharmacy Practice, Kulliyyah of  Pharmacy, International Islamic  University Malaysia, Kuantan  Campus, Pahang, Malaysia;  2college  of Pharmacy, Qatar University,  Doha, Qatar;  3Discipline of social  and Administrative Pharmacy, School  of Pharmaceutical sciences, Penang,  Malaysia;  4College of Pharmacy,  University of Basra, Basra, Iraq;   5School of Pharmacy, Faculty of  Medical and health sciences,  University of Auckland, Auckland,  new Zealand correspondence: shazia Qasim Jamshed   Pharmacy Practice, Kulliyyah of Pharmacy,  International Islamic University Malaysia,  Kuantan Campus, Pahang 25200, Malaysia   Email pharmacist1992@live.co mGeneral objective:  To evaluate the understanding and perceptions of generic medicines among  final-year Doctor of Pharmacy students in Karachi, Pakistan.",Non-OADS,/arxiv_data1/oa_pdf/be/0a/amep-6-359.PMC4440425.pdf
"Available  from: http://www.researchandmarkets.com/reports/2691063/paki - stan_pharmaceuticals_and_healthcare_report_q1.pd f. Accessed April  16, 2015.",OADS,/arxiv_data1/oa_pdf/be/0a/amep-6-359.PMC4440425.pdf
Available from: http://www.thenews.com.,Non-OADS,/arxiv_data1/oa_pdf/be/0a/amep-6-359.PMC4440425.pdf
Available  from: http://www.brecorder.com/pakistan/politics-a-policy/201103- govt- promoting -sale-of-effective-quality-of-generic-drugs-na-told.,Non-OADS,/arxiv_data1/oa_pdf/be/0a/amep-6-359.PMC4440425.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/be/0a/amep-6-359.PMC4440425.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/be/0a/amep-6-359.PMC4440425.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/46/bf/dddt-9-2653.PMC4440426.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 2653–2662Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2653Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S81799a thorough QT study to assess the effects of  tbo-filgrastim on cardiac repolarization in healthy  subjects liat adar1 noa avisar1 andreas lammerich2 robert B Kleiman3 Ofer spiegelstein1 1r&D, T eva Pharmaceutical industries  ltd, netanya, israel; 2Biosimilars  clinical Development, cPP Teva  ratiopharm, Merckle gmbh,   Ulm, germany; 3global cardiology,   eresearch T echnology inc,   Philadelphia, P a, UsaAbstract:  Tbo-filgrastim is a recombinant human granulocyte colony-stimulating factor  approved by the US Food and Drug Administration to reduce the duration of severe neutro - penia in patients with nonmyeloid malignancies receiving myelosuppressive anticancer drugs  associated with a clinically significant incidence of febrile neutropenia.",Non-OADS,/arxiv_data1/oa_pdf/46/bf/dddt-9-2653.PMC4440426.pdf
"In August 2012, tbo-filgrastim was approved  by the US Food and Drug Administration for the reduction in the duration of severe  neutropenia in patients with nonmyeloid malignancies receiving myelosuppressive  anticancer drugs associated with a clinically significant incidence of febrile neutropenia,  and is marketed in the US under the trade name Granix™.11correspondence: liat adar r&D, Teva Pharmaceutical industries ltd,  12 hatrufa street, industrial Zone,  netanya 42504, israel Tel +972 9 892 1741 Fax +972 9 865 3779 email liat.adar@teva.co.i l Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Adar et al Running head recto: Tbo-filgrastim QT study DOI: http://dx.doi.org/10.2147/DDDT.S81799",Non-OADS,/arxiv_data1/oa_pdf/46/bf/dddt-9-2653.PMC4440426.pdf
Available from: http://www.fda.gov/downloads/Drugs/ GuidanceComplia nceRegulatoryInformation/Guidances/UCM073153.,Non-OADS,/arxiv_data1/oa_pdf/46/bf/dddt-9-2653.PMC4440426.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/46/bf/dddt-9-2653.PMC4440426.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/bf/dddt-9-2653.PMC4440426.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d8/d2/ijn-10-3603.PMC4440427.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 3603–3622International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3603OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8039 7Development and molecular characterization  of polymeric micro-nanofibrous scaffold of a  defined 3-D niche for in vitro chemosensitivity  analysis against acute myeloid leukemia cells correspondence: Krishnakumar N  Menon; Ullas Mony amrita centre for Nanosciences and  Molecular Medicine, amrita Institute  of Medical sciences and research centre,  amrita Vishwa Vidyapeetham University,  amrita lane, Kochi-682 041, Kerala, India email krishnakumarmenon@aims.amrita.",Non-OADS,/arxiv_data1/oa_pdf/d8/d2/ijn-10-3603.PMC4440427.pdf
"Keywords:  daunorubicin, cytarabine, Bcl2, p27Kip1, cell adhesion-mediated drug resistance Introduction Hematological malignancy of acute myeloid leukemia (AML) type is highly heteroge - neous with a high incidence of relapse averaging 30%–50% in less than 5 years due to  drug resistance, even though 70%–80% patients undergo remission following induc - tion chemotherapy.1–3 Inability to clear the entire population of AML cells following  drug treatment has been attributed to the microenvironmental cell adhesion-mediated  drug-resistance (CAMDR) cues provided by the bone marrow 3-D structure to AML  cells.4 Differential interactions of AML cells with neighboring cells or with extracel - lular matrix (ECM) proteins in the bone marrow microenvironment have been shown  to impart CAMDR to AML cells.5–10 In this crucial scenario, the interaction of very  late antigen 4 (VLA 4) expressed by AML cells with stromal fibronectin (FN) plays  a major role in CAMDR.1,11 Thus, cell adhesion to a 3-D matrix could be effectively Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Nair et al Running head recto: Micro-nanofibrous scaffold for chemosensitivity analysis against AML cells DOI: http://dx.doi.org/10.2147/IJN.S80397",Non-OADS,/arxiv_data1/oa_pdf/d8/d2/ijn-10-3603.PMC4440427.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d8/d2/ijn-10-3603.PMC4440427.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/d2/ijn-10-3603.PMC4440427.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/65/9e/ndt-11-1203.PMC4440428.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNeuropsychiatric Disease and Treatment 2015:11 1203–1210Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1203OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7955 4The relationship of psychological trauma with  trichotillomania and skin picking eylem Özten1 Gökben Hızlı Sayar1 Gül Eryılmaz1 Gaye Kag ˘an2 Sibel Işık3 Og ˘uz Karamustafalıog ˘lu4 1Neuropsychiatry health, Practice,   and research center, Üsküdar  University, 2istanbul Neuropsychiatry  hospital, Üsküdar University, 3T urkish  Red Crescent Altıntepe Medical  center, 4Department of Psychology,   Faculty of human and social sciences,   Üsküdar University, istanbul, T urkeyObjective:  Interactions between psychological, biological and environmental factors are  important in development of trichotillomania and skin picking.",Non-OADS,/arxiv_data1/oa_pdf/65/9e/ndt-11-1203.PMC4440428.pdf
"The hair pulling behavior is  accompanied by a feeling of distress, and it leads to gratification or relief while pulling  the hair.1 TTM is mainly involved in pulling out hair, and less frequently pulling out  hairs from different parts of the body.2 The bodily area of pulling out hair is reported  as 75% scalp hair, 53% eyelashes, 42% eyebrows, 10% beard, and 17% pubic area,  and it is seen in more than one area with increasing age.3 TTM was classified under  the title of “Impulse Control Disorders Not Classified Elsewhere” in Diagnostic and  Statistical Manual of Mental Disorders , fourth edition, text revision (DSM-IV -R) and  as “Habit and Impulse Disorder” in International Classification of Diseases, tenth  revision (ICD-10).4 Although there are many assumptions about TTM, the etiology  is not clear.5 While discussing TTM to be classified within the obsessive spectrum  before Diagnostic and Statistical Manual of Mental Disorders , fifth edition (DSM-5), correspondence: eylem Özten NPİstanbul hastanesi alemda ğ caddessi,  siteyolu sokak No 27, Ümraniye,  İstanbul, Turkey Tel +90 21 6633 0633 Fax +90 21 6634 1250 email eylem.ozten@uskudar.edu.t r;  eylemozte n@yahoo.co mJournal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Özten et al Running head recto: Psychological trauma with trichotillomania and skin picking DOI: http://dx.doi.org/10.2147/NDT.S79554",Non-OADS,/arxiv_data1/oa_pdf/65/9e/ndt-11-1203.PMC4440428.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/65/9e/ndt-11-1203.PMC4440428.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/65/9e/ndt-11-1203.PMC4440428.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ae/d8/ott-8-1075.PMC4440429.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1075–1082OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1075Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8361 6circulating VegF as a biomarker for diagnosis  of ovarian cancer: a systematic review and  a meta-analysis Bin liang Qun he liansheng Zhong shaocheng Wang Zhongcheng Pan Tianjiao Wang Yujie Zhao Biochip center and state Key lab  of cell Biology, china Medical  University, shenyang, liaoning,   People’s republic of chinaAbstract:  VEGF is a frequently studied angiogenic factor in ovarian cancer (OC), and is  considered to have an important role in the progression of OC.",Non-OADS,/arxiv_data1/oa_pdf/ae/d8/ott-8-1075.PMC4440429.pdf
"VEGF, one of the key mediators of angiogenesis, promotes the recruitment and  proliferation of endothelial cells and their precursors within the tumor, and thus plays  a critical role in angiogenesis during tumor development.5,6 In 1994, Kondo et  al  first recognized the potential of VEGF as a serum diagnostic marker for malignant  disease.7 Accumulating evidence also has demonstrated that the circulating levels of correspondence: Yujie Zhao Biochip center and state Key lab  of cell Biology, china Medical University,  Beier road 92, heping District, shenyang,  liaoning 110001, People’s republic  of china  email zhaoyjchip@yeah.ne t Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Liang et al Running head recto: VEGF and ovarian cancer DOI: http://dx.doi.org/10.2147/OTT.S83616",OADS,/arxiv_data1/oa_pdf/ae/d8/ott-8-1075.PMC4440429.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ae/d8/ott-8-1075.PMC4440429.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/d8/ott-8-1075.PMC4440429.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/21/9b/dddt-9-2677.PMC4440430.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 2677–2685Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2677Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S7451 8The usefulness of ozone treatment in spinal pain velio Bocci1 emma Borrelli2 iacopo Zanardi1 valter Travagli1 1Department of Biotechnology,   Chemistry and Pharmacy, Università  degli Studi di Siena, 2Department of  Medical Biotechnologies, University of  Siena, Siena, italyObjective:  The aim of this review is to elucidate the biochemical, molecular, immunologi - cal, and pharmaceutical mechanisms of action of ozone dissolved in biological fluids.",Non-OADS,/arxiv_data1/oa_pdf/21/9b/dddt-9-2677.PMC4440430.pdf
"The lipid peroxidation by ozone leads to the simultaneous formation of both Correspondence: velio Bocci; valter  Travagli Università degli Studi di Siena, viale Aldo  Moro 2, 53100 Siena, italy Tel +39 05 7723 4226; 39 05 7723 4317 Fax +39 05 7723 4219; 39 05 7723 4333 email velio.bocci@unisi.i t;   valter.travagli@unisi.i tJournal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Bocci et al Running head recto: The usefulness of ozone treatment in spinal pain DOI: http://dx.doi.org/10.2147/DDDT.S74518",Non-OADS,/arxiv_data1/oa_pdf/21/9b/dddt-9-2677.PMC4440430.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/21/9b/dddt-9-2677.PMC4440430.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/21/9b/dddt-9-2677.PMC4440430.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/ijn-10-3593.PMC4440431.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nanomedicine 2015:10 3593–3601International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3593OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8248 2enhanced pharmacological activity of Vitamin B12  and Penicillin as nanoparticles Inbar Yariv1 anat lipovsky2 aharon gedanken2,3 rachel lubart4 Dror Fixler1 1Faculty of engineering and the  Institute of Nanotechnology  and advanced Materials, Bar-Ilan  University, ramat-gan, Israel;  2Department of chemistry, Kanbar  laboratory for Nanomaterials,   Institute of Nanotechnology and  advanced Materials, Bar-Ilan  University, ramat-gan, Israel;   3Department of Materials science  and engineering, National cheng Kung  University, Tainan, Taiwan; 4Physics  and chemistry Department, Bar-Ilan  University, ramat-gan, IsraelAbstract:  Sonochemistry has become a well-known technique for fabricating nanomaterials.",Non-OADS,/arxiv_data1/oa_pdf/b0/32/ijn-10-3593.PMC4440431.pdf
"It is well known that when the particle size decreases, the proportion of the surface correspondence: Dror Fixler Faculty of engineering and the Institute  of Nanotechnology and advanced  Materials, Bar-Ilan University, ramat-gan  5290002, Israel Tel +972 3 531 7598 Fax +972 3 738 4050 email dror.fixler@biu.ac.i l Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Y ariv et al Running head recto: Enhanced activity of Vitamin B12 and Penicillin as nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S82482",Non-OADS,/arxiv_data1/oa_pdf/b0/32/ijn-10-3593.PMC4440431.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b0/32/ijn-10-3593.PMC4440431.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/ijn-10-3593.PMC4440431.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/79/90/ndt-11-1191.PMC4440432.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNeuropsychiatric Disease and Treatment 2015:11 1191–1201Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1191OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8032 5Coping strategies, hope, and treatment efficacy  in pharmacoresistant inpatients with neurotic  spectrum disorders Marie Ociskova1,2 Jan Prasko2 Dana Kamaradova2 ales grambal2 Petra Kasalova2 Zuzana sigmundova2 Klara latalova2 Kristyna Vrbova2 1Department of Psychology, Faculty  of arts, 2Department of Psychiatry,   Faculty of Medicine and Dentistry,   Palacky University Olomouc,   University hospital Olomouc,   Olomouc, czech republicBackground:  Approximately 30%–60% of patients with neurotic spectrum disorders remain  symptomatic despite treatment.",Non-OADS,/arxiv_data1/oa_pdf/79/90/ndt-11-1191.PMC4440432.pdf
"Pavlova 6,   775 20 Olomouc, czech republic Tel +420 588 443 513 email praskojan@seznam.c z Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Ociskova et al Running head recto: Hope and treatment efficacy in resistant neuroses DOI: http://dx.doi.org/10.2147/NDT.S80325",Non-OADS,/arxiv_data1/oa_pdf/79/90/ndt-11-1191.PMC4440432.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/79/90/ndt-11-1191.PMC4440432.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/79/90/ndt-11-1191.PMC4440432.pdf
Available from:  http://www.edctp.org/fileadmin/documents/EMEA_ICH-GCP_Guide - lines_July_2002.pdf.,OADS,/arxiv_data1/oa_pdf/79/90/ndt-11-1191.PMC4440432.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f9/88/copd-10-947.PMC4440433.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2015:10 947–954International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  947OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8002 2Clinical, physiological, and radiological features  of asthma–chronic obstructive pulmonary  disease overlap syndrome T oshio suzuki Yuji Tada naoko Kawata Yukiko Matsuura Jun Ikari Yasunori Kasahara Koichiro Tatsumi Department of respirology, graduate  school of Medicine, Chiba University,   Chiba, JapanBackground:  Asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome  (ACOS) is associated with rapid decline in lung function, poorer health-related quality-of-life  outcomes, and frequent exacerbations, compared to COPD alone.",Non-OADS,/arxiv_data1/oa_pdf/f9/88/copd-10-947.PMC4440433.pdf
"However, there is little Correspondence: Yuji Tada Department of respirology, graduate  school of Medicine, Chiba University,  1-8-1 Inohana Chuo-ku, Chiba 260-8670,  Japan Tel +81 43 222 7171 Fax +81 43 226 2176 email ytada@faculty.chiba-u.j p Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Suzuki et al Running head recto: Clinical features of ACOS DOI: http://dx.doi.org/10.2147/COPD.S80022",Non-OADS,/arxiv_data1/oa_pdf/f9/88/copd-10-947.PMC4440433.pdf
"Available from: http://www.ginasthma.org/local/uploads/ files/AsthmaCOPDOverlap.pd f. Accessed March 10, 2015.",OADS,/arxiv_data1/oa_pdf/f9/88/copd-10-947.PMC4440433.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/f9/88/copd-10-947.PMC4440433.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f9/88/copd-10-947.PMC4440433.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3f/4f/opth-9-859.PMC4440434.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 859–864Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  859Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S6607 4Vitrectomy and internal limiting membrane  peeling for macular folds secondary to hypotony  in myopes Jeroni Nadal1–3 elisa Carreras2,3 Maria isabel Canut1–3 rafael i Barraquer1–3 1Centro de Oftalmologia Barraquer,   2Universitat autònoma de Barcelona,   3instituto Barraquer, Barcelona, spainBackground:  Hypotony maculopathy (HM) changes may persist, and visual acuity remains  poor, despite normalization of intraocular pressure (IOP).",Non-OADS,/arxiv_data1/oa_pdf/3f/4f/opth-9-859.PMC4440434.pdf
"The term “macular hypotony” was introduced Correspondence: elisa Carreras instituto Barraquer, 314 Muntaner,  Barcelona 08029, spain Tel +346 1631 0428 email elisa.carreras@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Case Series Y ear: 2015 Volume: 9 Running head verso: Nadal et al Running head recto: Vitrectomy and ILM peeling for macular folds DOI: http://dx.doi.org/10.2147/OPTH.S66074",Non-OADS,/arxiv_data1/oa_pdf/3f/4f/opth-9-859.PMC4440434.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/3f/4f/opth-9-859.PMC4440434.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/4f/opth-9-859.PMC4440434.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/49/97/jaa-8-039.PMC4440435.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Asthma and Allergy 2015:8 39–49Journal of Asthma and Allergy Dove press submit your manuscript | www.dovepress.co m Dove press  39Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S4930 6Bronchial thermoplasty in asthma:   current perspectives Balaji Laxmanan D Kyle Hogarth Section of Pulmonary and Critical  Care Medicine, University of Chicago  Medicine, Chicago, iL, USA Correspondence: Balaji Laxmanan;   D Kyle Hogarth   Section of Pulmonary and Critical   Care Medicine, University of Chicago  Medicine,  5841 S Maryland Ave,   MC 6076, Chicago, iL  60637, USA   Tel +1 77 3702 1806; +1 77 3702 4773  email balaji.laxmanan@uchospitals.ed u;  dhogarth@uchicago.ed uAbstract:  Bronchial thermoplasty (BT) is a novel therapy for patients with severe asthma.",Non-OADS,/arxiv_data1/oa_pdf/49/97/jaa-8-039.PMC4440435.pdf
"Future directions As a condition of the initial approval of BT, the United  States FDA required two additional postapproval evaluations,  including the  5-year follow-up results from the AIR-2 trial  (available at http://www.accessdata.fda.gov/cdrh_docs/pdf8/ P080032a.pd f).",Non-OADS,/arxiv_data1/oa_pdf/49/97/jaa-8-039.PMC4440435.pdf
"Available from: http://www.lung.org/finding-cures/our- research/trend-reports/asthma-trend-report.pd f. Accessed October  23,   2014.",Non-OADS,/arxiv_data1/oa_pdf/49/97/jaa-8-039.PMC4440435.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs307/en /.,Non-OADS,/arxiv_data1/oa_pdf/49/97/jaa-8-039.PMC4440435.pdf
"Available from:  http://www.ginasthma.org/local/uploads/files/GINA_Report_2015.pd f.  Accessed March 18, 2015.",OADS,/arxiv_data1/oa_pdf/49/97/jaa-8-039.PMC4440435.pdf
"Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-asthma-and-allergy-journa lThe Journal of Asthma and Allergy is an international, peer-reviewed  open-access journal publishing original research, reports, editorials  and commentaries on the following topics: Asthma; Pulmonary physi - ology; Asthma related clinical health; Clinical immunology and the  immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/49/97/jaa-8-039.PMC4440435.pdf
Visit http://www.dovepress.com/testimonials.ph p to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/49/97/jaa-8-039.PMC4440435.pdf
Available from: https://clinicaltrials.gov/ct2/ show/NCT0183959 1.,Non-OADS,/arxiv_data1/oa_pdf/49/97/jaa-8-039.PMC4440435.pdf
Available from: https://clinicaltrials.gov/ct2/ show/NCT0183236 3.,Non-OADS,/arxiv_data1/oa_pdf/49/97/jaa-8-039.PMC4440435.pdf
Available from:  https://clinicaltrials.gov/ct2/show/NCT0118527 5.,Non-OADS,/arxiv_data1/oa_pdf/49/97/jaa-8-039.PMC4440435.pdf
Available from:  https://clinicaltrials.gov/ct2/show/NCT0197492 1.,Non-OADS,/arxiv_data1/oa_pdf/49/97/jaa-8-039.PMC4440435.pdf
Available from: http://www.isrctn.com/ISRCTN9426392 2.,Non-OADS,/arxiv_data1/oa_pdf/49/97/jaa-8-039.PMC4440435.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3e/5e/opth-9-873.PMC4440436.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Ophthalmology 2015:9 873–876Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  873Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S8415 5Pharmacogenetics and nutritional  supplementation in age-related macular  degeneration Blake M Hampton Jaclyn L Kovach Stephen G Schwartz Department of Ophthalmology,   Bascom Palmer eye institute,   University of Miami Miller School  of Medicine, Miami, FL, USAAbstract:  The Age-Related Eye Disease Study (AREDS) recommended treatment with  antioxidants plus zinc in patients with intermediate or advanced age-related macular degeneration  in order to reduce progression risks.",Non-OADS,/arxiv_data1/oa_pdf/3e/5e/opth-9-873.PMC4440436.pdf
"Treatment with antioxidants plus zinc was associated with a statistically significant  reduction in disease progression in patients with intermediate (category 3) or advanced  (category 4) AMD by about 25% after 5 years.3 A subsequent RCT, AREDS2, reported no further benefit with the addition of  lutein plus zeaxanthin, docosahexaenoic acid plus eicosapentaenoic acid, or both.4 Correspondence: Stephen G Schwartz Bascom Palmer eye institute,  311 9th Street North, 100,  Naples, FL 34102, USA Tel +1 239 659 3937 Fax +1 239 659 3982 email sschwartz2@med.miami.ed u Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Hampton et al Running head recto: Pharmacogenetics and nutritional supplementation DOI: http://dx.doi.org/10.2147/OPTH.S84155",Non-OADS,/arxiv_data1/oa_pdf/3e/5e/opth-9-873.PMC4440436.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/3e/5e/opth-9-873.PMC4440436.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/5e/opth-9-873.PMC4440436.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provi ded the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/57/cku198.PMC4440449.pdf
"Available at: http://www.who.int/violence_injury_prevention/violence/en/ (20 March 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/48/57/cku198.PMC4440449.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/3a/sfu146.PMC4440461.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, andClin Kidney J (2015) 8: 248 –261 doi: 10.1093/ckj/sfv014 Advance Access publication 23 March 2015",Non-OADS,/arxiv_data1/oa_pdf/17/75/sfv014.PMC4440462.pdf
http://epp.eurostat.ec.europa.eu/portal/page/portal/ population/data/database .,OADS,/arxiv_data1/oa_pdf/17/75/sfv014.PMC4440462.pdf
Some recommendations based on low-grade evi- dence have been reported by the Italian Society ofNephrology ( http://www.nephromeet.com/web/procedure/ documenti.cfm?p=lg_2edizione# ).,Non-OADS,/arxiv_data1/oa_pdf/d5/ec/sfv016.PMC4440463.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/ec/sfv016.PMC4440463.pdf
"For this reason, it is mandatory to check frequently for haemoglobin levels in the peritoneal ﬂuid that would be a sign of abortion or amniorexis ( http://www.nephro meet.com/web/procedure/docu menti.cfm?p=lg_2edizione# ).",Non-OADS,/arxiv_data1/oa_pdf/d5/ec/sfv016.PMC4440463.pdf
"The aggressive management for such patients has the follow- ing major components ( http://www.nephromeet.com/web/ procedure/documenti.cfm?p=lg_2edizione# )[8,18,24]: (i) more intensive dialysis schedule with blood urea nitro- gen (BUN) levels <16 –18 mmol/L.",Non-OADS,/arxiv_data1/oa_pdf/d5/ec/sfv016.PMC4440463.pdf
"This is usually achieved by increasing the frequency of HD, switching to long nightly HD or lowering the volume of dwells to 800 mL raising their frequency as well in patients on peritoneal dialysis ( http://www.nephromeet.com/web/ procedure/documenti.cfm?p=lg_2edizione# ).",Non-OADS,/arxiv_data1/oa_pdf/d5/ec/sfv016.PMC4440463.pdf
"Moreover, it is important to add 20 g/ day of proteins to daily maternal needs for the correctfetal growth [ 2,38](http://www.nephromeet.com/web/ procedure/documenti.cfm?p=lg_2edizione# ).",Non-OADS,/arxiv_data1/oa_pdf/d5/ec/sfv016.PMC4440463.pdf
The caloric intake in this clinical setting should be of 35 kcal/kg of body weight/day in HD and 25 kcal/kg ofbody weight/day in peritoneal dialysis and folate supple- mentation with 1 mg/day should be administered starting from the ﬁrst trimester ( http://www.nephromeet.com/ web/procedure/documenti.cfm?p=lg_2edizione# ).,Non-OADS,/arxiv_data1/oa_pdf/d5/ec/sfv016.PMC4440463.pdf
"Published by Oxford University Press on behalf of ERAEDTA.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/9d/sfv017.PMC4440464.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/e1/sfv018.PMC4440465.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0b/27/sfv019.PMC4440466.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/8d/sfv020.PMC4440467.pdf
"Fluorodeoxyglucose (18F-FDG or FDG), a radiolabeled glucose molecule, is the radiotracer used for this imagingtechnique.18F-FDG has a radioactivity half-life of ∼110 min (identical to that of ﬂuorine 18 [18F]) and is not known to cause contrast-induced nephropathy [ http://dailymed.nlm.",Non-OADS,/arxiv_data1/oa_pdf/d0/8d/sfv020.PMC4440467.pdf
BV AS v.3 represents an improvement on the two earlier versions and can be freely accessed online [ http://vasculitis.org/images/ documents/bvas%203.0.pdf (date of access 19 March 2015); http://www.epsnetwork.co.uk/BV AS/bvas_ ﬂow.html (date of access 09 January 2015)].,Non-OADS,/arxiv_data1/oa_pdf/d0/8d/sfv020.PMC4440467.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ba/fd/sfv021.PMC4440468.pdf
"Published by Oxford University Press on behalf of ERAEDTA.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/3c/sfv022.PMC4440469.pdf
"Irrespective of the origin, the toll of disaster victims is growing ( http://earthquake.usgs.gov/earthquakes/world/ world_deaths.php ) due to a dramatic rise in global popula- tion density with ﬁnancially deprived people being forced to live in the most endangered areas.",Non-OADS,/arxiv_data1/oa_pdf/a0/cd/sfv024.PMC4440471.pdf
"After the Haiti earthquake, 230 000 people died, and an- other 300 000 were injured, with an earthquake magnitude of 7.0 on the Richter ’ss c a l e( http://news.bbc.co.uk/2/hi/americas/ 8507531.stm ;http://earthquake.usgs.gov/earthquakes/pager/ events/us/2010rja6/index.html .",OADS,/arxiv_data1/oa_pdf/a0/cd/sfv024.PMC4440471.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/cd/sfv024.PMC4440471.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/7f/sfv025.PMC4440472.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/cd/sfv026.PMC4440473.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/93/sfv027.PMC4440474.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/06/3c/sfv029.PMC4440475.pdf
"Comparison of the impact of dialysis treatment type on patient survival [online]: http://clinicaltrials.gov/ct2/show/ NCT00510549 (25 September 2008, date last accessed) 46.",Non-OADS,/arxiv_data1/oa_pdf/06/3c/sfv029.PMC4440475.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/91/sfv030.PMC4440476.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/8d/sfv033.PMC4440477.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/43/2a/sfv035.PMC4440478.pdf
"Source: UNdata 2012 ( https:// data.un.org/Data ), except for Scotland and Spanish Regions 2013 ( http://www.ine.es/en/prensa/np835_en.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/43/2a/sfv035.PMC4440478.pdf
Source: UNdata ( https://data.un.org/ Data ).,OADS,/arxiv_data1/oa_pdf/43/2a/sfv035.PMC4440478.pdf
"Mutations of the Molecular Vision  2015; 21:532-537 <http://www.molvis.org/molvis/v 21/532> Received 19 February 2015 | Accepted 30 April 2015 | Published 2 May 2015© 2015 Molecular Vision 532Inactivation of acyclovir-sensitive and -resistant strains of herpes  simplex virus type 1 in vitro by photodynamic antimicrobial  chemotherapy Miftahul Akhyar Latief,1,2,3 Taiichiro Chikama,1 Ji-Ae Ko,1 Yoshiaki Kiuchi,1 Takemasa Sakaguchi,4 Akira  Obana5 1Department of Ophthalmology and Visual Science, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima,  Japan; 2Medical Faculty, Muhammadiyah University, Makassar, South Sulawesi, Indonesia; 3Department of Ophthalmology,  Hasanuddin University, Makassar, South Sulawesi, Indonesia; 4Department of Virology, Graduate School of Biomedical Sciences,  Hiroshima University, Hiroshima, Japan; 5Department of Ophthalmology, Seirei Hamamatsu General Hospital, Shizuoka, Japan Purpose:  To evaluate the efficacy of photodynamic antimicrobial chemotherapy (PACT) with the new porphyrin deriva - tive TONS 504 and a light-emitting diode (LED) against acyclovir (ACV)-sensitive and -resistant herpes simplex virus  type 1 (HSV-1).",Non-OADS,/arxiv_data1/oa_pdf/7f/7a/mv-v21-532.PMC4440479.pdf
Molecular Vision  2015; 21:532-537 <http://www.molvis.org/molvis/v 21/532> © 2015 Molecular Vision  533viral DNA polymerase have also been associated with ACV  resistance in a small proportion of HSV isolates [ 4].,Non-OADS,/arxiv_data1/oa_pdf/7f/7a/mv-v21-532.PMC4440479.pdf
"Molecular Vision  2015; 21:532-537 <http://www.molvis.org/molvis/v 21/532> © 2015 Molecular Vision  534measurements, we included a 1-min rest period between each  3-min light exposure to avoid a problematic increase in the  temperature of the incubation medium (data not shown) [ 11].",Non-OADS,/arxiv_data1/oa_pdf/7f/7a/mv-v21-532.PMC4440479.pdf
"Molecular Vision  2015; 21:532-537 <http://www.molvis.org/molvis/v 21/532> © 2015 Molecular Vision  535manner dependent on LED energy and TONS 504 concentra - tion (Table 1, Figure 1).",Non-OADS,/arxiv_data1/oa_pdf/7f/7a/mv-v21-532.PMC4440479.pdf
Molecular Vision  2015; 21:532-537 <http://www.molvis.org/molvis/v 21/532> © 2015 Molecular Vision  536experiments revealed the lack of effect of TONS 504-PACT on  host cell viability as evaluated based on nuclear morphology  compared with the corresponding value for uninfected cells  not subjected to TONS 504-PACT.,Non-OADS,/arxiv_data1/oa_pdf/7f/7a/mv-v21-532.PMC4440479.pdf
Molecular Vision  2015; 21:532-537 <http://www.molvis.org/molvis/v 21/532> © 2015 Molecular Vision  5374.,Non-OADS,/arxiv_data1/oa_pdf/7f/7a/mv-v21-532.PMC4440479.pdf
"Moreover, molecular analyses of  TAg-RB tumors have indicated that these tumors recapitu - late several of the gene expression changes documented in Molecular Vision  2015; 21:515-522 <http://www.molvis.org/molvis/v 21/515> Received 19 January 2015 | Accepted 29 April 2015 | Published 1 May 2015© 2015 Molecular Vision 515Optical coherence tomography enables imaging of tumor  initiation in the TAg-RB mouse model of retinoblastoma Andrea A. Wenzel,1 Michael N. O’Hare,1,2 Mehdi Shadmand,1 Timothy W. Corson1,3,4,5 1Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana University School of Medicine, Indianapolis,  IN; 2School of Biomedical Science, University of Ulster, Coleraine, Northern Ireland, UK; 3Department of Biochemistry and  Molecular Biology, Indiana University School of Medicine, Indianapolis, IN; 4Department of Pharmacology and Toxicology,  Indiana University School of Medicine, Indianapolis, IN; 5Indiana University Melvin and Bren Simon Cancer Center,  Indianapolis, IN Purpose:  Retinoblastoma is the most common primary intraocular malignancy in children.",Non-OADS,/arxiv_data1/oa_pdf/e4/b9/mv-v21-515.PMC4440496.pdf
"Molecular Vision  2015; 21:515-522 <http://www.molvis.org/molvis/v 21/515> © 2015 Molecular Vision  516human retinoblastoma [ 11,19-22].",Non-OADS,/arxiv_data1/oa_pdf/e4/b9/mv-v21-515.PMC4440496.pdf
Molecular Vision  2015; 21:515-522 <http://www.molvis.org/molvis/v 21/515> © 2015 Molecular Vision  517Ocular optical coherence tomography (OCT) is one  such method.,Non-OADS,/arxiv_data1/oa_pdf/e4/b9/mv-v21-515.PMC4440496.pdf
Molecular Vision  2015; 21:515-522 <http://www.molvis.org/molvis/v 21/515> © 2015 Molecular Vision  518 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/e4/b9/mv-v21-515.PMC4440496.pdf
"Molecular Vision  2015; 21:515-522 <http://www.molvis.org/molvis/v 21/515> © 2015 Molecular Vision  519point of therapeutic intervention, in vivo imaging of the first  weeks of tumor growth in a retinoblastoma animal model  has not been performed previously.",Non-OADS,/arxiv_data1/oa_pdf/e4/b9/mv-v21-515.PMC4440496.pdf
"Molecular Vision  2015; 21:515-522 <http://www.molvis.org/molvis/v 21/515> © 2015 Molecular Vision  520Tumor burden at this stage ranged from one to four  individual tumors per TAg-RB eye, but tumors in the far  periphery may have been missed on exam due to the limita - tions of the OCT and fundus camera optics.",Non-OADS,/arxiv_data1/oa_pdf/e4/b9/mv-v21-515.PMC4440496.pdf
Molecular Vision  2015; 21:515-522 <http://www.molvis.org/molvis/v 21/515> © 2015 Molecular Vision  5213.,Non-OADS,/arxiv_data1/oa_pdf/e4/b9/mv-v21-515.PMC4440496.pdf
Molecular Vision  2015; 21:515-522 <http://www.molvis.org/molvis/v 21/515> © 2015 Molecular Vision  52229.,Non-OADS,/arxiv_data1/oa_pdf/e4/b9/mv-v21-515.PMC4440496.pdf
"Eyes were cut  into 20 µm thick sections, washed in PBS (137 mM sodium  chloride, 2.7 mM potassium chloride, 1.5 mM potassium Molecular Vision  2015; 21:538-547 <http://www.molvis.org/molvis/v 21/538> Received 11 February 2015 | Accepted 30 April 2015 | Published 2 May 2015© 2015 Molecular Vision 538Third harmonic generation microscopy of a mouse retina Omid Masihzadeh,1 Tim C. Lei,2 Scott R. Domingue,3 Malik Y. Kahook,1 Randy A. Bartels,3 David A. Ammar1 1Department of Ophthalmology, University of Colorado Denver, Aurora, CO; 2Department of Electrical Engineering, University  of Colorado Denver, Denver, CO; 3Department of Electrical Engineering, Colorado State University, Fort Collins, CO Purpose:  To demonstrate lipid-specific imaging of the retina through the use of third harmonic generation (THG), a  multiphoton microscopic technique in which tissue contrast is generated from optical inhomogeneities.",Non-OADS,/arxiv_data1/oa_pdf/ea/12/mv-v21-538.PMC4440497.pdf
"Molecular Vision  2015; 21:538-547 <http://www.molvis.org/molvis/v 21/538> © 2015 Molecular Vision  539phosphate monobasic, 8.1 mM sodium phosphate dibasic,  pH 7.4), and then mounted in PBS for THG/TPAF imaging.",Non-OADS,/arxiv_data1/oa_pdf/ea/12/mv-v21-538.PMC4440497.pdf
"Molecular Vision  2015; 21:538-547 <http://www.molvis.org/molvis/v 21/538> © 2015 Molecular Vision  540+), and based on the position, size, and DNA staining, we  concluded that these were the cells of the ganglion cell layer  (GCL).",OADS,/arxiv_data1/oa_pdf/ea/12/mv-v21-538.PMC4440497.pdf
Molecular Vision  2015; 21:538-547 <http://www.molvis.org/molvis/v 21/538> © 2015 Molecular Vision  541noticeable difference here was the source of the THG signal  predominantly from the pigment granules in the RPE cells  (+).,Non-OADS,/arxiv_data1/oa_pdf/ea/12/mv-v21-538.PMC4440497.pdf
Molecular Vision  2015; 21:538-547 <http://www.molvis.org/molvis/v 21/538> © 2015 Molecular Vision  542segments contain a large degree of tightly-packed protein and  lipid disks compared to the inner segments.,Non-OADS,/arxiv_data1/oa_pdf/ea/12/mv-v21-538.PMC4440497.pdf
Molecular Vision  2015; 21:538-547 <http://www.molvis.org/molvis/v 21/538> © 2015 Molecular Vision  543three-dimensional scaffolds [ 22-24].,Non-OADS,/arxiv_data1/oa_pdf/ea/12/mv-v21-538.PMC4440497.pdf
Molecular Vision  2015; 21:538-547 <http://www.molvis.org/molvis/v 21/538> © 2015 Molecular Vision  544setups that would result in additional layers of complexity  and cost.,Non-OADS,/arxiv_data1/oa_pdf/ea/12/mv-v21-538.PMC4440497.pdf
"Molecular Vision  2015; 21:538-547 <http://www.molvis.org/molvis/v 21/538> © 2015 Molecular Vision  5458 mW of average power for 22 s exposure (the acquisition  time per frame), our radiation power is more than five times  the American National Standards Institute (ANSI) MPE.",Non-OADS,/arxiv_data1/oa_pdf/ea/12/mv-v21-538.PMC4440497.pdf
Molecular Vision  2015; 21:538-547 <http://www.molvis.org/molvis/v 21/538> © 2015 Molecular Vision  546tissue in confocal laser scanning microscopy (CLSM).,Non-OADS,/arxiv_data1/oa_pdf/ea/12/mv-v21-538.PMC4440497.pdf
"Molecular Vision  2015; 21:538-547 <http://www.molvis.org/molvis/v 21/538> © 2015 Molecular Vision  547Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R.",Non-OADS,/arxiv_data1/oa_pdf/ea/12/mv-v21-538.PMC4440497.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f9/d5/hiv-7-157.PMC4440576.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pHIV/AIDS – Research and Palliative Care 2015:7 157–165HIV/AIDS – Research and Palliative Care Dove press submit your manuscript | www.dovepress.co m Dove press  157ORIg InAl ReSeARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HIV.S8164 9Factors affecting acceptance of provider-initiated  HIV testing and counseling services among  outpatient clients in selected health facilities   in Harar T own, eastern ethiopia Sami Abdurahman1 Berhanu Seyoum2 lemessa Oljira2 Fitsum Weldegebreal2 1Harari Regional Health Bureau,   2Haramaya University, College   of Health and Medical Sciences,  Harar, ethiopia Correspondence: Fitsum Weldegebreal   Haramaya University, College of Health  and Medical Sciences, Department of  Medical laboratory Sciences, PO Box  235, Harar, ethiopia   email fwmlab2000@gmail.co mPurpose:  To improve the slow uptake of HIV counseling and testing, the World Health Orga - nization (WHO) and the Joint United Nations Programme on HIV/AIDS (UNAIDS) have  developed draft guidelines on provider-initiated testing and counseling (PITC).",Non-OADS,/arxiv_data1/oa_pdf/f9/d5/hiv-7-157.PMC4440576.pdf
"HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hivaids---research-and-palliative-care-journa lHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open-access journal focusing on advances in research in HIV ,  its clinical progression and management options including antiviral  treatment, palliative care and public healthcare policies to control  viral spread.",Non-OADS,/arxiv_data1/oa_pdf/f9/d5/hiv-7-157.PMC4440576.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f9/d5/hiv-7-157.PMC4440576.pdf
"Available from: http://cnhde.ei.columbia.edu/files/5/6/2008-Feb- Fri-102213.pd f. Accessed on June 1, 2011.",OADS,/arxiv_data1/oa_pdf/f9/d5/hiv-7-157.PMC4440576.pdf
"This is an open access article, published  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0).",Non-OADS,/arxiv_data1/oa_pdf/d0/e0/JVR-06-01.PMC4440708.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1b/4b/dddt-9-2647.PMC4440878.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 2647–2652Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2647Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8291 7construction of interference vector targeting   Ep-CAM  gene and its effects on colorectal cancer  cell proliferation Yanmei Qi1 Fengqiang Zhou2 lu Zhang2 lei liu2 hong Xu2 huiguang guo2 1Department of gastroenterology,   2Department of general surgery,   Binzhou People’s hospital, Binzhou,   shandong, People’s republic of chinaBackground:  Prior study indicates that abnormal protein expression and functional changes  in the development and progression of colorectal cancer is related to gene expression.",Non-OADS,/arxiv_data1/oa_pdf/1b/4b/dddt-9-2647.PMC4440878.pdf
"In-depth study of molecular events in  the heterogeneity is an important method to determine the tumor treatment and new  therapeutic targets.4,5correspondence: Fengqiang Zhou Department of general surgery,  Binzhou People’s hospital, 515,  huanghe 7th road, Bincheng,  Binzhou 256600, shandong,  People’s republic of china Tel +86 543 328 2500 Fax +86 543 328 2500 email zhouffhu8013@yeah.ne t Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Qi et al Running head recto: Ep-CAM  gene expression on colorectal cancer cells DOI: http://dx.doi.org/10.2147/DDDT.S82917",Non-OADS,/arxiv_data1/oa_pdf/1b/4b/dddt-9-2647.PMC4440878.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/1b/4b/dddt-9-2647.PMC4440878.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/4b/dddt-9-2647.PMC4440878.pdf
"181© 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Journal of Pathology and Translational Medicine 2015; 49: 181-208 http://dx.doi.org/10.4132/jptm.2015.02.25▒ REVIEW ▒ Galectins: Double-edged Swords in the Cross-roads of Pregnancy  Complications and Female Reproductive Tract Inflammation and Neoplasia Nandor Gabor Than1,2,3,4,5  Roberto Romero1 · Andrea Balogh1,6  Eva Karpati3,6  Salvatore Andrea Mastrolia7,8  Orna Staretz-Chacham9  Sinuhe Hahn10 · Offer Erez1,2,7  Zoltan Papp4 · Chong Jai Kim1,11,12 1Perinatology Research Branch, Eunice   Kennedy Shriver National Institute of Child Health  and Human Development, National Institutes of Health, Department of Health and Human  Services, Detroit, MI, USA;  2Department of  Obstetrics and Gynecology, Wayne State  University School of Medicine, Detroit, MI, USA;  3Institute of Enzymology, Research Centre for  Natural Sciences, Hungarian Academy of  Sciences Budapest, Budapest, Hungary;  4Maternity Private Department, Kutvolgyi  Clinical Block, Semmelweis University, Budapest,  Hangary; 5First Department of Pathology and  Experimental Cancer Research, Semmelweis  University, Budapest, Hungary; 6Department of  Immunology, Eotvos Lorand University,  Budapest, Hungary; 7Department of Obstetrics  and Gynecology, Ben-Gurion University, Beer-Sheva, Israel;  8Department of Obstetrics  and Gynecology, University of Bari Aldo Moro, Bari, Italy;  9Department of Neonatology,  Ben-Gurion University, Beer-Sheva, Israel;  10Department of Biomedicine, University Hospital  Basel, Basel, Switzerland; 11Department of  Pathology, Wayne State University, Detroit, MI, USA;  12Department of Pathology, Asan Medical  Center, University of Ulsan College of Medicine, Seoul, KoreaGalectins are an evolutionarily ancient and widely expressed family of lectins that have unique  glycan-binding characteristics.",Non-OADS,/arxiv_data1/oa_pdf/7a/9b/jptm-49-3-181.PMC4440931.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.02.25182     •  Than NG, et al.",OADS,/arxiv_data1/oa_pdf/7a/9b/jptm-49-3-181.PMC4440931.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.02.25Galectins in Pregnancy, Inflammation, and Neoplasia   •     183 shuttle into the nucleus where they function in pre-mRNA splic - ing.8,59 In spite of the fact that they do not have a secretory signal  sequence, galectins can be secreted from cells via a non-classical  pathway, avoiding the endoplasmic reticulum and Golgi appara - tus, which is characteristic of only a small set of proteins (e.g.",Non-OADS,/arxiv_data1/oa_pdf/7a/9b/jptm-49-3-181.PMC4440931.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.02.25184     •  Than NG, et al.",OADS,/arxiv_data1/oa_pdf/7a/9b/jptm-49-3-181.PMC4440931.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.02.25Galectins in Pregnancy, Inflammation, and Neoplasia   •     185 tube and induces apoptosis of cells not protected by galectin-3.",Non-OADS,/arxiv_data1/oa_pdf/7a/9b/jptm-49-3-181.PMC4440931.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.02.25186     •  Than NG, et al.",OADS,/arxiv_data1/oa_pdf/7a/9b/jptm-49-3-181.PMC4440931.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.02.25Galectins in Pregnancy, Inflammation, and Neoplasia   •     187 GALECTINS IN TUMORS OF THE FEMALE  REPRODUCTIVE TRACT The multifunctional role of galectins in cell growth, differen- tiation, apoptosis, adhesion, invasion, and angiogenesis explains  why they are associated with different tumors.",Non-OADS,/arxiv_data1/oa_pdf/7a/9b/jptm-49-3-181.PMC4440931.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.02.25188     •  Than NG, et al.",OADS,/arxiv_data1/oa_pdf/7a/9b/jptm-49-3-181.PMC4440931.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.02.25Galectins in Pregnancy, Inflammation, and Neoplasia   •     189 Galectins in tumor immune tolerance Studies published to date mainly address the involvement of  galectin-1 in tumor immune escape.",Non-OADS,/arxiv_data1/oa_pdf/7a/9b/jptm-49-3-181.PMC4440931.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.02.25190     •  Than NG, et al.",OADS,/arxiv_data1/oa_pdf/7a/9b/jptm-49-3-181.PMC4440931.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.02.25Galectins in Pregnancy, Inflammation, and Neoplasia   •     191 fined.",Non-OADS,/arxiv_data1/oa_pdf/7a/9b/jptm-49-3-181.PMC4440931.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.02.25192     •  Than NG, et al.",OADS,/arxiv_data1/oa_pdf/7a/9b/jptm-49-3-181.PMC4440931.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.02.25Galectins in Pregnancy, Inflammation, and Neoplasia   •     193 TIM-3+ uNK cells was detected in human miscarriages and abor - tion-prone murine models, and a Th2/Th1 imbalance was de- tected in TIM-3+ uNK cells in human and mouse miscarriages,  suggesting the importance of the galectin-9/TIM-3 pathway.235  Moreover, Treg cells increase their galectin-9 expression with advancing gestational age in accord with the increasing galec- tin-9 concentrations in maternal blood, suggesting that galec-tin-9 expressing Treg cells may have important roles in the maintenance of pregnancy.",Non-OADS,/arxiv_data1/oa_pdf/7a/9b/jptm-49-3-181.PMC4440931.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.02.25194     •  Than NG, et al.",OADS,/arxiv_data1/oa_pdf/7a/9b/jptm-49-3-181.PMC4440931.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.02.25Galectins in Pregnancy, Inflammation, and Neoplasia   •     195 IUGR is one of the most heterogeneous syndromes in obstet- rics; it is associated with fetal malformations and chromosomal  abnormalities, as well as maternal autoimmune disorders and  placental dysfunction resulting from poor implantation, making the understanding of an IUGR fetus a challenge.",Non-OADS,/arxiv_data1/oa_pdf/7a/9b/jptm-49-3-181.PMC4440931.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.02.25196     •  Than NG, et al.",OADS,/arxiv_data1/oa_pdf/7a/9b/jptm-49-3-181.PMC4440931.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.02.25Galectins in Pregnancy, Inflammation, and Neoplasia   •     197 ground risks, MAP , Doppler PI, and a panel of blood biomarkers  that can yield much higher predictive value and accuracy than  individual markers,306 especially for early-onset (< 34 weeks) and  preterm (< 37 weeks) preeclampsia.",Non-OADS,/arxiv_data1/oa_pdf/7a/9b/jptm-49-3-181.PMC4440931.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.02.25198     •  Than NG, et al.",OADS,/arxiv_data1/oa_pdf/7a/9b/jptm-49-3-181.PMC4440931.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.02.25Galectins in Pregnancy, Inflammation, and Neoplasia   •     199 in the fetal membranes?",Non-OADS,/arxiv_data1/oa_pdf/7a/9b/jptm-49-3-181.PMC4440931.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.02.25200     •  Than NG, et al.",OADS,/arxiv_data1/oa_pdf/7a/9b/jptm-49-3-181.PMC4440931.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.02.25Galectins in Pregnancy, Inflammation, and Neoplasia   •     201 95.",Non-OADS,/arxiv_data1/oa_pdf/7a/9b/jptm-49-3-181.PMC4440931.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.02.25202     •  Than NG, et al.",OADS,/arxiv_data1/oa_pdf/7a/9b/jptm-49-3-181.PMC4440931.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.02.25Galectins in Pregnancy, Inflammation, and Neoplasia   •     203 ase-9 by galectin-7 through p38 MAPK signaling in HeLa human  cervical epithelial adenocarcinoma cells.",Non-OADS,/arxiv_data1/oa_pdf/7a/9b/jptm-49-3-181.PMC4440931.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.02.25204     •  Than NG, et al.",OADS,/arxiv_data1/oa_pdf/7a/9b/jptm-49-3-181.PMC4440931.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.02.25Galectins in Pregnancy, Inflammation, and Neoplasia   •     205 ulation of expression.",Non-OADS,/arxiv_data1/oa_pdf/7a/9b/jptm-49-3-181.PMC4440931.pdf
http://dx.doi.org/10.1038/cmi.2014.126.,Non-OADS,/arxiv_data1/oa_pdf/7a/9b/jptm-49-3-181.PMC4440931.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.02.25206     •  Than NG, et al.",OADS,/arxiv_data1/oa_pdf/7a/9b/jptm-49-3-181.PMC4440931.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.02.25Galectins in Pregnancy, Inflammation, and Neoplasia   •     207 HELLP syndrome: an overview.",Non-OADS,/arxiv_data1/oa_pdf/7a/9b/jptm-49-3-181.PMC4440931.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.02.25208     •  Than NG, et al.",OADS,/arxiv_data1/oa_pdf/7a/9b/jptm-49-3-181.PMC4440931.pdf
"209© 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Advances in the Endoscopic Assessment of Inflammatory Bowel Diseases:  Cooperation between Endoscopic and Pathologic Evaluations Jae Hee Cheon Department of Internal Medicine,   Yonsei University College of Medicine,   Seoul, KoreaEndoscopic assessment has a crucial role in the management of inflammatory bowel disease  (IBD).",Non-OADS,/arxiv_data1/oa_pdf/b7/4b/jptm-49-3-209.PMC4440932.pdf
"Key Words:  Inflammatory bowel diseases; High definition endoscopy; Chromoendoscopy; Narrow  band imaging; Microscopy, confocal; iScan; Autofluorescence imaging; EndocytoscopyReceived:  March 30, 2015 Accepted:  April 9, 2015 Corresponding Author Jae Hee Cheon, M.D., Ph.D.  Department of Internal Medicine and   Institute of Gastroenterology, Yonsei University  College of Medicine, 50-1 Yonsei-ro,   Seodaemun-gu, Seoul 120-752, Korea  Tel: +82-2-2228-1990 Fax: +82-2-393-6884 E-mail: geniushee@yuhs.acJournal of Pathology and Translational Medicine 2015; 49: 209-217 http://dx.doi.org/10.4132/jptm.2015.04.09▒ REVIEW ▒ Inflammatory bowel disease (IBD) includes Crohn’s disease  (CD) and ulcerative colitis (UC), is a chronic, relapsing inflam - matory disease in the gastrointestinal tract.",Non-OADS,/arxiv_data1/oa_pdf/b7/4b/jptm-49-3-209.PMC4440932.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.09210     •  Cheon JH However, these biopsies can be time consuming and laborious.",Non-OADS,/arxiv_data1/oa_pdf/b7/4b/jptm-49-3-209.PMC4440932.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.09Advances in Endoscopy in IBD   •     211 staining agents (e.g., congo red and phenol red) can be used in  dye-based chromoendoscopy.17,18 Several studies have shown the  superiority of chromoendoscopy compared to conventional white  light endoscopy.",Non-OADS,/arxiv_data1/oa_pdf/b7/4b/jptm-49-3-209.PMC4440932.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.09212     •  Cheon JH white light colonoscopy alone.,Non-OADS,/arxiv_data1/oa_pdf/b7/4b/jptm-49-3-209.PMC4440932.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.09Advances in Endoscopy in IBD   •     213 the cellular structure of the mucosa with 1,500 fold magnifica - tion.38 Currently, two endomicroscopy systems are available in - cluding an integrated endoscopy system (iCLE, Pentax) and a  probe-based system (pCLE, Cellvizio, Mauna Kea Technologies,  Paris, France).",Non-OADS,/arxiv_data1/oa_pdf/b7/4b/jptm-49-3-209.PMC4440932.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.09214     •  Cheon JH a relatively high quantum yield, so the extracellular matrix usu - ally contributes to the autofluorescence emission more than cel - lular components.",OADS,/arxiv_data1/oa_pdf/b7/4b/jptm-49-3-209.PMC4440932.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.09Advances in Endoscopy in IBD   •     215 dure should be confirmed with more well designed clinical in - vestigations.,Non-OADS,/arxiv_data1/oa_pdf/b7/4b/jptm-49-3-209.PMC4440932.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.09216     •  Cheon JH differentiation of neoplastic and nonneoplastic lesions in the colon  (with videos).,Non-OADS,/arxiv_data1/oa_pdf/b7/4b/jptm-49-3-209.PMC4440932.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.09Advances in Endoscopy in IBD   •     217 sia in colonic polyps.,Non-OADS,/arxiv_data1/oa_pdf/b7/4b/jptm-49-3-209.PMC4440932.pdf
"218pISSN 2383-7837 eISSN 2383-7845 © 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Pathology-MRI Correlation of Hepatocarcinogenesis: Recent Update Jimi Huh1 · Kyung Won Kim1,2  Jihun Kim2,3 · Eunsil Yu2,3 1Department of Radiology, 2Asan Liver Center,   3Department of Pathology, Asan Medical Center,   University of Ulsan College of Medicine,   Seoul, KoreaUnderstanding the important alterations during hepatocarcinogenesis as well as the characteris - tic magnetic resonance imaging (MRI) and histopathological features will be helpful for managing  patients with chronic liver disease and hepatocellular carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/c1/3b/jptm-49-3-218.PMC4440933.pdf
"Key Words:  Hepatocarcinogenesis; Magnetic resonance image; Carcinoma, hepatocellular; PathologyReceived:  April 7, 2015 Accepted:  April 14, 2015 Corresponding Author Kyung Won Kim, M.D., Ph.D. Department of Radiology, Asan Medical Center,  University of Ulsan College of Medicine,   88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736,  Korea  Tel: +82-2-3010-4377 Fax: +82-2-3010-8724 E-mail: medimash@gmail.comJournal of Pathology and Translational Medicine 2015; 49: 218-229 http://dx.doi.org/10.4132/jptm.2015.04.15▒ REVIEW ▒ Hepatocellular carcinoma (HCC) is the sixth most common  cancer worldwide and the third most common cause of death  from cancer.1 Asia is an endemic area of HCC.",Non-OADS,/arxiv_data1/oa_pdf/c1/3b/jptm-49-3-218.PMC4440933.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.15Pathology and MRI for Hepatocarcinogenesis   •     219 allel to the evolution of hepatic fibrosis or cirrhosis.13,14  This linear, repetitive, and successive process of the expansion  and development of less differentiated, aberrant clonal popula - tions of hepatocytes causes their evolution over time.15 These de - differentiated clonal populations eventually completely replace  those of the more differentiated environment.",Non-OADS,/arxiv_data1/oa_pdf/c1/3b/jptm-49-3-218.PMC4440933.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.15220     •  Huh J, et al.",OADS,/arxiv_data1/oa_pdf/c1/3b/jptm-49-3-218.PMC4440933.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.15Pathology and MRI for Hepatocarcinogenesis   •     221 large lesions greater than 2 cm in diameter, which are termed  “large HCCs,” have variable macroscopic features.",Non-OADS,/arxiv_data1/oa_pdf/c1/3b/jptm-49-3-218.PMC4440933.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.15222     •  Huh J, et al.",OADS,/arxiv_data1/oa_pdf/c1/3b/jptm-49-3-218.PMC4440933.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.15Pathology and MRI for Hepatocarcinogenesis   •     223 echo or turbo spin-echo, and sequences exaggerating T2 of tis - sues, including single-shot fast spin-echo or half-Fourier acquisi - tion single-shot turbo spin-echo.29  T1-weighted, dual gradient-echo sequence (in-phase and  oppposed-phase) A T1-weighted, dual gradient-echo sequence is composed of an in-phase image and an opposed-phase image.",Non-OADS,/arxiv_data1/oa_pdf/c1/3b/jptm-49-3-218.PMC4440933.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.15224     •  Huh J, et al.",OADS,/arxiv_data1/oa_pdf/c1/3b/jptm-49-3-218.PMC4440933.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.15Pathology and MRI for Hepatocarcinogenesis   •     225 greater, the intranodular portal supply definitely decreases,  whereas the intranodular arterial supply tends to progressively  increase.",Non-OADS,/arxiv_data1/oa_pdf/c1/3b/jptm-49-3-218.PMC4440933.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.15226     •  Huh J, et al.",OADS,/arxiv_data1/oa_pdf/c1/3b/jptm-49-3-218.PMC4440933.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.15Pathology and MRI for Hepatocarcinogenesis   •     227 Dysplastic nodules Common imaging findings of DNs are hyperintensity on T1- WIs and isointensity or hypointensity on T2-WIs.27,41 The T1  hyperintensity can be explained by the fact that DNs accumu - late copper or iron, which are paramagnetic materials leading to  T1 hyperintensity depending on the concentration.",Non-OADS,/arxiv_data1/oa_pdf/c1/3b/jptm-49-3-218.PMC4440933.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.15228     •  Huh J, et al.",OADS,/arxiv_data1/oa_pdf/c1/3b/jptm-49-3-218.PMC4440933.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.15Pathology and MRI for Hepatocarcinogenesis   •     229 14.,Non-OADS,/arxiv_data1/oa_pdf/c1/3b/jptm-49-3-218.PMC4440933.pdf
"230pISSN 2383-7837 eISSN 2383-7845 © 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Effectiveness and Limitations of Core Needle Biopsy in the Diagnosis  of Thyroid Nodules: Review of Current Literature Jung Hyun Yoon · Eun-Kyung Kim  Jin Young Kwak · Hee Jung Moon Department of Radiology, Severance Hospital,  Research Institute of Radiological Science,  Yonsei University College of Medicine, Seoul,  KoreaFine needle aspiration (FNA) is currently accepted as an easy, safe, and reliable tool for the diag - nosis of thyroid nodules.",Non-OADS,/arxiv_data1/oa_pdf/ea/35/jptm-49-3-230.PMC4440934.pdf
"Key Words:  Thyroid; Neoplasm; Core needle biopsy; UltrasonographyReceived:  March 5, 2015 Accepted:  March 20, 2015 Corresponding Author Eun-Kyung Kim, M.D., Ph.D. Department of Radiology, Severance Hospital,  Research Institute of Radiological Science,  Yonsei University College of Medicine, 50-1  Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea  Tel: +82-2-2228-7400 Fax: +82-2-393-3035 E-mail: ekkim@yuhs.acJournal of Pathology and Translational Medicine 2015; 49: 230-235 http://dx.doi.org/10.4132/jptm.2015.03.21▒ REVIEW ▒ At present, thyroid nodules are a common problem.",Non-OADS,/arxiv_data1/oa_pdf/ea/35/jptm-49-3-230.PMC4440934.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.21Core Needle Biopsy of Thyroid Nodules   •     231 less, there currently remains a lack of evidence and no definite  guideline on how CNB should be used in the diagnosis of thy - roid nodules.",Non-OADS,/arxiv_data1/oa_pdf/ea/35/jptm-49-3-230.PMC4440934.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.21232     •  Yoon JH, et al.",OADS,/arxiv_data1/oa_pdf/ea/35/jptm-49-3-230.PMC4440934.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.21Core Needle Biopsy of Thyroid Nodules   •     233 diagnostic tool.,Non-OADS,/arxiv_data1/oa_pdf/ea/35/jptm-49-3-230.PMC4440934.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.21234     •  Yoon JH, et al.",OADS,/arxiv_data1/oa_pdf/ea/35/jptm-49-3-230.PMC4440934.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.21Core Needle Biopsy of Thyroid Nodules   •     235 any benefit for the diagnosis when fine-needle aspiration cytology  analysis shows inconclusive results?,Non-OADS,/arxiv_data1/oa_pdf/ea/35/jptm-49-3-230.PMC4440934.pdf
"236pISSN 2383-7837 eISSN 2383-7845 © 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Proposal of an Appropriate Decalcification Method of Bone Marrow   Biopsy Specimens in the Era of Expanding Genetic Molecular Study Sung-Eun Choi · Soon Won Hong   Sun Och Yoon Department of Pathology, Yonsei University   College of Medicine, Seoul, Korea Background:  The conventional method for decalcification of bone specimens uses hydrochloric  acid (HCl) and is notorious for damaging cellular RNA, DNA, and proteins, thus complicating mo - lecular and immunohistochemical analyses.",Non-OADS,/arxiv_data1/oa_pdf/50/9e/jptm-49-3-236.PMC4440935.pdf
"Key Words:  Decalcification technique; Ethylenediaminetetraacetic acid disodium salt dehydrate;  Hydrochloric acid; RDO GOLD; Bone marrowReceived:  January 27, 2015 Revised:  February 24, 2015 Accepted:  March 16, 2015 Corresponding Author Sun Och Yoon, M.D., Ph.D. Department of Pathology,   Yonsei University College of Medicine,   50-1 Yonsei-ro, Seodaemun-gu,   Seoul 120-752, Korea Tel: +82-2-2228-1763 Fax: +82-2-2227-7939 E-mail: revita@naver.comJournal of Pathology and Translational Medicine 2015; 49: 236-242 http://dx.doi.org/10.4132/jptm.2015.03.16▒ ORIGINAL ARTICLE ▒ Sampling bone tissue is usually performed for the diagnosis  of hematologic malignancy, metastatic tumor, or primary bone  tumor.",Non-OADS,/arxiv_data1/oa_pdf/50/9e/jptm-49-3-236.PMC4440935.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.16Comparison of Three Decalcification Agents   •     237 biopsied bone marrow specimens were available.,OADS,/arxiv_data1/oa_pdf/50/9e/jptm-49-3-236.PMC4440935.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.16238     •  Choi S-E, et al.",OADS,/arxiv_data1/oa_pdf/50/9e/jptm-49-3-236.PMC4440935.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.16Comparison of Three Decalcification Agents   •     239 HCl group are depicted in Table 3 and Fig.,Non-OADS,/arxiv_data1/oa_pdf/50/9e/jptm-49-3-236.PMC4440935.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.16240     •  Choi S-E, et al.",OADS,/arxiv_data1/oa_pdf/50/9e/jptm-49-3-236.PMC4440935.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.16Comparison of Three Decalcification Agents   •     241 extracted nucleic acid from stored tissues containing bone and  compared the quantity, purity, and Ct value of the DNA and/or  RNA after real-time PCR.1-4 Few studies have used specimens  sampled with diagnostic purpose in clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/50/9e/jptm-49-3-236.PMC4440935.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.16242     •  Choi S-E, et al.",OADS,/arxiv_data1/oa_pdf/50/9e/jptm-49-3-236.PMC4440935.pdf
"243© 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Smad1 Expression in Follicular Lymphoma Jai Hyang Go Department of Pathology,   Dankook University College of Medicine,  Cheonan, KoreaBackground:  Follicular lymphomas present with various immunohistologic patterns.",Non-OADS,/arxiv_data1/oa_pdf/0f/38/jptm-49-3-243.PMC4440936.pdf
"Department of Pathology,   Dankook University College of Medicine,   119 Dandae-ro, Dongnam-gu,   Cheonan 330-997, Korea Tel: +82-41-550-6972 Fax: +82-41-561-9127 E-mail: cyjy555@ hanmail.netJournal of Pathology and Translational Medicine 2015; 49: 243-248 http://dx.doi.org/10.4132/jptm.2015.03.30▒ ORIGINAL ARTICLE ▒ Follicular lymphoma (FL) is the neoplastic counterpart of  normal germinal center (GC) B-cells and can present with vari - ous immunohistologic patterns which make them difficult to  distinguish from other B-cell lymphomas.1 Of the GC markers  used in the diagnosis of FL, CD10 is a traditional marker of GC  B cells and has long been regarded as a reliable marker of both  GCs and FL.2 The reported CD10 positivity rates in FL vary  widely, though most reports indicate positivity rate of 60% to  90%.3 Furthermore, CD10 showed less expression in grade 3  FL than in indolent grades 1 or 2 FL.4  Another marker for GC B cells is the Bcl6 protein.",Non-OADS,/arxiv_data1/oa_pdf/0f/38/jptm-49-3-243.PMC4440936.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.30244     •  Go JH we stained for follicular dendritic cells using CD21.,Non-OADS,/arxiv_data1/oa_pdf/0f/38/jptm-49-3-243.PMC4440936.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.30Smad1, Bcl6, Follicular Lymphoma   •     245 positive for Smad1.",Non-OADS,/arxiv_data1/oa_pdf/0f/38/jptm-49-3-243.PMC4440936.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.30246     •  Go JH associated with GC cells.9 However, CD10 positivity in FL var - ies widely, and most reports on the topic indicate that 60% to  90% of tumors are CD10 positive.3 Furthermore, CD10 expres - sion is frequently weak to negative in WHO grade 3 FLs,10 and  in one study, CD10 was detected in only 20% of these tumors.1  Therefore, the lack of CD10 expression does not preclude FL1 or  exclude the possibility that neoplastic lymphocytes originated  from follicular center cells in diffuse large B-cell lymphoma  (DLBCL).10 In the present study, CD10 was positive in 63% of  the 27 FL cases as follows: grade 1 (6 of 6, 100%), grade 2 (4 of  4, 100%), and grade 3 (7 of 17, 41%); follicular (14 of 17,  82%), follicular and diffuse (3 of 9, 33%), and focally follicular  (0 of 1, 0%).",Non-OADS,/arxiv_data1/oa_pdf/0f/38/jptm-49-3-243.PMC4440936.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.30Smad1, Bcl6, Follicular Lymphoma   •     247 small lymphocytic lymphoma.",Non-OADS,/arxiv_data1/oa_pdf/0f/38/jptm-49-3-243.PMC4440936.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.30248     •  Go JH Ras/MEK signaling pathways for TGFbeta.,OADS,/arxiv_data1/oa_pdf/0f/38/jptm-49-3-243.PMC4440936.pdf
"249© 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 MUC2 Expression Is Correlated with Tumor Differentiation and   Inhibits Tumor Invasion in Gastric Carcinomas:   A Systematic Review and Meta-analysis Jung-Soo Pyo · Jin Hee Sohn   Guhyun Kang1 · Dong-Hoon Kim   Kyungeun Kim · In-Gu Do   Dong Hyun Kim Department of Pathology, Kangbuk Samsung  Hospital, Sungkyunkwan University School of  Medicine, Seoul; 1Department of Pathology,   Inje University Sanggye Paik Hospital, Seoul,  KoreaBackground:  While MUC2 is expressed in intestinal metaplasia and malignant lesions, the clinico - pathological significance of MUC2 expression is not fully elucidated in gastric carcinoma (GC).",Non-OADS,/arxiv_data1/oa_pdf/60/9b/jptm-49-3-249.PMC4440937.pdf
"Department of Pathology, Kangbuk Samsung  Hospital, Sungkyunkwan University School of  Medicine, 29 Saemunan-ro, Jongno-gu, Seoul  110-746, Korea  Tel: +82-2-2001-2391 Fax: +82-2-2001-2398 E-mail: jhpath.sohn@samsung.comJournal of Pathology and Translational Medicine 2015; 49: 249-256 http://dx.doi.org/10.4132/jptm.2015.03.27▒ ORIGINAL ARTICLE ▒ Mucin expression shows variable patterns in the gastrointes - tinal tract based on organ and specific conditions.",Non-OADS,/arxiv_data1/oa_pdf/60/9b/jptm-49-3-249.PMC4440937.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.27250     •  Pyo J-S, et al.",OADS,/arxiv_data1/oa_pdf/60/9b/jptm-49-3-249.PMC4440937.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.27Meta-analysis for MUC2 in Gastric Cancer   •     251 munohistochemical study (Fig.,Non-OADS,/arxiv_data1/oa_pdf/60/9b/jptm-49-3-249.PMC4440937.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.27252     •  Pyo J-S, et al.",OADS,/arxiv_data1/oa_pdf/60/9b/jptm-49-3-249.PMC4440937.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.27Meta-analysis for MUC2 in Gastric Cancer   •     253 cancer reported that MUC2 positivity was significantly corre - lated with higher pT3 and pT4 stages.21 Correlation with nodal  metastasis was controversial in both GC and colon cancer meta- analysis, while our current immunohistochemical study showed  a correlation between MUC2 expression and lower nodal me - tastasis in GC.",Non-OADS,/arxiv_data1/oa_pdf/60/9b/jptm-49-3-249.PMC4440937.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.27254     •  Pyo J-S, et al.",OADS,/arxiv_data1/oa_pdf/60/9b/jptm-49-3-249.PMC4440937.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.27Meta-analysis for MUC2 in Gastric Cancer   •     255 cut-off value and other cut-off values overlapped at 22.9%– 90.7% and 27.3%–67.4%, respectively.",OADS,/arxiv_data1/oa_pdf/60/9b/jptm-49-3-249.PMC4440937.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.27256     •  Pyo J-S, et al.",OADS,/arxiv_data1/oa_pdf/60/9b/jptm-49-3-249.PMC4440937.pdf
http://dx.doi.org/10.1007/s00432- 014-1890-1.,Non-OADS,/arxiv_data1/oa_pdf/60/9b/jptm-49-3-249.PMC4440937.pdf
"257© 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 IDH Mutation Analysis in Ewing Sarcoma Family Tumors Ki Yong Na · Byeong-Joo Noh1   Ji-Youn Sung2 · Youn Wha Kim2  Eduardo Santini Araujo3  Yong-Koo Park2 Department of Pathology, Central Physical  Examination Agency, Daegu; 1Department of  Pathology, Graduate School of Medicine, Kyung  Hee University, Seoul; 2Department of   Pathology, Kyung Hee University College of  Medicine, Seoul, Korea; 3Orthopedic Pathology  Laboratory, Buenos Aires, ArgentinaBackground:  Isocitrate dehydrogenase (IDH) catalyzes the oxidative decarboxylation of isocitrate  to yield α-ketoglutarate ( α-KG) with production of reduced nicotinamide adenine dinucleotide  (NADH).",Non-OADS,/arxiv_data1/oa_pdf/e2/e5/jptm-49-3-257.PMC4440938.pdf
"Department of Pathology, Kyung Hee University  Hospital, 23 Kyungheedae-ro, Dongdaemun-gu,  Seoul 130-872, Korea Tel: +82-2-958-8742 Fax: +82-2-958-8740 E-mail: ykpark@khmc.or.krJournal of Pathology and Translational Medicine 2015; 49: 257-261 http://dx.doi.org/10.4132/jptm.2015.04.14▒ ORIGINAL ARTICLE ▒ Ewing sarcoma (ES) is the second most common primary bone  sarcoma of those that typically develop in children and young  adults.",Non-OADS,/arxiv_data1/oa_pdf/e2/e5/jptm-49-3-257.PMC4440938.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.14258     •  Na KY, et al.",OADS,/arxiv_data1/oa_pdf/e2/e5/jptm-49-3-257.PMC4440938.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.14IDH Mutation in ESFT   •     259 burg, Germany) was used for the samples bearing IDH1  muta - tions, revealed by either direct PCR or PNA clamping.",Non-OADS,/arxiv_data1/oa_pdf/e2/e5/jptm-49-3-257.PMC4440938.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.14260     •  Na KY, et al.",OADS,/arxiv_data1/oa_pdf/e2/e5/jptm-49-3-257.PMC4440938.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.14IDH Mutation in ESFT   •     261 ma Res 2012; 2: 7.,Non-OADS,/arxiv_data1/oa_pdf/e2/e5/jptm-49-3-257.PMC4440938.pdf
"262pISSN 2383-7837 eISSN 2383-7845 © 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Follicular Proliferative Lesion Arising in Struma Ovarii Min Jee Park · Min A Kim   Mi Kyung Shin1 · Hye Sook Min2 Department of Pathology, Seoul National  University College of Medicine, Seoul;  1Department of Pathology, Hallym University  College of Medicine, Seoul; 2Department of  Epidemiology and Preventive Medicine,  Graduate School of Public Health,  Seoul National University, Seoul, KoreaMalignant struma ovarii is extremely rare and difficult to diagnose histologically, particularly in  cases of follicular carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/be/e7/jptm-49-3-262.PMC4440939.pdf
"Key Words:  Follicular proliferative lesion; Adenocarcinoma, follicular; Malignant struma ovariiReceived:  February 25, 2015 Revised:  March 21, 2015 Accepted:  March 26, 2015 Corresponding Author Hye Sook Min, M.D., Ph.D. Department of Epidemiology and Preventive  Medicine, Graduate School of Public Health,  Seoul National University, 1 Gwanak-ro,  Gwanak-gu, Seoul 151-742, Korea  Tel: +82-2-880-2743 Fax: +82-2-762-9105 E-mail: lilloa@snu.ac.krJournal of Pathology and Translational Medicine 2015; 49: 262-266 http://dx.doi.org/10.4132/jptm.2015.03.26▒ CASE STUDY ▒ A struma ovarii is a monodermal variant of an ovarian mature  teratoma containing thyroid tissue, either exclusively or predomi - nantly.1 Malignant change in a struma ovarii is a rare event, and  the criteria used to detect such changes are identical to those used  to evaluate the thyroid gland.",Non-OADS,/arxiv_data1/oa_pdf/be/e7/jptm-49-3-262.PMC4440939.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.26Follicular Lesion in Struma Ovarii   •     263 observed, and one microscopic focus of vascular invasion was ob - served after meticulous examination (Fig.",Non-OADS,/arxiv_data1/oa_pdf/be/e7/jptm-49-3-262.PMC4440939.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.26264     •  Park MJ, et al.",OADS,/arxiv_data1/oa_pdf/be/e7/jptm-49-3-262.PMC4440939.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.26Follicular Lesion in Struma Ovarii   •     265 A new subtype of follicular carcinoma of the ovary, described  by Roth and Karseladze,9 presents an even greater diagnostic  challenge.",Non-OADS,/arxiv_data1/oa_pdf/be/e7/jptm-49-3-262.PMC4440939.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.26266     •  Park MJ, et al.",OADS,/arxiv_data1/oa_pdf/be/e7/jptm-49-3-262.PMC4440939.pdf
"267© 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Traumatic Bowel Perforation and Inguinal Hernia Masking   a Mesenteric Calcifying Fibrous Tumor Dong Hyun Kim* · Kyueng-Whan Min1* · Dong-Hoon Kim · Seoung Wan Chae   Jin Hee Sohn · Jung-Soo Pyo · Sung-Im Do · Kyungeun Kim · Hyun Joo Lee Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul;   1Department of Pathology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, KoreaJournal of Pathology and Translational Medicine 2015; 49: 267-269 http://dx.doi.org/10.4132/jptm.2015.03.20▒ BRIEF CASE REPORT ▒ Calcifying fibrous tumors (CFTs) are uncommon benign tu - mors occurring in children and young adults.",Non-OADS,/arxiv_data1/oa_pdf/3e/60/jptm-49-3-267.PMC4440940.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.20268     •  Kim DH, et al.",OADS,/arxiv_data1/oa_pdf/3e/60/jptm-49-3-267.PMC4440940.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.20Calcifying Fibrous Tumor with Perforation   •     269 toid nodular transformation of the spleen.8 A study of gastric  CFT reported that IgG4+ plasma cells were seen in this tumor.9  Larson et al.10 also suggested that CFT could be an IgG4 related  disease.,Non-OADS,/arxiv_data1/oa_pdf/3e/60/jptm-49-3-267.PMC4440940.pdf
"270pISSN 2383-7837 eISSN 2383-7845 © 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cytomegalovirus-Associated Intussusception with   Florid Vascular Proliferation in an Infant Heejung Park · Sanghui Park1 · Young Ju Hong2 · Sun Wha Lee3 · Min-Sun Cho1 Department of Pathology, National Health Insurance Service Ilsan Hospital, Goyang; Departments of 1Pathology, 2Surgery, and 3Radiology,   Ewha Womans University School of Medicine, Seoul, KoreaJournal of Pathology and Translational Medicine 2015; 49: 270-273 http://dx.doi.org/10.4132/jptm.2015.04.01▒ BRIEF CASE REPORT ▒ Intussusception is usually idiopathic, with no pathologic lead  point except for the presence of reactive lymphoid hyperplasia,  which is probably associated with gastrointestinal infection or a  reaction to newly introduced food proteins.",Non-OADS,/arxiv_data1/oa_pdf/ec/6e/jptm-49-3-270.PMC4440941.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.01CMV-Associated Infantile Intussusception   •     271 showed multifocal hemorrhages with fibroblastic proliferation,  resembling reorganizing thrombus (Fig.",Non-OADS,/arxiv_data1/oa_pdf/ec/6e/jptm-49-3-270.PMC4440941.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.01272     •  Park H, et al.",OADS,/arxiv_data1/oa_pdf/ec/6e/jptm-49-3-270.PMC4440941.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.01CMV-Associated Infantile Intussusception   •     273 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ec/6e/jptm-49-3-270.PMC4440941.pdf
"274pISSN 2383-7837 eISSN 2383-7845 © 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.A Case of Primary Subpleural Pulmonary Microcystic Myxoma  Coincidentally Occurred with Pulmonary Adenocarcinoma Jungsuk Ahn · Na Rae Kim · Seung Yeon Ha · Keun-Woo Kim1 · Kook Yang Park1 · Yon Mi Sung2 Departments of Pathology, 1Thoracic Surgery, and 2Radiology, Gachon University Gil Medical Center, Incheon, KoreaJournal of Pathology and Translational Medicine 2015; 49: 274-278 http://dx.doi.org/10.4132/jptm.2015.03.12▒ BRIEF CASE REPORT ▒ Myxoma occurs most commonly in the heart, which is regard - ed as the origin of primitive mesenchymal cells that differentiate  into multiple tissues.",Non-OADS,/arxiv_data1/oa_pdf/0c/84/jptm-49-3-274.PMC4440942.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.12A Case of Pulmonary Microcystic Myxoma   •     275 and some neutrophils (Fig.,Non-OADS,/arxiv_data1/oa_pdf/0c/84/jptm-49-3-274.PMC4440942.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.12276     •  Ahn J, et al.",OADS,/arxiv_data1/oa_pdf/0c/84/jptm-49-3-274.PMC4440942.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.12A Case of Pulmonary Microcystic Myxoma   •     277 tumors yield extremely low cellular mucin predominance with  only a few floating epithelial cell nests.,Non-OADS,/arxiv_data1/oa_pdf/0c/84/jptm-49-3-274.PMC4440942.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.12278     •  Ahn J, et al.",OADS,/arxiv_data1/oa_pdf/0c/84/jptm-49-3-274.PMC4440942.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and re- production in any medium, provided the original author(s) and the source are credited.",Non-OADS,/arxiv_data1/oa_pdf/95/c7/wound.2015.0637.PMC4440986.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncom-mercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF WOMEN’S HEALTH Volume 24, Number 5, 2015DOI: 10.1089/jwh.2014.4920 367",Non-OADS,/arxiv_data1/oa_pdf/42/1c/jwh.2014.4920.PMC4440999.pdf
Retrieved from http://www.cs.rutgers.edu/~decarlo/readings/koenderink-percep84.,Non-OADS,/arxiv_data1/oa_pdf/a4/65/i-perception-5-497.PMC4441026.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/39/e7/mtm20146.PMC4441045.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/fa/44/mtm201420a.PMC4441046.pdf
"Statistical analysis Statistical analysis and graphs were made using GraphPad Prism version 5.02 for Windows (GraphPad Software, San Diego, CA, http://www.graphpad.",OADS,/arxiv_data1/oa_pdf/82/95/mtm201518.PMC4441047.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/82/95/mtm201518.PMC4441047.pdf
Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.259143.115.© 2015 Xue et al.,OADS,/arxiv_data1/oa_pdf/ad/86/1000.PMC4441048.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/ad/86/1000.PMC4441048.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.256404.114.© 2015 Su et al.,OADS,/arxiv_data1/oa_pdf/be/cc/1006.PMC4441049.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/be/cc/1006.PMC4441049.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/be/cc/1006.PMC4441049.pdf
"The development of Miwi mutant sperm fails at the roundspermatidstage.Miceexpressingonlyacatalyticallyincompetent MIWI protein have precisely the same 5Present address: Institute of Molecular and Cell Biology, Singapore 138673, SingaporeCorresponding author: greg.hannon@cruk.cam.ac.ukArticle is online at http://www.genesdev.org/cgi/doi/10.1101/gad.260455.115.© 2015 Goh et al.",Non-OADS,/arxiv_data1/oa_pdf/14/f9/1032.PMC4441051.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/14/f9/1032.PMC4441051.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/14/f9/1032.PMC4441051.pdf
2002) and interacts Corresponding author: ohnok@med.nagoya-u.ac.jp Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.255737.114.© 2015 Masuda et al.,OADS,/arxiv_data1/oa_pdf/ca/4c/1045.PMC4441052.pdf
"This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License(Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/ca/4c/1045.PMC4441052.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.259432.115.© 2015 Fang et al.,Non-OADS,/arxiv_data1/oa_pdf/12/a5/1058.PMC4441053.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/12/a5/1058.PMC4441053.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/12/a5/1058.PMC4441053.pdf
"Colorectal cancer (CRC), one of the most common types of cancer worldwide, is associated with high mortalityrates (http://globocan.iarc.fr/Default.aspx).",Non-OADS,/arxiv_data1/oa_pdf/f5/72/1074.PMC4441054.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.256693.114.© 2015 Tu et al.,OADS,/arxiv_data1/oa_pdf/f5/72/1074.PMC4441054.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/f5/72/1074.PMC4441054.pdf
"Aftersix months, it is available under a Creative Commons License (Attribu-tion-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/f5/72/1074.PMC4441054.pdf
GSEA (http://www.broadinstitute.org/gsea/index.jsp) was used to identify gene sets and pathways associated with a set of up-reg-ulated or down-regulated genes.,OADS,/arxiv_data1/oa_pdf/f5/72/1074.PMC4441054.pdf
"PD and mitochondrial dysfunction PD is the second most common neurodegenerative disor- der, predominantly affecting individuals over the age of65, although cases with a much earlier onset have been [Keywords : PARKIN; ubiquitin; deubiquitination; mitophagy; PINK1; phosphorylation]Corresponding author: ted.fon@mcgill.caArticle is online at http://www.genesdev.org/cgi/doi/10.1101/gad.262758.115.© 2015 Durcan and Fon This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License(Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/bd/6e/989.PMC4441056.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/75/de/btu548.PMC4441069.pdf
SeeAppendix 1 for the MEDLINE strategy.Searching other resources Grey literature We will conduct a grey literature search of the following resour ces to identify studies not indexed in the databases listed abov e. •Open Grey ( http://www.opengrey.eu/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/aa/CD011512-0001.PMC4441071.pdf
•EU Cordis ( http://cordis.europa.eu/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/aa/CD011512-0001.PMC4441071.pdf
•International Monetary Fund (MF) ( http://www.imf.org/ external/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/aa/CD011512-0001.PMC4441071.pdf
•World Bank ( http://www.worldbank.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/aa/CD011512-0001.PMC4441071.pdf
•Institute of Development Studies ( http://www.ids.ac.uk/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/aa/CD011512-0001.PMC4441071.pdf
"Trial registries •International Clinical T rials Registry Platform (ICTRP), World Health Organization (WHO) ( http://www.who.int/ictrp/ en/).",OADS,/arxiv_data1/oa_pdf/35/aa/CD011512-0001.PMC4441071.pdf
"•ClinicalT rials.gov, US National Institutes of Health (NIH) (http://clinicaltrials.gov/ ).",OADS,/arxiv_data1/oa_pdf/35/aa/CD011512-0001.PMC4441071.pdf
http://apps.who.int/iris/bitstream/10665/69023/1/EIP_ FER_DP .E_03.1.pdf?ua=1 (accessed 1 February 2015).,OADS,/arxiv_data1/oa_pdf/35/aa/CD011512-0001.PMC4441071.pdf
http://epocoslo.cochrane.org/ sites/epocoslo.cochrane.org/ﬁles/uploads/ 05%20What%20study%20designs%20should%20be%20included%2 0in%20an%20EPOC%20review%202013%2008%2012_ 0.pdf (accessed 1 February 2015).,OADS,/arxiv_data1/oa_pdf/35/aa/CD011512-0001.PMC4441071.pdf
http://epoc.cochrane.org/ sites/epoc.cochrane.org/ﬁles/uploads/14%20Sug- gested%20risk%20of%20bias%20criteria%20for%20EPOC%20 reviews%202013%2008%2012_ 0.pdf (accessed 1 February 2015).,OADS,/arxiv_data1/oa_pdf/35/aa/CD011512-0001.PMC4441071.pdf
"Kofman 2006 Kofman M, Pollitz K. Health insurance regulation by states and the federal government: a review of current approaches and proposals for change.http://www.allhealth.org/brieﬁngmaterials/ HealthInsuranceReportKofmanandPollitz-95.pdf (accessed 1 February 2015).",Non-OADS,/arxiv_data1/oa_pdf/35/aa/CD011512-0001.PMC4441071.pdf
http://www.oecd.org/els/health-systems/31916207.pdf (accessed 1 February 2015).,Non-OADS,/arxiv_data1/oa_pdf/35/aa/CD011512-0001.PMC4441071.pdf
http://www.who.int/health_ ﬁnancing/taxed_based_ﬁnancing_dp_04_4.pdf (accessed 1 February 2015).,Non-OADS,/arxiv_data1/oa_pdf/35/aa/CD011512-0001.PMC4441071.pdf
http://ec.europa.eu/social/BlobServlet?,Non-OADS,/arxiv_data1/oa_pdf/35/aa/CD011512-0001.PMC4441071.pdf
Available from: http://www.ntfpinfo.us/docs/other/ VirginiaTech2001‑SweetgumFactsheet.pdf [Last cited on  2008 Nov 10].,OADS,/arxiv_data1/oa_pdf/3f/e7/PRev-9-1.PMC4441155.pdf
Available from: http://hort.ufl.,Non-OADS,/arxiv_data1/oa_pdf/3f/e7/PRev-9-1.PMC4441155.pdf
Available from:  http://www.lostcreekwitch.com/98/sweetgum/ [Last cited on  2014 Feb 22].,Non-OADS,/arxiv_data1/oa_pdf/3f/e7/PRev-9-1.PMC4441155.pdf
Available from: http://www.drugsfuture.com/chemdata/taraxerol.,Non-OADS,/arxiv_data1/oa_pdf/56/7b/PRev-9-19.PMC4441157.pdf
Available from: http://medind.nic.in/eaa/ t11/i1/ eaat11i1p16.pdf.,OADS,/arxiv_data1/oa_pdf/ce/7a/PRev-9-41.PMC4441161.pdf
Available from: http://www.herbalcureindia.com/herbs/Ficus  racemosa.html.,Non-OADS,/arxiv_data1/oa_pdf/6e/f2/PRev-9-73.PMC4441165.pdf
Available from:  http://www.efloras.org/florataxon.aspx?flora_id=2 and taxon_ id=220011977) [Last accessed on 2014 May 02].,OADS,/arxiv_data1/oa_pdf/42/8c/PRev-9-81.PMC4441166.pdf
The stimulus onset asynchrony was on average 5.125 s and it was jittered between 4 s and 10 s. The order and timing ofevents were optimized using the Optseq2 software (http://surfer.nmr.mgh.harvard.edu/optseq/).,OADS,/arxiv_data1/oa_pdf/29/12/mp201536a.PMC4441258.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Chronic cannabis impairs reality monitoring J Riba et al 777 © 2015 Macmillan Publishers Limited Molecular Psychiatry (2015), 772 –777",Non-OADS,/arxiv_data1/oa_pdf/29/12/mp201536a.PMC4441258.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b4/84/cia-10-871.PMC4441356.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Interventions in Aging 2015:10 871–877Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  871OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S8341 4Frailty syndrome and self-care ability in elderly  patients with heart failure Izabella Uchmanowicz1 Marta Wleklik1 robbert JJ gobbens2,3 1Department of Clinical nursing,   Wrocław Medical University, Wrocław,   Poland; 2Faculty of health, sports and  social Work, Inholland University  of Applied sciences, Amsterdam,   3Zonnehuisgroep Amstelland,   Amstelveen, the netherlandsBackground:  Chronic heart failure is a serious medical condition.",Non-OADS,/arxiv_data1/oa_pdf/b4/84/cia-10-871.PMC4441356.pdf
"The relationship between HF and frailty syndrome (FS) is of Correspondence: Izabella Uchmanowicz Department of Clinical nursing,  Wrocław Medical University, ul Bartla 5,  51-618 Wrocław, Poland Tel +48 71 784 1824 Fax +48 71 345 9324 email izabella.uchmanowicz@umed.wroc.p l Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Uchmanowicz et al Running head recto: Frailty syndrome and self-care in elderly HF patients DOI: http://dx.doi.org/10.2147/CIA.S83414",Non-OADS,/arxiv_data1/oa_pdf/b4/84/cia-10-871.PMC4441356.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/b4/84/cia-10-871.PMC4441356.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/b4/84/cia-10-871.PMC4441356.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/94/d7/copd-10-955.PMC4441357.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2015:10 955–960International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  955OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8334 1Prevalence of colorectal adenomatous polyps  in patients with chronic obstructive pulmonary  disease eun Mi Chun seo Woo Kim so Yeon lim Division of Pulmonary and Critical  Care Medicine, Department of  Internal Medicine, ewha Womans  University school of Medicine, seoul,   republic of KoreaBackground:  Colorectal adenomatous polyps are precancerous lesions of colorectal cancer.",Non-OADS,/arxiv_data1/oa_pdf/94/d7/copd-10-955.PMC4441357.pdf
"In particular, adenomatous polyps are known as more highly potential precursor  lesions for colorectal cancers than hyperplastic polyps.7,8 Botteri et al found a significant  association between smoking and the incidence of adenomatous polyps.9 The risk of  colorectal adenoma is related to the dose of tobacco carcinogens such as polycyclic  aromatic hydrocarbons.10 Smokers are associated with an increased frequency of muta - tions in the mismatch repair enzymes in colorectal neoplasia, showing a twofold greater Correspondence: eun Mi Chun Division of Pulmonary and Critical  Care Medicine, Department of Internal  Medicine, ewha Womans University  school of Medicine, Mokdong hospital,  1071 anyangcheon-ro Yangcheon-gu,   158-710 seoul, republic of Korea Tel +82 2 2650 5131 Fax +82 2 2650 2559 email cem@ewha.ac.k r Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Chun et al Running head recto: Colorectal adenomatous polyps in COPD DOI: http://dx.doi.org/10.2147/COPD.S83341",Non-OADS,/arxiv_data1/oa_pdf/94/d7/copd-10-955.PMC4441357.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/94/d7/copd-10-955.PMC4441357.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/94/d7/copd-10-955.PMC4441357.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/60/a8/dddt-9-2687.PMC4441358.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2687–2694Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2687Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7957 6impact of JAK2(V617F)  mutation status on  treatment response to anagrelide in essential  thrombocythemia: an observational, hypothesis- generating study nicola cascavilla1 Valerio De stefano2 Fabrizio Pane3 alessandro Pancrazzi4 alessandra iurlo5 Marco gobbi6 Francesca Palandri7 giorgina specchia8 a Marina liberati9 Mariella D’adda10 gianluca gaidano11 rajmonda Fjerza4 heinrich achenbach12 Jonathan smith13 Paul Wilde13 alessandro M Vannucchi4 1Division of hematology, casa sollievo della  sofferenza hospital, irccs , san giovanni  rotondo, italy; 2institute of hematology,   catholic University, rome, italy; 3Department  of clinical Medicine and surgery, University of  naples Federico ii, naples, italy; 4Department of  experimental and clinical Medicine, University  of Florence, Florence, italy; 5Oncohematology  Unit, Fondazione irccs  ca’ granda, Ospedale  Maggiore Policlinico, Milan, italy; 6irccs aOU  san Martino, genova, italy; 7Department of  specialistic, Diagnostic and experimental Medicine,   st Orsola-Malpighi hospital, University of  Bologna, Bologna, italy; 8Unit of hematology with  Transplantation, Department of emergency and  Organ Transplantation, University of Bari, Bari,   italy; 9Ospedale santa Maria, T erni, italy; 10Division  of hematology, azienda Ospedaliera spedali civili  di Brescia, Brescia, italy; 11Division of hematology,   Department of Translational Medicine, amedeo  avogadro University of eastern Piedmont,   novara, italy; 12research and Development, shire  gmbh, eysins, switzerland; 13shire Pharmaceutical  Development ltd, Basingstoke, United KingdomAbstract:  A JAK2(V617F) mutation is found in approximately 55% of patients with essential  thrombocythemia (ET), and represents a key World Health Organization diagnostic criterion.",Non-OADS,/arxiv_data1/oa_pdf/60/a8/dddt-9-2687.PMC4441358.pdf
"Available data show the JAK2  mutation to  be associated with an increased risk of arterial thrombosis in patients with ET.12,13 The  risk of evolution to myelofibrosis may also be increased by the JAK2 mutation and  appears to vary according to allele burden,9,13 although conflicting data are available.4  In 2008, the World Health Organization (WHO) identified the JAK2  mutation as a  key diagnostic criterion for Philadelphia-negative MPNs.14 The JAK2  mutation does  not differentiate between ET and other clonal MPNs (such as polycythemia vera and correspondence: alessandro M Vannucchi Department of experimental and clinical Medicine,  University of Florence, largo Brambilla, 3, 50134  Florence, italy Tel +39 05 5794 7688 Fax +39 05 5427 1826 email amvannucchi@unifi.i t Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Cascavilla et al Running head recto: JAK2  impact on response to anagrelide DOI: http://dx.doi.org/10.2147/DDDT.S79576",Non-OADS,/arxiv_data1/oa_pdf/60/a8/dddt-9-2687.PMC4441358.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/60/a8/dddt-9-2687.PMC4441358.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/60/a8/dddt-9-2687.PMC4441358.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/copd-10-961.PMC4441359.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2015:10 961–967International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  961OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S7954 7Factors associated with inadequate diagnosis  of COPD: On-sint cohort analysis alberto Fernández-Villar1 José luis lópez-Campos2,3 Cristina represas represas1 lucía Marín Barrera3 Virginia leiro Fernández1 Cecilia lópez ramírez3 ricard Casamor4 1Department of Pneumology,   Complexo hospitalario de Vigo,   Instituto de Investigación Biomédica  de Vigo, Vigo, 2Medical- surgical Unit  of respiratory Diseases, Instituto  de Biomedicina de sevilla, hospital  Universitario Virgen del rocío/ Universidad de sevilla, seville,   3Centro de Investigación Biomédica  en red de respiratorio, Instituto  de salud Carlos III, Madrid, 4Medical  Department, novartis Farmacéutica,   Barcelona, spainBackground:  The purpose of this study was to evaluate the frequency of inadequate diagnosis  and factors predictive of this in patients with chronic obstructive pulmonary disease (COPD)  participating in the On-Sint study.",Non-OADS,/arxiv_data1/oa_pdf/1f/b9/copd-10-961.PMC4441359.pdf
spain Tel +34 986 816 069 Fax +34 986 816 029 email alberto.fernandez.villar@sergas.e s Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Fernández-Villar et al Running head recto: Inadequate diagnosis of COPD DOI: http://dx.doi.org/10.2147/COPD.S79547,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/copd-10-961.PMC4441359.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/1f/b9/copd-10-961.PMC4441359.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/copd-10-961.PMC4441359.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/b0/14/ircmj-17-03-25637.PMC4441770.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/37/e3/ircmj-17-03-17973.PMC4441771.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/50/57/ircmj-17-03-19030.PMC4441772.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/10/5a/ircmj-17-03-13478.PMC4441773.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/b9/ce/ircmj-17-03-13577.PMC4441774.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/83/9d/ircmj-17-03-19489.PMC4441775.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/52/5c/ircmj-17-03-18208.PMC4441776.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/b2/19/ircmj-17-03-19078.PMC4441777.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/00/f9/ircmj-17-03-24262.PMC4441778.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/28/9c/ircmj-17-03-19389.PMC4441779.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/63/01/ircmj-17-03-21599.PMC4441780.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/f6/33/ircmj-17-03-26354.PMC4441781.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/bd/76/ircmj-17-03-15986.PMC4441782.pdf
"To inform well, a website  (http://iranmhs.tums.ir), including all related informa - tion such as new guidance for unexpected cases was de - signed.",Non-OADS,/arxiv_data1/oa_pdf/bd/76/ircmj-17-03-15986.PMC4441782.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/a4/2b/ircmj-17-03-18944.PMC4441783.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/c6/28/ircmj-17-03-24691.PMC4441784.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/d5/b7/ircmj-17-03-26258.PMC4441785.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/88/f4/ircmj-17-03-18879.PMC4441786.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/60/ef/ircmj-17-03-19660.PMC4441787.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/6e/05/ircmj-17-03-25919.PMC4441788.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/2d/9c/ircmj-17-03-23617.PMC4441789.pdf
"Copyright © 2015 The Korean Society of Environmental Health and Toxicology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 9 http://e-eht.org/ Introduction Globally, increasing numbers of countries are becoming old- age societies [1]; in particular, the South Korean population is  aging more rapidly than that of most advanced countries [2].",Non-OADS,/arxiv_data1/oa_pdf/68/87/eht-30-e2015002.PMC4441797.pdf
"Association of urinary 3-phenoxybenzoic acid  levels with self-reported depression symptoms in a  rural elderly population in Asan, South Korea Bokyeong Kim1, Ara Jung1, Dongmin Yun1, Mira Lee1, Mee-Ri Lee2, Y oon-Hyeong Choi3,  Y ongbae Kim4, Choonghee Park5, Yun-Chul Hong6, Sungroul Kim1 1Department of Environmental Health Sciences, Soonchunhyang University, Asan; 2Department of Preventive Medicine, Seoul  National University College of Medicine, Seoul; 3Department of Preventive Medicine, Gacheon University College of Medicine,  Incheon;  4Department of Preventive Medicine, Soonchunhyang University College of Medicine, Cheonan; 5Environmental  Health Research Division, National Institute of Environmental Research, Incheon; 6Environmental Health Center, Seoul  National University College of Medicine, Seoul, Korea • Original ArticleOpen Access Environmental Health and Toxicology Volume: 30, Article ID: e2015002, 9 pages http://dx.doi.org/10.5620/eht.e2015002 eISSN: 2233-6567  Objectives  This study aimed to evaluate the association between presence of depres - sion symptoms and the exposure level to insecticides among aged population in rural  area, determined via measured levels of urinary 3-phenoxybenzoic acid (3-PBA), after  controlling for socioeconomic confounding factors.",Non-OADS,/arxiv_data1/oa_pdf/68/87/eht-30-e2015002.PMC4441797.pdf
"Keywords  Aging population, Depression, Insecticid, 3-Phenoxybenzoic acid Correspondence:  Sungroul Kim 22 Soonchunhyang-ro, Asan 336-745, Korea Tel: +82-41-530-1249  Fax: +82-41-530-1272 E-mail: sungroul.kim@gmail.com  Received:  January 7, 2015 Accepted:  April 2, 2015 Published online:  April 2, 2015 This article is available from: http://e-eht.org/",Non-OADS,/arxiv_data1/oa_pdf/68/87/eht-30-e2015002.PMC4441797.pdf
"http://e-eht.org/ Page 2 of 9Environmental Health and Toxicology    2015;30:e2015002 Depression is a common illness among the elderly [4], and ge - riatric depression has been reported to carry a higher risk of sui - cide compared with depression in other age groups [3].",Non-OADS,/arxiv_data1/oa_pdf/68/87/eht-30-e2015002.PMC4441797.pdf
"http://e-eht.org/ Page 3 of 9Bokyeong Kim, et al.",Non-OADS,/arxiv_data1/oa_pdf/68/87/eht-30-e2015002.PMC4441797.pdf
http://e-eht.org/ Page 4 of 9Environmental Health and Toxicology    2015;30:e2015002 61.6% of female subjects answered they had health insurance.,Non-OADS,/arxiv_data1/oa_pdf/68/87/eht-30-e2015002.PMC4441797.pdf
"http://e-eht.org/ Page 5 of 9Bokyeong Kim, et al.",Non-OADS,/arxiv_data1/oa_pdf/68/87/eht-30-e2015002.PMC4441797.pdf
"http://e-eht.org/ Page 6 of 9Environmental Health and Toxicology    2015;30:e2015002 female and 4.70 (95% CI, 1.72 to 12.88) and 6.83 (95% CI,   2.09 to 22.35) for male.",Non-OADS,/arxiv_data1/oa_pdf/68/87/eht-30-e2015002.PMC4441797.pdf
"http://e-eht.org/ Page 7 of 9Bokyeong Kim, et al.",Non-OADS,/arxiv_data1/oa_pdf/68/87/eht-30-e2015002.PMC4441797.pdf
"http://e-eht.org/ Page 8 of 9Environmental Health and Toxicology    2015;30:e2015002 ported in 2012, indicating a decreasing tendency [25].",Non-OADS,/arxiv_data1/oa_pdf/68/87/eht-30-e2015002.PMC4441797.pdf
Available from: http://www.un.org/esa/population/pub - lications/worldageing19502050/.,Non-OADS,/arxiv_data1/oa_pdf/68/87/eht-30-e2015002.PMC4441797.pdf
Available from: http://csis.org/files/ media/csis/pubs/070321_gai_agingkorea_eng.pdf.,OADS,/arxiv_data1/oa_pdf/68/87/eht-30-e2015002.PMC4441797.pdf
Available from: http://www.epa.gov/ oppsrrd1/reevaluation/pyrethroids-pyrethrins.html.,OADS,/arxiv_data1/oa_pdf/68/87/eht-30-e2015002.PMC4441797.pdf
Available from: http://www.beyondpesticides.org/infoservices/ pesticidefactsheets/toxic/pyrethroid.php.,Non-OADS,/arxiv_data1/oa_pdf/68/87/eht-30-e2015002.PMC4441797.pdf
Available from: http://consultgerirn.org/uploads/ File/trythis/try_this_4.pdf.,Non-OADS,/arxiv_data1/oa_pdf/68/87/eht-30-e2015002.PMC4441797.pdf
Available from: http://www.who.int/ healthinfo/survey/ageingdefnolder/en/.,Non-OADS,/arxiv_data1/oa_pdf/68/87/eht-30-e2015002.PMC4441797.pdf
Available  from: http://kosis.kr/statHtml/statHtml.do?orgId=106&tblId=DT_1 06T_013427&vw_cd=&list_id=&scrId=&seqNo=&lang_ mode=ko&obj_var_id=&itm_id=&conn_path=K1&path= Korean).,OADS,/arxiv_data1/oa_pdf/68/87/eht-30-e2015002.PMC4441797.pdf
Available from: http://www.nier.go.kr/NIER/EgovMove - PageMain.do?linkPage=nier-nf-03&nId=13571& Command= RE  AD (Korean).,Non-OADS,/arxiv_data1/oa_pdf/68/87/eht-30-e2015002.PMC4441797.pdf
"http://e-eht.org/ Page 9 of 9Bokyeong Kim, et al.",Non-OADS,/arxiv_data1/oa_pdf/68/87/eht-30-e2015002.PMC4441797.pdf
Available from: http://kosis.kr/statHt - ml/statHtml.do?orgId=117&tblId=DT_11702_N062&conn_ path=I3 (Korean).,OADS,/arxiv_data1/oa_pdf/68/87/eht-30-e2015002.PMC4441797.pdf
Available from: http://kosis.kr/statHtml/ statHtml.do?orgId=101&tblId=DT_2KAAF05&conn_path=I3   (Korean).,OADS,/arxiv_data1/oa_pdf/68/87/eht-30-e2015002.PMC4441797.pdf
2014. http://www.who.int/mental_health/suicide- prevention/world_report_2014/en/ (accessed 15 Sep 2014).,Non-OADS,/arxiv_data1/oa_pdf/38/f6/bmjdrc-2014-000063.PMC4442133.pdf
http://www.dtu.ox.ac.uk (accessed Jun 2012).21.,Non-OADS,/arxiv_data1/oa_pdf/38/f6/bmjdrc-2014-000063.PMC4442133.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjdrc-2015-000085).,Non-OADS,/arxiv_data1/oa_pdf/08/ec/bmjdrc-2015-000085.PMC4442134.pdf
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0097143 (accessed 18 Jan 2015).,Non-OADS,/arxiv_data1/oa_pdf/08/ec/bmjdrc-2015-000085.PMC4442134.pdf
http://modernfarmer.com/2014/03/piglet-attacking-virus-get -worse/ .,Non-OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
http://news.nationalgeographic.com/news/2014/05/140501-pigs -virus-meat-prices-food-science-health/ .,Non-OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
J VetDiagn Invest 25:649 – 654. http://dx.doi.org/10.1177/1040638713501675 .,Non-OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
http://dx.doi.org/10.3201/eid2007.140296 .,Non-OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
http://dx.doi.org/10.3201/eid2010.140491 .,Non-OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
EFSA J 12:3877. http://dx.doi.org/10.2903/ j.efsa.2014.3877 .,Non-OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
http://gain.fas.usda.gov/Recent%20GAIN %20Publications/Multiple%20PED%20Outbreaks%20Likely%20to%20Impact%20Pork%20Production%20%20_Kiev_Ukraine_12-10-2014.pdf .,Non-OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
http://dx.doi.org/10.1086/ 383129 .,Non-OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
http://dx.doi.org/10.1006/ viro.1999.9832 .,OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
http://dx.doi.org/ 10.3201/eid1708.101528 .,Non-OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
Vet Rec87:681– 686. http://dx.doi.org/10.1136/vr.87.22.681 .,Non-OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
http://dx.doi.org/10.1007/s11262 -011-0642-4 .,Non-OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
Vet Microbiol157:456 – 463. http://dx.doi.org/10.1016/j.vetmic.2011.12.032 .,OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
http://dx.doi.org/10.1371/journal.pone.0025434 .,Non-OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
http://dx.doi.org/10.1371/journal.pone.0043106 .,Non-OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
Transbound Emerg Dis 61: 397– 410. http://dx.doi.org/10.1111/tbed.12269 .,Non-OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
http://www.oie.int/ﬁleadmin/Home/eng/Our_scientiﬁc_expertise/docs/pdf/A_factsheet_PEDV.pdf .,Non-OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
http://dx.doi.org/10.3201/eid1806.111688 .,Non-OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
http://dx.doi.org/10.1111/ zph.12001 .,Non-OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
http://dx.doi.org/10.1128/JVI.06236-11 .,Non-OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
Virology 361: 412– 425. http://dx.doi.org/10.1016/j.virol.2006.11.024 .,Non-OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
"http://dx.doi.org/10.1006/viro.1996.0059 .35.Kedl R, Schmechel S, Schiff L .",OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
J Virol 86:12456. http://dx.doi.org/10.1128/JVI.02254-12 .,Non-OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
http://dx.doi.org/10.1371/journal.pone.0003803 .,Non-OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
BMC Vet Res 9:206. http://dx.doi.org/10.1186/ 1746-6148-9-206 .,Non-OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
Ann Neurol13:602– 607. http://dx.doi.org/10.1002/ana.410130604 .,Non-OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
http://dx.doi.org/10.3201/eid1111.050868 .,Non-OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
http://dx.doi.org/10.1128/mBio.00737-13 .,Non-OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
http://dx.doi.org/10.1093/bioinformatics/8.3.275 .,Non-OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
http://dx.doi.org/10.1093/molbev/mst197 .,Non-OADS,/arxiv_data1/oa_pdf/65/5e/mBio.00593-15.PMC4442135.pdf
http://dx.doi.org/10.1590/S0042 -96862003000300010 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1016/S0140- 6736(05)71877-8 .,OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1097/01.inf.0000219524.64448.90 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1038/nature09074 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
Science341:1241214. http://dx.doi.org/10.1126/science.1241214 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
Nature 510: 417– 421. http://dx.doi.org/10.1038/ nature13421 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1016/j.cell.2013.11.024 .,OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
J Infect Dis 121: 46 – 47. http://dx.doi.org/10.1093/infdis/ 121.1.46 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/ 10.1099/00222615-11-2-137 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1093/clinids/16.Supplement_2.S77 .,OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/ 10.1097/MPG.0b013e3181831867 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1038/ nature05414 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1038/4441022a .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1038/ismej.2010.92 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1016/j.chom.2014.02.005 .,OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
Gut Pathog 5:1. http://dx.doi.org/10.1186/1757-4749-5-1 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
Nature515:423– 426. http://dx.doi.org/10.1038/nature13738 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
Austral Ecol 26:32– 46. http://dx.doi.org/10.1111/j.1442 -9993.2001.01070.pp.x .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1038/ nature12820 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1038/nature11053 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1126/science.1171700 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1053/ j.gastro.2014.07.020 .,OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
Res Micro-biol 161:635– 642. http://dx.doi.org/10.1016/j.resmic.2010.06.002 .,OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1038/ nature08937 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1038/nature08970 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1128/AEM.05239-11 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1126/scitranslmed.3000322 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1371/journal.pbio.0050177 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1038// nrmicro2970 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
J Bacteriol 187: 5996 – 6004. http://dx.doi.org/10.1128/JB.187.17.5996-6004.2005 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1038/ nature12907 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/ 10.1126/science.1109051 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
Nature 501: 426 – 429. http://dx.doi.org/10.1038/ nature12447 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
Nature 457: 480 – 484. http://dx.doi.org/10.1038/ nature07540 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1890/1540 -9295(2003)001[0376:ASSIE]2.0.CO;2 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/ 10.1126/science.272.5270.1910 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1073/ pnas.0408992102 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/ 10.1099/00207713-40-2-205 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
Clin Microbiol Rev 18: 465– 483. http://dx.doi.org/10.1128/CMR.18.3.465-483.2005 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1126/science.1208344 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1038/ nature12503 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1126/science.1229000 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1093/infdis/jit509 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1042/ BJ20040605 .Microbial Succession Follows Human Secretory Diarrhea May/June 2015 Volume 6 Issue 3 e00381-15®mbio.asm.org 13,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1086/421275 .,OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1128/JCM.00316-09 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
Proc Natl Acad SciUSA 108(Suppl 1):4516 – 4522. http://dx.doi.org/10.1073/ pnas.1000080107 .,OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1038/ismej.2012.8 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1016/j.cell.2012.10.052 .,OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1038/nmeth.f.303 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1128/ AEM.03006-05 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1093/nar/gkr1044 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
BMCBioinformatics 4:41. http://dx.doi.org/10.1186/1471-2105-4-41 .,OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1093/nar/ 28.1.27 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1038/ismej.2009.97 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1371/ journal.pcbi.1002687 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
"SciPy: Open source scientiﬁc tools for python, http://www.scipy.org/ .",OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://cc.oulu.ﬁ/~jarioksa/opetus/metodi/vegantutor.pdf .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://www.r-project.org .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://vegan-forge-r-project.org/FAQ- vegan.html .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
http://dx.doi.org/10.1093/nar/28.1.33 .,Non-OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
71:8228 – 8235. http://dx.doi.org/ 10.1128/AEM.71.12.8228-8235.2005 .David et al.,OADS,/arxiv_data1/oa_pdf/59/e6/mBio.00381-15.PMC4442136.pdf
Mol Phylogenet Evol 45:863– 874. http://dx.doi.org/10.1016/j.ympev.2007.06.019 .,OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
BMC Evol Biol 8:220. http://dx.doi.org/10.1186/1471-2148-8-220 .,OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.4161/gmic.1.3.11673 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/ 10.1038/nature08696 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/ 10.1093/molbev/msq153 .,OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1371/ journal.pone.0022602 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1126/science.1155725 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1038/nrmicro1978 .,OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1126/ science.1198719 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
Science 331: 463– 467. http://dx.doi.org/10.1126/science.1200387 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1073/ pnas.1005297107 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1128/AEM.01838 -08.,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1139/W10-113 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
J Appl Bacteriol 67:411– 415. http://dx.doi.org/10.1111/j.1365-2672.1989.tb02511.x .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1007/s00248-007-9225-2 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1093/ bioinformatics/btp636 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
Austral Ecol 26:32– 46. http://dx.doi.org/10.1046/j.1442 -9993.2001.01070.x .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/ 10.1023/A:1010933404324 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1038/nature12198 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
Comput Stat DataAnal 48:869 – 885. http://dx.doi.org/10.1016/j.csda.2004.03.017 .,OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1038/nature11053 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1007/BF02825892 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1099/00207713-41-2 -306 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
nov. Int J Syst Evol Microbiol 60:845– 849. http://dx.doi.org/10.1099/ijs.0.014712-0 .,OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1016/j.cell.2012.01.035 .,OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
Nat Chem Biol 10:416 – 424. http://dx.doi.org/ 10.1038/nchembio.1535 .,OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
Nat Rev Microbiol 11:639 – 647. http://dx.doi.org/10.1038/ nrmicro3089 .,OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1038/ismej.2009.88 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1038/37348 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1038/ nature12480 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1038/ nature12506 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
Nature 457: 480 – 484. http://dx.doi.org/10.1038/ nature07540 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1111/j.1439 -0396.2012.01299.x .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1186/gb-2011-12-5-r50 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
Science 341: 1237439. http://dx.doi.org/10.1126/ science.1237439 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1126/science.1208344 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1111/1365-2435.12302 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1128/AEM.01367-13 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
ISME J 7:880 – 884. http://dx.doi.org/10.1038/ismej.2012.153 .,OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
Int J Syst Bacteriol 44:812– 826. http://dx.doi.org/10.1099/00207713 -44-4-812 .,OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
Nature 464:59 – 65. http://dx.doi.org/10.1038/nature08821 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1093/molbev/msm099 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
J Commun4:2163. http://dx.doi.org/10.1038/ncomms3163 .,OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1128/ AEM.00062-07 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1038/nmeth.f.303 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1093/nar/gkl244 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1093/ bioinformatics/btq461 .,OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
ISME J 6:610 – 618. http://dx.doi.org/ 10.1038/ismej.2011.139 .,OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1093/nar/gkh293 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
Appl Environ Microbiol 71: 8228 – 8235. http://dx.doi.org/10.1128/AEM.71.12.8228-8235.2005 .,OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://dx.doi.org/10.1038/ismej.2009.97 .,Non-OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
http://www.r-project.org/doc/Rnews/Rnews_2002-3.pdf .Xue et al.,OADS,/arxiv_data1/oa_pdf/bd/05/mBio.00022-15.PMC4442137.pdf
"Adapter contamination was removed using scythe( https://github.com/ucdavis-bioinformatics/scythe ), 5 =ends were trimmed by 5 bp with seqtk ( https://github.com/lh3/seqtk/ ), and poor- quality reads were trimmed with sickle ( https://github.com/ucdavis- bioinformatics/sickle ).",Non-OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
Envi - ron Sci Technol 44:8429 – 8434. http://dx.doi.org/10.1021/es1024228 .,Non-OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
http://dx.doi.org/10.1016/j.aca.2006.01.085 .,OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
Kinetics and mechanism of formation of chlorate ion from the hypochlorous acid/chlorite ion reaction at pH 6-10.Environ Sci Technol 25:468 – 474. http://dx.doi.org/10.1021/ es00015a014 .,Non-OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
http://dx.doi.org/10.1128/ JB.185.10.3210-3213.2003 .,Non-OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
http://dx.doi.org/10.1007/ s002030050390 .,Non-OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
"http://dx.doi.org/10.1128/AEM.69.9.5585-5592.2003 .7.Clark IC, Melnyk RA, Engelbrektson A, Coates JD .",OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
http://dx.doi.org/10.1128/mBio.00379-13 .,Non-OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
http://dx.doi.org/10.1128/AEM.05758-11 .,Non-OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
http://dx.doi.org/10.1146/ annurev.micro.61.080706.093257 .,Non-OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
http://dx.doi.org/10.1128/JB.01262-10 .,Non-OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
http://dx.doi.org/10.1371/journal.pgen.1002385 .,Non-OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
http://dx.doi.org/10.1111/mmi.12746 .,Non-OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
http://dx.doi.org/10.1146/ annurev.mi.31.100177.002353 .,Non-OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
http://dx.doi.org/10.1016/0092 -8674(84)90317-9 .,OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
http://dx.doi.org/10.1016/0092 -8674(83)90228-3 .,OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
http://dx.doi.org/10.1016/S0092-8674(00)00176-8 .,OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
http://dx.doi.org/ 10.1093/nar/gkg595 .,Non-OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
http://dx.doi.org/10.1371/ journal.pone.0051643 .,Non-OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
J Bacteriol 189:656 – 662. http://dx.doi.org/10.1128/JB.01194-06 .,Non-OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
http://dx.doi.org/10.1016/ j.bbabio.2012.04.011 .,OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
http://dx.doi.org/10.1128/ AEM.00568-06 .,Non-OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
http://dx.doi.org/ 10.1128/JB.183.19.5491-5495.2001 .,Non-OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
FEBSLett265:85– 87. http://dx.doi.org/10.1016/0014-5793(90)80889-Q .,OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
http://dx.doi.org/10.1111/j.1574 -6968.1993.tb06496.x .,Non-OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
http://dx.doi.org/10.1046/j.1462-2920.1999.00042.x .,OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
Nat Genet 43:491– 498. http://dx.doi.org/10.1038/ng.806 .,OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
http://dx.doi.org/10.1093/bioinformatics/ btp352 .,Non-OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
J Biol Inorg Chem 17:647– 662. http://dx.doi.org/10.1007/s00775-012 -0885-0 .,OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
http://dx.doi.org/10.1021/es103715f .,Non-OADS,/arxiv_data1/oa_pdf/98/03/mBio.00282-15.PMC4442138.pdf
"Sequences were analyzed through the Pyro-Tagger computational pipeline ( http://pyrotagger.jgi-psf.org ) for se- quence trimming, clustering into operational taxonomic units (OTUs)based on 97% sequence identity, and taxonomic assignment by BLASTnagainst the Greengenes database (61).",OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
"All assem-bled contigs of /H110221,800 bp, as well as the contigs generated from the New- bler assembly, were combined and merged using minimus2 (-DMINID/H1100598 -D OVERLAP /H1100580) (AMOS: http://sourceforge.net/projects/ amos ).",OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/10.1007/s10980-012-9758-8 .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/10.1016/j.gloenvcha.2013.03.006 .,OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/ 10.1029/96WR01338 .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/10.1672/08-97.1 .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/10.1034/j.1600-0889.2001.530501.x .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/10.1007/s13157-011-0215-2 .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/10.1007/s13157-009-0003-4 .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/10.1093/aob/mcp201 .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/10.1111/gcb.12131 .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/10.1038/ismej.2009.2 .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/ 10.1016/0304-3770(91)90090-R .,OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/ 10.1104/pp.102.019661 .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/ 10.1046/j.1365-2486.2003.00655.x .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/10.1146/ annurev.arplant.57.032905.105159 .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/10.1196/annals.1419.019 .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/10.1099/ijs.0.014811-0 .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/ 10.1016/0378-1097(92)90802-U .,OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/10.1016/B978-0-12-387661 -4.00004-5 .,OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/10.1128/AEM.02233-07 .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/10.1016/S0723 -2020(83)80017-4 .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/10.1371/journal.pone.0020453 .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
Nature 384:420. http://dx.doi.org/ 10.1038/384420a0 .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/ 10.1264/jsme2.21.1 .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
Plant Soil 321: 61– 81. http://dx.doi.org/10.1007/s11104-008-9796-9 .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/ 10.1029/96GB03761 .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
Nature 450:879 – 882. http://dx.doi.org/10.1038/nature06411 .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/ 10.1038/nature08883 .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
Mol Microbiol 58:682– 692. http://dx.doi.org/10.1111/j.1365 -2958.2005.04861.x .,OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/10.1111/ j.1758-2229.2010.00192.x .48.,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/10.1111/ j.1365-2958.2007.05783.x .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/10.1038/ nrmicro1931 .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/10.1007/BF00379530 .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/10.1007/s00248-002-1037-9 .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/10.1016/S0168 -6496(98)00011-7 .,OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/ 10.1016/S0168-6496(97)00102-5 .,OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/10.1007/s11273-009-9143-9 .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
J Sediment Res 64:681– 683. http://dx.doi.org/10.1306/D4267E60-2B26-11D7-8648000102C1865D .,OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
ISME J4:642– 647. http://dx.doi.org/10.1038/ismej.2009.153 .,OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/ 10.1111/j.1462-2920.2009.02051.x .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
Sci Rep 4:6480. http://dx.doi.org/10.1038/srep06480 .,OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/10.1126/science.1107851 .,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/10.1093/sysbio/syq010 .,OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
http://dx.doi.org/10.1093/molbev/ msn067 .Microbial Communities in a Restored Wetland May/June 2015 Volume 6 Issue 3 e00066-15®mbio.asm.org 15,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/mBio.00066-15.PMC4442139.pdf
"Further analysis of the strongest 500 infection up- anddownregulating hits using the “cellular components enrichment”tool of the STRING database ( http://www.string-db.org ) revealed substantial differences between these two classes of targets: whileinfection-limiting targets (the knockdown of which increases in-fection) are predominantly nuclear proteins, those hits whoseknockdown limited infection are mostly associated with periph-eral cellular structures related to cell membrane and cytoskeleton(Fig.",Non-OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
http://dx.doi.org/10.1101/ cshperspect.a010009 .,Non-OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
Curr Opin Microbiol 8:35– 45. http://dx.doi.org/ 10.1016/j.mib.2004.12.013 .,OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
http://dx.doi.org/10.1016/S0092-8674(00)00141-0 .,OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
http://dx.doi.org/10.1111/j.1462-5822.2008.01200.x .,Non-OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
http://dx.doi.org/ 10.1083/jcb.201105152 .,Non-OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
http://dx.doi.org/10.1038/ncb1292 .,Non-OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
http://dx.doi.org/10.1016/ j.chom.2007.10.001 .,OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
"http://dx.doi.org/10.1242/jcs.02285 .11.Sousa S, Cabanes D, Bougnères L, Lecuit M, Sansonetti P, Tran-Van- Nhieu G, Cossart P .",Non-OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
http://dx.doi.org/10.1111/j.1462-5822.2007.00984.x .,Non-OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
http://dx.doi.org/10.1038/385265a0 .,Non-OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
http://dx.doi.org/10.1038/ nrm2026 .,Non-OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
http://dx.doi.org/ 10.1083/jcb.145.5.1009 .,Non-OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
http://dx.doi.org/ 10.1038/nrm2867 .,Non-OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
http://dx.doi.org/10.3791/51043 .,Non-OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
http://dx.doi.org/10.1074/jbc.274.24.17025 .,OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
http://dx.doi.org/10.1083/jcb.200104037 .,Non-OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
http://dx.doi.org/ 10.1038/ncb2279 .,Non-OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
http://dx.doi.org/10.1016/ 0014-5793(93)80958-W .,OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
http://dx.doi.org/10.1111/j.1600-0854.2007.00683.x .,Non-OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
http://dx.doi.org/10.1074/ jbc.274.17.11459 .,Non-OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
http://dx.doi.org/10.1371/journal.pone.0063213 .,Non-OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
J Biol Chem 280:42325– 42335. http://dx.doi.org/10.1074/jbc.M506651200 .,OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
J Cardiovasc Pharmacol58:462– 469. http://dx.doi.org/10.1097/FJC.0b013e31822001e3 .,Non-OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
http://dx.doi.org/10.1146/annurev.cellbio.19.111301.112449 .,OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
Mol Cell 23:621– 629. http://dx.doi.org/10.1016/ j.molcel.2006.08.012 .,OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
http://dx.doi.org/10.1038/ncb935 .,Non-OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
http://dx.doi.org/10.1242/ jcs.130161 .,Non-OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
http://dx.doi.org/10.1073/ pnas.0506461102 .,Non-OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
http://dx.doi.org/10.1016/S1097-2765(01)00393-8 .,OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
Nat Commun5:3758. http://dx.doi.org/10.1126/science.1116008 .,OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
Recruitment of the Arp2/3 complex to vinculin: coupling membrane protrusion to matrix adhesion.J Cell Biol 159:881– 891. http://dx.doi.org/10.1083/jcb.200206043 .,Non-OADS,/arxiv_data1/oa_pdf/d3/23/mBio.00598-15.PMC4442140.pdf
"Proteins were annotated more accurately using theCAZY database ( http://www.cazy.org ) (37), and mean values for each of the three biological replicates were calculated.",OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
"Mass spectrometry was performedwith a Q Exactive Plus mass spectrometer (Thermo) in positive modeusing a repetitively full MS scan followed by collision-induced dissocia-tion (CID) of the 10 most dominant ions selected from the ﬁrst MS scan.The mass spectrometry data were analyzed using MaxQuant v1.5 software(62, 63) versus the C. clariﬂavum section of the UniProt database ( http:// www.uniprot.org /) or of the NCBI-nr database ( http://www.ncbi.nlm.ni- h.gov ) with a 1% false discovery rate (FDR).",OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
Protein concentration was determined byabsorbance at 280 nm and evaluated based on the extinction coefﬁcientcalculated using the Expasy ProtParam tool ( http://web.expasy.org /protparam/ ).,OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/10.1128/ MMBR.69.1.124-154.2005 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
Science 315:804 – 807. http://dx.doi.org/ 10.1126/science.1137016 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
Science 311: 484 – 489. http://dx.doi.org/ 10.1126/science.1114736 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/10.1023/A:1018431705579 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
Plant Physiol 153: 444 – 455. http://dx.doi.org/ 10.1104/pp.110.156646 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/ 10.1016/0167-7799(94)90039-6 .,OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/ 10.1016/S0959-440X(98)80143-7 .,OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/10.1146/ annurev.micro.57.030502.091022 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/ 10.1038/nrmicro925 .,OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
Cellulosomes: highly efﬁcient nanoma- chines designed to deconstruct plant cell wall complex carbohydrates.Annu Rev Biochem 79:655– 681. http://dx.doi.org/10.1146/annurev -biochem-091208-085603 .,OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/10.1016/0378-1097(92)90022-G .,OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/10.1128/MMBR.00028-05 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/10.1042/BJ20040892 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/10.1099/ijs.0.003483-0 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/10.4056/sigs.2535732 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
Biotechnol Biofuels 7:136. http://dx.doi.org/10.1186/s13068-014 -0136-4 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
BMC Genomics 13:210. http://dx.doi.org/10.1186/1471-2164-13-210 .,OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/10.7717/ peerj.636 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
Biotechnol Biofuels 7:100. http://dx.doi.org/10.1186/1754-6834-7-100 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/10.1111/j.1742-4658.2009.07025.x .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/10.1002/pmic.200900311 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/10.1099/mic.0.27605-0 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/10.1371/journal.pone.0005271 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
J Bacteriol 189: 6787– 6795. http://dx.doi.org/10.1128/JB.00882-07 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/10.1002/ pmic.200401199 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/10.1021/pr400788e .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/10.1111/j.1365 -2958.1993.tb01576.x .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/10.1093/nar/gkn663 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/10.1038/ nature10098 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/10.1007/s10911-012-9252-6 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/ 10.1016/j.immuni.2010.02.006 .,OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/10.1042/ BJ20091152 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/10.1007/BF00902740 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/10.1128/JB.187.7.2261-2266.2005 .,OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/10.1128/JB.185.2.504-512.2003 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
J Biol Chem 281:8815– 8828. http://dx.doi.org/ 10.1074/jbc.M510559200 .,OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/10.1016/0006-291X(89)92657-0 .,OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
J Bacteriol 190:4321– 4327. http://dx.doi.org/10.1128/JB.00097-08 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
J Bacteriol 185: 4548 – 4557. http://dx.doi.org/10.1128/JB.185.15.4548-4557.2003 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/10.1128/JB.186.17.5782 -5789.2004 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
Anal Chem 31:426 – 428. http://dx.doi.org/10.1021/ ac60147a030 .,OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/ 10.1038/nbt.1511 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/10.1021/ pr101065j .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/10.1083/jcb.200911091 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
BiotechnolBiofuels 6:182. http://dx.doi.org/10.1186/1754-6834-6-182 .,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/10.1196/annals.1419.008 .Artzi et al.,Non-OADS,/arxiv_data1/oa_pdf/89/05/mBio.00411-15.PMC4442141.pdf
http://dx.doi.org/ 10.1146/annurev-biochem-060713-035600 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
Nat Struct Biol 10:645– 651. http://dx.doi.org/10.1038/nsb948 .,OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/ 10.1021/bi0518186 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1074/jbc.M112.447607 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1074/jbc.271.20.12095 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1074/jbc.272.16.10353 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
Nat Rev Microbiol 11:467– 481. http://dx.doi.org/10.1038/nrmicro3047 .,OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1146/annurev -micro-092412-155751 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1016/S0092 -8674(00)81750-X .,OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/ 10.1093/emboj/19.19.5071 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1128/AAC.00256-11 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
Int J Antimicrob Agents29:630 – 636. http://dx.doi.org/10.1016/j.ijantimicag.2006.12.012 .,OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.4103/0974 -777X.68538 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1111/j.1462-2920.2010.02175.x .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1093/infdis/jiq086 .,OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
InfectControl Hosp Epidemiol 28:423– 429. http://dx.doi.org/10.1086/513120 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1017/S0950268807009478 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://www.eurosurveillance.org/ ViewArticle.aspx?ArticleId /H1100519045 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
Antimicrob Agents Chemother 54:4971– 4977. http://dx.doi.org/10.1128/AAC.00834-10 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1586/eri.12.78 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/ 10.1179/096805105X35242 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1073/ pnas.86.13.5054 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1128/mBio.01313-14 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1128/IAI.00016-10 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1128/IAI.00704-12 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/ 10.1021/ja4029654 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1021/ac403796n .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1146/annurev.bi.59.070190.001021 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1111/j.1365-2958.2005.04711.x .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1074/jbc.M010730200 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1146/annurev.immunol.21.120601.141126 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1038/nature07830 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1016/ j.coi.2005.02.007 .,OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1016/S0065 -2911(08)60145-9 .,OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
J Bacteriol182:4077– 4086. http://dx.doi.org/10.1128/JB.182.14.4077-4086.2000 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1128/AAC.01533-08 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
"http://dx.doi.org/10.1371/journal.pone.0022674 .47.Iwashkiw JA, Seper A, Weber BS, Scott NE, Vinogradov E, Stratilo C, Reiz B, Cordwell SJ, Whittal R, Schild S, Feldman MF .",OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1371/journal.ppat.1002758 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1128/IAI.73.7.3842-3850.2005 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1128/JB.182.13.3843 -3845.2000 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1016/0165 -2478(85)90100-2 .,OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/ 10.1016/j.peptides.2006.11.010 .,OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
J ClinInvest 90:447– 455. http://dx.doi.org/10.1172/JCI115880 .,OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
BMC Genomics 12:308. http://dx.doi.org/ 10.1186/1471-2164-12-308 .,OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
FEBS Lett 261: 464 – 467. http://dx.doi.org/10.1016/0014 -5793(90)80616-Q .,OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1021/bi9630826 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1016/S0006-3495(00)76398-3 .,OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1006/plas.1996.0038 .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1111/j.1365 -2958.2011.07765.x .,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1385/1 -59745-167-3:237 .LpxMAbProtects A. baumannii from CAMPs and Desiccation May/June 2015 Volume 6 Issue 3 e00478-15®mbio.asm.org 11,Non-OADS,/arxiv_data1/oa_pdf/44/39/mBio.00478-15.PMC4442142.pdf
http://dx.doi.org/10.1126/science.1146498 .,Non-OADS,/arxiv_data1/oa_pdf/0b/7e/mBio.00193-15.PMC4442143.pdf
http://dx.doi.org/ 10.1007/s00253-010-2573-8 .,Non-OADS,/arxiv_data1/oa_pdf/0b/7e/mBio.00193-15.PMC4442143.pdf
http://dx.doi.org/10.1038/ nature12977 .,Non-OADS,/arxiv_data1/oa_pdf/0b/7e/mBio.00193-15.PMC4442143.pdf
http://dx.doi.org/10.1016/j.jip.2007.02.014 .,OADS,/arxiv_data1/oa_pdf/0b/7e/mBio.00193-15.PMC4442143.pdf
Vet Res 41:54.http://dx.doi.org/10.1051/ vetres/2010027 .,Non-OADS,/arxiv_data1/oa_pdf/0b/7e/mBio.00193-15.PMC4442143.pdf
http://dx.doi.org/10.1016/j.jip.2012.12.009 .,OADS,/arxiv_data1/oa_pdf/0b/7e/mBio.00193-15.PMC4442143.pdf
Mol Ecol 20:619 – 628. http://dx.doi.org/ 10.1111/j.1365-294X.2010.04959.x .,OADS,/arxiv_data1/oa_pdf/0b/7e/mBio.00193-15.PMC4442143.pdf
http://dx.doi.org/10.1371/ journal.pone.0036393 .,Non-OADS,/arxiv_data1/oa_pdf/0b/7e/mBio.00193-15.PMC4442143.pdf
http://dx.doi.org/10.1111/mec.12209 .,Non-OADS,/arxiv_data1/oa_pdf/0b/7e/mBio.00193-15.PMC4442143.pdf
http://dx.doi.org/ 10.1371/journal.pone.0041250 .,Non-OADS,/arxiv_data1/oa_pdf/0b/7e/mBio.00193-15.PMC4442143.pdf
http://dx.doi.org/10.1371/journal.pone.0095056 .,Non-OADS,/arxiv_data1/oa_pdf/0b/7e/mBio.00193-15.PMC4442143.pdf
http://dx.doi.org/10.1128/AEM.07810-11 .,Non-OADS,/arxiv_data1/oa_pdf/0b/7e/mBio.00193-15.PMC4442143.pdf
http://dx.doi.org/10.1007/s12275-012-2188-0 .,Non-OADS,/arxiv_data1/oa_pdf/0b/7e/mBio.00193-15.PMC4442143.pdf
http://dx.doi.org/ 10.1099/ijs.0.049569-0 .,Non-OADS,/arxiv_data1/oa_pdf/0b/7e/mBio.00193-15.PMC4442143.pdf
Appl Environ Microbiol http://dx.doi.org/10.1128/AEM.01861-14 .,OADS,/arxiv_data1/oa_pdf/0b/7e/mBio.00193-15.PMC4442143.pdf
http://dx.doi.org/10.1051/apido:19670103 .,OADS,/arxiv_data1/oa_pdf/0b/7e/mBio.00193-15.PMC4442143.pdf
http://dx.doi.org/10.1007/s13238-010-0109-8 .,Non-OADS,/arxiv_data1/oa_pdf/0b/7e/mBio.00193-15.PMC4442143.pdf
Insect Biochem MolBiol 35:443– 459. http://dx.doi.org/10.1016/j.ibmb.2005.01.014 .,OADS,/arxiv_data1/oa_pdf/0b/7e/mBio.00193-15.PMC4442143.pdf
http://dx.doi.org/ 10.1371/journal.pgen.1002168 .,Non-OADS,/arxiv_data1/oa_pdf/0b/7e/mBio.00193-15.PMC4442143.pdf
http://dx.doi.org/10.1371/ journal.ppat.1004067 .,Non-OADS,/arxiv_data1/oa_pdf/0b/7e/mBio.00193-15.PMC4442143.pdf
http://dx.doi.org/ 10.1073/pnas.1009223107 .,Non-OADS,/arxiv_data1/oa_pdf/0b/7e/mBio.00193-15.PMC4442143.pdf
http://dx.doi.org/10.2307/ 3282015 .,Non-OADS,/arxiv_data1/oa_pdf/0b/7e/mBio.00193-15.PMC4442143.pdf
http://dx.doi.org/10.1371/ journal.pbio.0020239 .,Non-OADS,/arxiv_data1/oa_pdf/0b/7e/mBio.00193-15.PMC4442143.pdf
http://dx.doi.org/10.1128/ AEM.03283-14 .,Non-OADS,/arxiv_data1/oa_pdf/0b/7e/mBio.00193-15.PMC4442143.pdf
Science 313:848 – 851. http://dx.doi.org/10.1126/science.1127059 .,Non-OADS,/arxiv_data1/oa_pdf/0b/7e/mBio.00193-15.PMC4442143.pdf
http://dx.doi.org/10.1099/ijs.0.044875-0 .,Non-OADS,/arxiv_data1/oa_pdf/0b/7e/mBio.00193-15.PMC4442143.pdf
R package version 0.1.1. http://CRAN.R-project.org/ package /H11005beeswarm .,Non-OADS,/arxiv_data1/oa_pdf/0b/7e/mBio.00193-15.PMC4442143.pdf
http://dx.doi.org/10.1303/aez.2009.281 .,Non-OADS,/arxiv_data1/oa_pdf/0b/7e/mBio.00193-15.PMC4442143.pdf
http://dx.doi.org/10.3896/IBRA.1.52.4.07 .Engel et al.,OADS,/arxiv_data1/oa_pdf/0b/7e/mBio.00193-15.PMC4442143.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1. de Boer WEL, Besseling JJM, Willems JHBM.",Non-OADS,/arxiv_data1/oa_pdf/e6/5a/bmjopen-2014-006315.PMC4442145.pdf
"Geneva: World Health Organisation, 2001 http://www.who.int/cassifications/icf/site/beginners/bg.pdf 5.",Non-OADS,/arxiv_data1/oa_pdf/e6/5a/bmjopen-2014-006315.PMC4442145.pdf
http://bioinfo.amc.uva.nl/human-genetics/pubreminer/ (accessed Aug 2013).,Non-OADS,/arxiv_data1/oa_pdf/e6/5a/bmjopen-2014-006315.PMC4442145.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-007365).,Non-OADS,/arxiv_data1/oa_pdf/2e/9e/bmjopen-2014-007365.PMC4442146.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/2e/9e/bmjopen-2014-007365.PMC4442146.pdf
"Secondary Organisatie, 2013. http://www.huisartsen-ozl.nl/ (accessed1 Jun 2014).",Non-OADS,/arxiv_data1/oa_pdf/2e/9e/bmjopen-2014-007365.PMC4442146.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-006674).,Non-OADS,/arxiv_data1/oa_pdf/5b/14/bmjopen-2014-006674.PMC4442147.pdf
Data sharing statement Additional data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.8n7gf.,OADS,/arxiv_data1/oa_pdf/5b/14/bmjopen-2014-006674.PMC4442147.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/5b/14/bmjopen-2014-006674.PMC4442147.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-007137).,Non-OADS,/arxiv_data1/oa_pdf/6f/1e/bmjopen-2014-007137.PMC4442149.pdf
"Second, all the effect sizesfrom the original studies will be included in the meta-analysis by the meta or metafor package in R project (http://www.r-project.org).",Non-OADS,/arxiv_data1/oa_pdf/6f/1e/bmjopen-2014-007137.PMC4442149.pdf
To view please visit the journal (http://dx.doi.org/10.1136/openhrt-2014- 000224).,Non-OADS,/arxiv_data1/oa_pdf/21/0c/openhrt-2014-000224.PMC4442150.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-007008).,Non-OADS,/arxiv_data1/oa_pdf/14/1c/bmjopen-2014-007008.PMC4442151.pdf
http://nidss.cdc.gov.tw/SingleDisease.aspx?pt=s&Dc=2&Dt=1&disease=006&d=3&s=determined_ cnt&i=all&RK=Y 26.,OADS,/arxiv_data1/oa_pdf/14/1c/bmjopen-2014-007008.PMC4442151.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-007654).,Non-OADS,/arxiv_data1/oa_pdf/3b/73/bmjopen-2015-007654.PMC4442152.pdf
"For example, IMPROOF, a group of e-cigarette supporters (http://www.improofmovement.",Non-OADS,/arxiv_data1/oa_pdf/3b/73/bmjopen-2015-007654.PMC4442152.pdf
"Network visualisations are then created from thesedyadic relationships, using the Gephi software package (https://gephi.org).",OADS,/arxiv_data1/oa_pdf/3b/73/bmjopen-2015-007654.PMC4442152.pdf
"The dictionary of words comes from the Multi-Perspective Question Answering (MPQA)Subjectivity Lexicon (http://mpqa.cs.pitt.edu), which identi ﬁes 6451 words as positive or negative, with an additional strong or weak quanti ﬁer.",Non-OADS,/arxiv_data1/oa_pdf/3b/73/bmjopen-2015-007654.PMC4442152.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/3b/73/bmjopen-2015-007654.PMC4442152.pdf
Soc Sci Res Netw 2011. http://dx.doi.org/ 10.2139/ssrn.1943168 4.,OADS,/arxiv_data1/oa_pdf/3b/73/bmjopen-2015-007654.PMC4442152.pdf
http:// www.ncbi.nlm.nih.gov/pmc/articles/PMC4260378/ http://dx.doi.org/10.1186/s12916-014-0225-z 12.,Non-OADS,/arxiv_data1/oa_pdf/3b/73/bmjopen-2015-007654.PMC4442152.pdf
"New York: Free Press, 2003.http://www.amazon.de/exec/obidos/ASIN/0743222091 13.",Non-OADS,/arxiv_data1/oa_pdf/3b/73/bmjopen-2015-007654.PMC4442152.pdf
106 http://www.uniroma2.it/ didattica/direzioneestrategie/deposito/cross_prusak.pdf 15.,Non-OADS,/arxiv_data1/oa_pdf/3b/73/bmjopen-2015-007654.PMC4442152.pdf
"SAGE Publications, Incorporated, 2012. http://www.uk.sagepub.com/booksProdDesc.nav?prodId=Book234903 18.",Non-OADS,/arxiv_data1/oa_pdf/3b/73/bmjopen-2015-007654.PMC4442152.pdf
J Soc Struct 2013;14:pii: 4. http://www.cmu.edu/ joss/content/articles/volume14/ChuWipfliValente.pdf 20.,Non-OADS,/arxiv_data1/oa_pdf/3b/73/bmjopen-2015-007654.PMC4442152.pdf
http://steveborgatti.com/papers/2modeconcepts.pdf 21.,Non-OADS,/arxiv_data1/oa_pdf/3b/73/bmjopen-2015-007654.PMC4442152.pdf
"Oxford: Oxford University Press, 2010. http://www.amazon.com/Social-Networks-Health-Methods-Applications/dp/0195301013 22.",Non-OADS,/arxiv_data1/oa_pdf/3b/73/bmjopen-2015-007654.PMC4442152.pdf
"McGraw-Hill, 1983:470. http://books.google.com/books?id=7f5TAAAAMAAJ 23.",Non-OADS,/arxiv_data1/oa_pdf/3b/73/bmjopen-2015-007654.PMC4442152.pdf
ncbi.nlm.nih.gov/pmc/articles/PMC4258055/ http://dx.doi.org/10.1186/s12971-014-0022-7 26.,Non-OADS,/arxiv_data1/oa_pdf/3b/73/bmjopen-2015-007654.PMC4442152.pdf
"http://www.ncbi.nlm.nih.gov/ pmc/articles/PMC4210950/ http://dx.doi.org/10.2196/jmir.3622 8 Chu K-H, et al.BMJ Open 2015; 5:e007654.",Non-OADS,/arxiv_data1/oa_pdf/3b/73/bmjopen-2015-007654.PMC4442152.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-007506).,Non-OADS,/arxiv_data1/oa_pdf/93/b9/bmjopen-2014-007506.PMC4442153.pdf
http:// dnalab-www.uia.ac.be/dnalab/hhh/; http://hereditaryhearingloss.org/(accessed 19 Mar 2015).,OADS,/arxiv_data1/oa_pdf/93/b9/bmjopen-2014-007506.PMC4442153.pdf
http://www.ncbi.nlm.nih.gov/books/ NBK1251/ (accessed 19 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/93/b9/bmjopen-2014-007506.PMC4442153.pdf
http://www.hgmd.cf.ac.uk/ac/index.php (accessed 11 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/93/b9/bmjopen-2014-007506.PMC4442153.pdf
"To help users clearly identify areas of overlap between the two guidelines, an annotated version of the BTS CAP Guideline has been produced and is available on the BTS website: http://www.brit-thoracic.org.uk FUTURE DIRECTIONS The BTS Standards of Care Committee will, at a later date, decide on the timing and scope of a future update of the BTS CAP Guideline building on the excellence ofthe NICE Pneumonia Guideline.",Non-OADS,/arxiv_data1/oa_pdf/9a/8b/bmjresp-2015-000091.PMC4442154.pdf
2014. http://www.nice.org.uk/guidance/cg191 3.,Non-OADS,/arxiv_data1/oa_pdf/9a/8b/bmjresp-2015-000091.PMC4442154.pdf
2014. https://www.brit- thoracic.org.uk/audit-and-quality-improvement/bts-care-bundles- for-cap-and-copd/ 4.,Non-OADS,/arxiv_data1/oa_pdf/9a/8b/bmjresp-2015-000091.PMC4442154.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/6e/ca/bmjopen-2015-007812.PMC4442156.pdf
http://www.fhi.no/artikler/?id=84900 (accessed 11 Feb 2015).,Non-OADS,/arxiv_data1/oa_pdf/94/fe/bmjopen-2014-006422.PMC4442157.pdf
Euro Surveill 2012;17:pii: 20147. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20147 11.,Non-OADS,/arxiv_data1/oa_pdf/94/fe/bmjopen-2014-006422.PMC4442157.pdf
2014. http://www.ssb.no/en/utdanning/artikler-og-publikasjoner/facts-about-education-in-norway-2015?fane=om (accessed 11 Feb 2015).12.,Non-OADS,/arxiv_data1/oa_pdf/94/fe/bmjopen-2014-006422.PMC4442157.pdf
http://www.dagensmedisin.np/nyheter/farre-enn-30-prosent-vil-hpv-vaksineres/ 25.,OADS,/arxiv_data1/oa_pdf/94/fe/bmjopen-2014-006422.PMC4442157.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-006886).,Non-OADS,/arxiv_data1/oa_pdf/7d/20/bmjopen-2014-006886.PMC4442158.pdf
The CKD was de ﬁned according to the KDIGO clinical practice guideline (available at http://www.kdigo.org).,Non-OADS,/arxiv_data1/oa_pdf/7d/20/bmjopen-2014-006886.PMC4442158.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-008046).,Non-OADS,/arxiv_data1/oa_pdf/86/3f/bmjopen-2015-008046.PMC4442170.pdf
"electronic data extraction software, the ‘Canning tool ’ (http://www.canningtool.com.au), developed for this trial.",Non-OADS,/arxiv_data1/oa_pdf/86/3f/bmjopen-2015-008046.PMC4442170.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1. International Agency for Research on Cancer, 2014. http://globocan.",Non-OADS,/arxiv_data1/oa_pdf/86/3f/bmjopen-2015-008046.PMC4442170.pdf
2011. http://www.aihw.gov.au/cancer/cancer-in-australia/#deaths(accessed 2 Oct 2014).,Non-OADS,/arxiv_data1/oa_pdf/86/3f/bmjopen-2015-008046.PMC4442170.pdf
"Australia: Lung Foundation Research Australia, 2011. http://www.lungfoundation.com.au/showusyourlungs 24.",Non-OADS,/arxiv_data1/oa_pdf/86/3f/bmjopen-2015-008046.PMC4442170.pdf
2006. http://www.phac-aspc.gc.ca/injury-bles/facts-eng.php3.,OADS,/arxiv_data1/oa_pdf/4d/6c/bmjopen-2015-008088.PMC4442171.pdf
http://www.nwi.pdx.edu/index.shtml 11.,Non-OADS,/arxiv_data1/oa_pdf/4d/6c/bmjopen-2015-008088.PMC4442171.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-007588).,Non-OADS,/arxiv_data1/oa_pdf/38/c4/bmjopen-2015-007588.PMC4442173.pdf
"Data sharing statement Additional data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.gg47h Open Access This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.",Non-OADS,/arxiv_data1/oa_pdf/38/c4/bmjopen-2015-007588.PMC4442173.pdf
Intrauterine insemination discussed by the ESHRE Capri Workshop Group 2009. http://www.eshre.eu/ (accessed 30 Aug 2014).,Non-OADS,/arxiv_data1/oa_pdf/38/c4/bmjopen-2015-007588.PMC4442173.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/93/18/lupus-2015-000089.PMC4442174.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-006606).,Non-OADS,/arxiv_data1/oa_pdf/cf/24/bmjopen-2014-006606.PMC4442176.pdf
http://www.ncepod.org.uk/2005aap.htm (accessed Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/cf/24/bmjopen-2014-006606.PMC4442176.pdf
http://www.nice.org.uk/Guidance/CG50/NiceGuidance/pdf (accessed Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/cf/24/bmjopen-2014-006606.PMC4442176.pdf
"London: RCP, 2012. https://www.rcplondon.ac.uk/resources/national-early-warning-score-news(accessed Mar 2015).",Non-OADS,/arxiv_data1/oa_pdf/cf/24/bmjopen-2014-006606.PMC4442176.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-006918).,Non-OADS,/arxiv_data1/oa_pdf/72/14/bmjopen-2014-006918.PMC4442177.pdf
2012. http://www.qsrinternational.com/ products_nvivo.aspx 19.,Non-OADS,/arxiv_data1/oa_pdf/72/14/bmjopen-2014-006918.PMC4442177.pdf
2013. http://ofqual.gov.uk/help-and-advice/ comparing-qualifications/ 34.,Non-OADS,/arxiv_data1/oa_pdf/72/14/bmjopen-2014-006918.PMC4442177.pdf
"2010. http://www.ons.gov.uk/ons/guide-method/classifications/current-standard-classifications/soc2010/soc2010-volume-3-ns-sec –rebased-on- soc2010 –user-manual/index.html 8 Hayden C, et al.BMJ Open 2015; 5:e006918.",OADS,/arxiv_data1/oa_pdf/72/14/bmjopen-2014-006918.PMC4442177.pdf
http://www.nhsemployers.org/~/media/ Employers/Documents/Campaigns/Flu%20fighter/Digital%20resources/Clinical%20evidence%2021%20August_1.pdf(accessed 11 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/14/15/bmjresp-2015-000079.PMC4442178.pdf
https://www.gov.uk/government/statistics/seasonal- flu-vaccine-uptake-in-healthcare-workers-1-september-2014-to-31-january-2015 (accessed 11 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/14/15/bmjresp-2015-000079.PMC4442178.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-007466).,Non-OADS,/arxiv_data1/oa_pdf/a3/42/bmjopen-2014-007466.PMC4442189.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a3/42/bmjopen-2014-007466.PMC4442189.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-007806).,Non-OADS,/arxiv_data1/oa_pdf/d7/ba/bmjopen-2015-007806.PMC4442191.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-006907).,Non-OADS,/arxiv_data1/oa_pdf/1f/60/bmjopen-2014-006907.PMC4442192.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/1f/60/bmjopen-2014-006907.PMC4442192.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-007898).,Non-OADS,/arxiv_data1/oa_pdf/f7/e5/bmjopen-2015-007898.PMC4442193.pdf
"These data are available to researchers on request and subject to approval from the relevant data custodians and ethics committees, and via linkage conducted by the NSW Centre for Health Record Linkage (http://www.cherel.org.au) or theAustralian Institute of Health and Welfare Data Integration Services Centre (http://www.aihw.gov.au/organisation-detail/?id=10737420129).",OADS,/arxiv_data1/oa_pdf/f7/e5/bmjopen-2015-007898.PMC4442193.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f7/e5/bmjopen-2015-007898.PMC4442193.pdf
"Sydney: Centre for Epidemiology and Evidence, 2013. http://www.health.nsw.gov.au/epidemiology/Pages/NSW-Population-Health-Survey.aspx (accessed1 Dec 2014).",Non-OADS,/arxiv_data1/oa_pdf/f7/e5/bmjopen-2015-007898.PMC4442193.pdf
"Commonwealth of Australia, 2014. http://www.aedc.gov.au/resources/detail/public-table-by-local-government-area-(lga) —2012 (accessed 28 Nov 2014).",Non-OADS,/arxiv_data1/oa_pdf/f7/e5/bmjopen-2015-007898.PMC4442193.pdf
"Commonwealth of Australia, 2014. http://www.aedc.gov.au/resources/community-profiles (accessed 28 Nov 2014).",Non-OADS,/arxiv_data1/oa_pdf/f7/e5/bmjopen-2015-007898.PMC4442193.pdf
"Canberra: ABS, 2007. http://www.abs.gov.au/ ausstats/abs@.nsf/Previousproducts/3235.0MainFeatures99992007?opendocument&tabname=Summary&prodno=3235.0&issue=2007&num=&view= (accessed 15 Oct 2014).",Non-OADS,/arxiv_data1/oa_pdf/f7/e5/bmjopen-2015-007898.PMC4442193.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 007838).,Non-OADS,/arxiv_data1/oa_pdf/74/03/bmjopen-2015-007838.PMC4442194.pdf
Trial registration number: http://www.crd.york.ac.,Non-OADS,/arxiv_data1/oa_pdf/74/03/bmjopen-2015-007838.PMC4442194.pdf
13 METHODS The protocol was registered at (http://www.crd.york.ac.uk/PROSPERO/) (review registration number CRD42013006472) and attached as a supplement; key points are summarised here.,Non-OADS,/arxiv_data1/oa_pdf/74/03/bmjopen-2015-007838.PMC4442194.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/74/03/bmjopen-2015-007838.PMC4442194.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/95/2d/bmjopen-2014-007518.PMC4442195.pdf
http://www.midstaffspublicinquiry.com/report (accessed Aug 2014).,Non-OADS,/arxiv_data1/oa_pdf/95/2d/bmjopen-2014-007518.PMC4442195.pdf
2008. http://www.rcn.org.uk/ development/practice/dignity (accessed Aug 2014).,Non-OADS,/arxiv_data1/oa_pdf/95/2d/bmjopen-2014-007518.PMC4442195.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-007426).,Non-OADS,/arxiv_data1/oa_pdf/9f/1e/bmjopen-2014-007426.PMC4442196.pdf
"There are two other ongoing population studies on Irish childhood,the Health Behaviours of School-Aged Children (HBSC) 14and the longitudinal Growing Up in Ireland study, (http://www.growingup.ie), both providingimportant information on the health pro ﬁle of Irish children.",Non-OADS,/arxiv_data1/oa_pdf/9f/1e/bmjopen-2014-007426.PMC4442196.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9f/1e/bmjopen-2014-007426.PMC4442196.pdf
20. http://www.bath.ac.uk/pain (accessed 2013).21.,Non-OADS,/arxiv_data1/oa_pdf/9f/1e/bmjopen-2014-007426.PMC4442196.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 006706).,Non-OADS,/arxiv_data1/oa_pdf/24/e4/bmjopen-2014-006706.PMC4442197.pdf
http://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/4402.0.55.003Main+Features1June%202011?OpenDocument 14.,Non-OADS,/arxiv_data1/oa_pdf/24/e4/bmjopen-2014-006706.PMC4442197.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/2f/cd/bmjopen-2014-007418.PMC4442198.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-007377).,Non-OADS,/arxiv_data1/oa_pdf/b9/a6/bmjopen-2014-007377.PMC4442205.pdf
http://www.nimh.nih.gov/about/director/2013/transforming-diagnosis.shtml 20.,Non-OADS,/arxiv_data1/oa_pdf/b9/a6/bmjopen-2014-007377.PMC4442205.pdf
2014. http://data.worldbank.,Non-OADS,/arxiv_data1/oa_pdf/b9/a6/bmjopen-2014-007377.PMC4442205.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-007324).,Non-OADS,/arxiv_data1/oa_pdf/6f/9d/bmjopen-2014-007324.PMC4442208.pdf
2014. https://www.framinghamheartstudy.,Non-OADS,/arxiv_data1/oa_pdf/6f/9d/bmjopen-2014-007324.PMC4442208.pdf
http://statistics.gov.my/portal/index.php?option=com_content&id=471:population-finder&Itemid=111&lang=en (accessed 13 Feb 2015).,OADS,/arxiv_data1/oa_pdf/6f/9d/bmjopen-2014-007324.PMC4442208.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-007822).,Non-OADS,/arxiv_data1/oa_pdf/bb/b5/bmjopen-2015-007822.PMC4442210.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/bb/b5/bmjopen-2015-007822.PMC4442210.pdf
"World Health Organization, 2014. http://www.who.int/ mental_health/suicide-prevention/world_report_2014/en/ (accessed27 Dec 2014).",Non-OADS,/arxiv_data1/oa_pdf/bb/b5/bmjopen-2015-007822.PMC4442210.pdf
http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=2001280&tool=pmcentrez&rendertype=abstract (accessed 21 Mar 2014).,OADS,/arxiv_data1/oa_pdf/bb/b5/bmjopen-2015-007822.PMC4442210.pdf
http://www.pubmedcentral.nih.gov/articlerender.fcgi?,Non-OADS,/arxiv_data1/oa_pdf/bb/b5/bmjopen-2015-007822.PMC4442210.pdf
http://www.ncbi.nlm.nih.gov/ pubmed/16276756 (accessed 21 Mar 2014).,Non-OADS,/arxiv_data1/oa_pdf/bb/b5/bmjopen-2015-007822.PMC4442210.pdf
http://www.ncbi.nlm.nih.gov/pubmed/16130610 (accessed 21 Mar 2014).,Non-OADS,/arxiv_data1/oa_pdf/bb/b5/bmjopen-2015-007822.PMC4442210.pdf
http://www.ncbi.nlm.nih.gov/pubmed/20645550 (accessed 1 Jan 2015).,OADS,/arxiv_data1/oa_pdf/bb/b5/bmjopen-2015-007822.PMC4442210.pdf
http://www.ncbi.nlm.nih.gov/pubmed/12459820 (accessed 24 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/bb/b5/bmjopen-2015-007822.PMC4442210.pdf
http://journals.cambridge.org/abstract_ S0033291700030415 (accessed 19 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/bb/b5/bmjopen-2015-007822.PMC4442210.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-006333).,Non-OADS,/arxiv_data1/oa_pdf/3f/b1/bmjopen-2014-006333.PMC4442211.pdf
https://www.nice.org.uk/get-involved/citizens-council/citizens-council-report-2014 33.,Non-OADS,/arxiv_data1/oa_pdf/3f/b1/bmjopen-2014-006333.PMC4442211.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-007360).,Non-OADS,/arxiv_data1/oa_pdf/31/9b/bmjopen-2014-007360.PMC4442212.pdf
2007. http://qualityindicators.ahrq.gov/downloads/modules/pqi/v31/pqi_technical_specs_v31.pdf (accessed 4 Nov 2014).,OADS,/arxiv_data1/oa_pdf/31/9b/bmjopen-2014-007360.PMC4442212.pdf
http://acg.jhsph.org/index.php?option=com_content&view=article&id=46&Itemid=366(accessed 4 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/31/9b/bmjopen-2014-007360.PMC4442212.pdf
Vitoria- Gasteiz: 2004. http://en.eustat.es/estadisticas/tema_159/opt_0/ti_Population/temas.html#axzz37p2gs8HG (accessed 4 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/31/9b/bmjopen-2014-007360.PMC4442212.pdf
Comarca Uribe: 2010. http://uribe.osakidetza.net/es/html/4/2123.shtml(accessed 4 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/31/9b/bmjopen-2014-007360.PMC4442212.pdf
"Rockville, MD: Agency for Health Care Policy and Research (US),2006. http://www.ncbi.nlm.nih.gov/books/NBK52655/ (accessed29 Oct 2014).",Non-OADS,/arxiv_data1/oa_pdf/31/9b/bmjopen-2014-007360.PMC4442212.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 006915).,Non-OADS,/arxiv_data1/oa_pdf/74/ce/bmjopen-2014-006915.PMC4442213.pdf
2012 survey results of the cancer screening Secondary 2012 survey results of the cancerscreening 2013.12 2013. http://ncc.re.kr/webzine/201301/sub_08.jsp 12.,Non-OADS,/arxiv_data1/oa_pdf/74/ce/bmjopen-2014-006915.PMC4442213.pdf
2002. http://www.ihe.ca/documents/prevalence_chronic_pain_0.pdf(accessed Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/78/c6/bmjopen-2015-007650.PMC4442214.pdf
2014. http://www.umassmed.edu/cfm/stress-reduction/mbsr-8-week/ 18.,Non-OADS,/arxiv_data1/oa_pdf/78/c6/bmjopen-2015-007650.PMC4442214.pdf
2014. http://www.cadth.ca/en/resources/finding-evidence-is 41.,OADS,/arxiv_data1/oa_pdf/78/c6/bmjopen-2015-007650.PMC4442214.pdf
"2014. http://www.cochrane.org/sites/ default/files/uploads/forums/u389/ERC%20data%20collection%20form%20for%20intervention%20reviews%20for%20RCTs%20only.doc 6 Leung L, et al.BMJ Open 2015; 5:e007650.",OADS,/arxiv_data1/oa_pdf/78/c6/bmjopen-2015-007650.PMC4442214.pdf
2014. http://tech.cochrane.org/revman/download 43.,OADS,/arxiv_data1/oa_pdf/78/c6/bmjopen-2015-007650.PMC4442214.pdf
2011. http://handbook.cochrane.org/chapter_8/table_8_5_d_criteria_for_judging_risk_of_bias_in_the_risk_of.htm 44.,OADS,/arxiv_data1/oa_pdf/78/c6/bmjopen-2015-007650.PMC4442214.pdf
2011. http://handbook.cochrane.org/chapter_9/9_2_3_2_the_standardized_mean_difference.htm 46.,OADS,/arxiv_data1/oa_pdf/78/c6/bmjopen-2015-007650.PMC4442214.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-007128).,Non-OADS,/arxiv_data1/oa_pdf/f5/a9/bmjopen-2014-007128.PMC4442232.pdf
http://www.gipdatabank.nl/ 21.,Non-OADS,/arxiv_data1/oa_pdf/f5/a9/bmjopen-2014-007128.PMC4442232.pdf
http://www.z-index.nl/english22.,Non-OADS,/arxiv_data1/oa_pdf/f5/a9/bmjopen-2014-007128.PMC4442232.pdf
"Statistics Canada, 2009. http://www.statcan.gc.",OADS,/arxiv_data1/oa_pdf/b0/e5/bmjopen-2015-008291.PMC4442234.pdf
"National Center for Health Statistics, 2009. http://www.cdc.gov/nchs/data/hestat/ underweight/underweight_children.htm (accessed 30 May 2011).",Non-OADS,/arxiv_data1/oa_pdf/b0/e5/bmjopen-2015-008291.PMC4442234.pdf
"Statistics Canada, 2011. http://www.statcan.gc.ca/pub/92 –153-g/ 2011002/tech-eng.htm (accessed 1 Jun 2012).",OADS,/arxiv_data1/oa_pdf/b0/e5/bmjopen-2015-008291.PMC4442234.pdf
2008. http://www.gov.ns.,Non-OADS,/arxiv_data1/oa_pdf/b0/e5/bmjopen-2015-008291.PMC4442234.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 006385).,Non-OADS,/arxiv_data1/oa_pdf/b0/67/bmjopen-2014-006385.PMC4442236.pdf
"Competing interests “All authors have completed the Unified Competing Interests form at http://www.icmje.org/coi_disclosure.pdf (available on requestfrom the corresponding author) and declare that (1) all authors have support from their employment institutions for the submitted work; (2) any relationships of relevant authors with funding agencies in the previous 3 yearshave been mentioned in the ‘Conflicts of Interest ’section at the end of the manuscript; (3) spouses, partners, or children of none of the authors had any financial relationships that may be relevant to the submitted work; and (4) none of the authors had any non-financial interests that may be relevant to the submitted work.",Non-OADS,/arxiv_data1/oa_pdf/b0/67/bmjopen-2014-006385.PMC4442236.pdf
doi:10.1136/bmjopen-2015- 008300 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-008300).,Non-OADS,/arxiv_data1/oa_pdf/23/54/bmjopen-2015-008300.PMC4442237.pdf
"TRIAL STATUS This study has been registered at International Standard Randomized Trial Number Register, register numberISRCTN74743666 (http://www.controlled-trials.com/ ISRCTN74743666/).",Non-OADS,/arxiv_data1/oa_pdf/23/54/bmjopen-2015-008300.PMC4442237.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/23/54/bmjopen-2015-008300.PMC4442237.pdf
"Helsinki: Vammalan kirjapaino Oy, 2014. http://www.kela.fi/documents/10180/ 8 Haukka E, et al.BMJ Open 2015; 5:e008300.",Non-OADS,/arxiv_data1/oa_pdf/23/54/bmjopen-2015-008300.PMC4442237.pdf
2010. http://apps.who.int/classifications/icd10/browse/2010/en (accessed 24 Mar 2015).,OADS,/arxiv_data1/oa_pdf/23/54/bmjopen-2015-008300.PMC4442237.pdf
http://www.terveysportti.fi/ dtk/ltk/koti?p_artikkeli=pgr00035&p_haku=PHQ-9 (accessed24 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/23/54/bmjopen-2015-008300.PMC4442237.pdf
http://www.euroqol.org/fileadmin/user_upload/Documenten/PDF/User_Guide_v2_March_2009.pdf (accessed 24 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/23/54/bmjopen-2015-008300.PMC4442237.pdf
The meaning of working survey C. 1995. http://users.ugent.be/~rclaes/MOW/surv_c_e.pdf(accessed 24 Mar 2015).,OADS,/arxiv_data1/oa_pdf/23/54/bmjopen-2015-008300.PMC4442237.pdf
http://work.alberta.ca/documents/WHS-PUB-BCL002.pdf (accessed 24 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/23/54/bmjopen-2015-008300.PMC4442237.pdf
Health 2000 (http://www.terveys2000.fi/indexe.html).,OADS,/arxiv_data1/oa_pdf/23/54/bmjopen-2015-008300.PMC4442237.pdf
http://www.terveys2000.fi/lomakkeet/en/t2002en.pdf (accessed 24 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/23/54/bmjopen-2015-008300.PMC4442237.pdf
http://apps.who.int/bmi/index.jsp?introPage=intro_3.html (accessed 24 Mar 2015).,OADS,/arxiv_data1/oa_pdf/23/54/bmjopen-2015-008300.PMC4442237.pdf
Health 2000 (http://www.terveys2000.fi/indexe.html).,OADS,/arxiv_data1/oa_pdf/23/54/bmjopen-2015-008300.PMC4442237.pdf
http://www.terveys2000.fi/lomakkeet/ en/t2001en.pdf (accessed 24 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/23/54/bmjopen-2015-008300.PMC4442237.pdf
Health 2000 (http://www.terveys2000.fi/indexe.html).,OADS,/arxiv_data1/oa_pdf/23/54/bmjopen-2015-008300.PMC4442237.pdf
http://www.terveys2000.fi/lomakkeet/en/t2005en.pdf (accessed 24 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/23/54/bmjopen-2015-008300.PMC4442237.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-006570).,Non-OADS,/arxiv_data1/oa_pdf/69/5f/bmjopen-2014-006570.PMC4442239.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/69/5f/bmjopen-2014-006570.PMC4442239.pdf
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42014013275 29.,Non-OADS,/arxiv_data1/oa_pdf/69/5f/bmjopen-2014-006570.PMC4442239.pdf
Available at: http://www.fda.gov/cder/guidance/2718dft.,Non-OADS,/arxiv_data1/oa_pdf/69/5f/bmjopen-2014-006570.PMC4442239.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 006857).,Non-OADS,/arxiv_data1/oa_pdf/7c/7a/bmjopen-2014-006857.PMC4442241.pdf
Data sharing statement Additional data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.kv3q7.,OADS,/arxiv_data1/oa_pdf/7c/7a/bmjopen-2014-006857.PMC4442241.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-006704).,Non-OADS,/arxiv_data1/oa_pdf/1d/6a/bmjopen-2014-006704.PMC4442242.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a5/b3/bmjopen-2015-007680.PMC4442243.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-006103).,Non-OADS,/arxiv_data1/oa_pdf/86/48/bmjopen-2014-006103.PMC4442244.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 007436).,Non-OADS,/arxiv_data1/oa_pdf/fd/e1/bmjopen-2014-007436.PMC4442246.pdf
Funding RM ’s and JD ’s positions receive funding from a Screening and Test Evaluation Program (STEP) grant from the National Health and Medical Research Council (http://www.nhmrc.gov.au) (NHMRC) #633003; EB ’s position receives funding from an Australia Fellowship grant: Glasziou NHMRC #527500; the survey received part funding from a Bond University Vice-Chancellors Research Grant (http://www.bond.edu.au) and part fundingfrom a NHRMC (STEP) grant #633003.,Non-OADS,/arxiv_data1/oa_pdf/fd/e1/bmjopen-2014-007436.PMC4442246.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/fd/e1/bmjopen-2014-007436.PMC4442246.pdf
"Press release, 2012. http://choosingwisely.org/wp-content/uploads/2012/03/033012_Choosing-Wisely-National-Press-Rls-FINAL.pdf (accessed 9 Dec 2014).",Non-OADS,/arxiv_data1/oa_pdf/fd/e1/bmjopen-2014-007436.PMC4442246.pdf
Third Report of Session 2014 –15; 29 October 2014. http://www.publications.parliament.uk/pa/cm201415/cmselect/cmsctech/244/244.pdf (accessed 9 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/fd/e1/bmjopen-2014-007436.PMC4442246.pdf
November 2014. http://www.aomrc.org.uk/dmdocuments/Promoting%20value%20FINAL.pdf (accessed 9 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/fd/e1/bmjopen-2014-007436.PMC4442246.pdf
"AAPOR, 2011. http://www.aapor.org/ AAPORKentico/AAPOR_Main/media/MainSiteFiles/StandardDefinitions2011_1.pdf (accessed 21 Mar 2015).",Non-OADS,/arxiv_data1/oa_pdf/fd/e1/bmjopen-2014-007436.PMC4442246.pdf
"The Pew Research Centre, Assessing the Representativeness of Public Opinion Surveys May 15 2012. http://www.people-press.org/2012/05/15/assessing-the-representativeness-of-public-opinion-surveys/ (accessed 9 Dec 2014).",Non-OADS,/arxiv_data1/oa_pdf/fd/e1/bmjopen-2014-007436.PMC4442246.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-007810).,Non-OADS,/arxiv_data1/oa_pdf/0b/5c/bmjopen-2015-007810.PMC4442247.pdf
The website for MEASURE DHS is http://dhsprogram.com/data/ available-dataset.cfm.,OADS,/arxiv_data1/oa_pdf/0b/5c/bmjopen-2015-007810.PMC4442247.pdf
2013. http://www.countdown2015mnch.org/documents/2012Report/2012-complete-no-profiles.pdf2.,Non-OADS,/arxiv_data1/oa_pdf/0b/5c/bmjopen-2015-007810.PMC4442247.pdf
"New York: United Nations, 2011. http://www.un.org/millenniumgoals/MDG2011_PRa_EN.pdf 7.",Non-OADS,/arxiv_data1/oa_pdf/0b/5c/bmjopen-2015-007810.PMC4442247.pdf
2003. http://www.unicef.org/health/files/MMreductionstrategyShoo2003.pdf 10 –6–2003.,Non-OADS,/arxiv_data1/oa_pdf/0b/5c/bmjopen-2015-007810.PMC4442247.pdf
2014. http://www.unicef.org/ mdg/maternal.html 37.,Non-OADS,/arxiv_data1/oa_pdf/0b/5c/bmjopen-2015-007810.PMC4442247.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-006971).,Non-OADS,/arxiv_data1/oa_pdf/ae/ad/bmjopen-2014-006971.PMC4442248.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1. de Groot V, Beckerman H, Lankhorst GJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/ae/ad/bmjopen-2014-006971.PMC4442248.pdf
http://www.hscic.gov.uk/hes (accessed February 2014).,Non-OADS,/arxiv_data1/oa_pdf/ae/ad/bmjopen-2014-006971.PMC4442248.pdf
"Annual Report to the National Specialist Commissioning Advisory Group: The Royal College of Surgeons ofEngland, 2012. http://www.rcseng.ac.uk/surgeons/research/surgical-research/docs/liver-transplant-audit-report-2012/view(accessed Aug 2014).",Non-OADS,/arxiv_data1/oa_pdf/ae/ad/bmjopen-2014-006971.PMC4442248.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-007643).,Non-OADS,/arxiv_data1/oa_pdf/35/2c/bmjopen-2015-007643.PMC4442249.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-007689).,Non-OADS,/arxiv_data1/oa_pdf/e6/9f/bmjopen-2015-007689.PMC4442252.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1. International Diabetes Federation (IDF).,Non-OADS,/arxiv_data1/oa_pdf/e6/9f/bmjopen-2015-007689.PMC4442252.pdf
"Available from: http://www.who.int/tb/ post2015_TBstrategy.pdf?ua=1201 4, accessed on October  27, 2014.",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/IJMR-141-259.PMC4442320.pdf
Available from:  http://www.tbcindia.nic.,Non-OADS,/arxiv_data1/oa_pdf/b5/b4/IJMR-141-259.PMC4442320.pdf
Available from: http://www.stoptb.org/news/stories/2014/ns14_084.,Non-OADS,/arxiv_data1/oa_pdf/b5/b4/IJMR-141-259.PMC4442320.pdf
Available from: http://www.stoptb.,Non-OADS,/arxiv_data1/oa_pdf/b5/b4/IJMR-141-259.PMC4442320.pdf
"Available 22.  from: http://www.impatientoptimists.org/Posts/2015/01/ How-India-is-moving-the-needle-on-TB?utm _, accessed on   February 25 , 2015.",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/IJMR-141-259.PMC4442320.pdf
"Available	 from:	 http://www.who.int/mediacentre/news/ statements/2014/ebola-20140808/en /,	accessed	on	November	 20,	2014. WHO	Ebola	situation	report,	November,	 14,	2014.",Non-OADS,/arxiv_data1/oa_pdf/2b/58/IJMR-141-263.PMC4442321.pdf
"Available	 3.	 from:	 http://apps.who.int/iris/bitstream/10665/143216/1/ roadmapsitrep_14Nov2014_eng.pdf?ua= 1,	accessed	 on	 November	20,	2014.",OADS,/arxiv_data1/oa_pdf/2b/58/IJMR-141-263.PMC4442321.pdf
Available	 from:	 http://apps.who.int/iris/ bitstream/10665/143216/1/roadmapsitrep_14Nov2014_eng.,OADS,/arxiv_data1/oa_pdf/2b/58/IJMR-141-263.PMC4442321.pdf
"Available	 from:	 http://apps.who.int/iris/bitstream/10665/143216/1/ roadmapsitrep_14Nov2014_eng.pdf?ua=1 ,	accessed	 on	 November	23,	2014. WHO:	Nigeria	is	now	free	of	Ebola	virus	transmission.",Non-OADS,/arxiv_data1/oa_pdf/2b/58/IJMR-141-263.PMC4442321.pdf
"Available	 from:	 http://www.who.int/mediacentre/news/ ebola/20-october-2014/en/index1.htm l,	accessed	on	November	 19,	2014).",Non-OADS,/arxiv_data1/oa_pdf/2b/58/IJMR-141-263.PMC4442321.pdf
"Available	 from:	 http://www.cdc.gov/media/releases/2014/ s1027-revised-guidance-monitoring.htm l,	accessed	 on	 November	19,	2014. WHO:	Ebola	response	roadmap	situation	report:	November	 11.",Non-OADS,/arxiv_data1/oa_pdf/2b/58/IJMR-141-263.PMC4442321.pdf
"Available	 from:	 http://apps.who.int/iris/bits  tream/10665/141468/1/roadmapsi trep_12nov2014-eng.pdf/ ua=1,	accessed	on	November	13,	2014.",OADS,/arxiv_data1/oa_pdf/2b/58/IJMR-141-263.PMC4442321.pdf
Available	 from:	 http://nicd.nic.,Non-OADS,/arxiv_data1/oa_pdf/2b/58/IJMR-141-263.PMC4442321.pdf
"Available from: 22.  http://www.ninds.nih.gov/doctors/nih_stroke_scale.pdf,  accessed  on April 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/1b/11/IJMR-141-299.PMC4442327.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and repr oduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/08/bc/TODENTJ-8-251.PMC4442406.pdf
Available from: http://www.ncbi.nlm.nih.gov/About/primer/pharm.,Non-OADS,/arxiv_data1/oa_pdf/c2/90/IJPhS-77-135.PMC4442460.pdf
Available from: http://www.genetics.edu.au.,Non-OADS,/arxiv_data1/oa_pdf/c2/90/IJPhS-77-135.PMC4442460.pdf
Available from: http://www.apps.who.int/medicinedocs/ en/d/Jwhozip32e.,OADS,/arxiv_data1/oa_pdf/28/d5/IJPhS-77-178.PMC4442466.pdf
Available from: http://www.apps.who.int/medicinedocs/en/d/Js2218e/  [Last accessed on 2013 Feb 5].5.,OADS,/arxiv_data1/oa_pdf/28/d5/IJPhS-77-178.PMC4442466.pdf
Available from: http://www.accessdata.fda.gov/scripts/ cder/ob/default.cfm.,OADS,/arxiv_data1/oa_pdf/90/c3/IJPhS-77-190.PMC4442468.pdf
Printers  Castle: Kochi; 2005 Available from: http://www.spices.res.in/pdf/ package/cinnamon.pdf [Last cited on 2013 Dec 14].,Non-OADS,/arxiv_data1/oa_pdf/85/b4/IJPhS-77-243.PMC4442477.pdf
Available from: http://webprod.hc-sc.gc.ca/nhpid-bdipsn/monoReq.,OADS,/arxiv_data1/oa_pdf/85/b4/IJPhS-77-243.PMC4442477.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.ASTROBIOLOGY Volume 15, Number 5, 2015DOI: 10.1089/ast.2014.1178 341",Non-OADS,/arxiv_data1/oa_pdf/77/fc/ast.2014.1178.PMC4442567.pdf
Further detailed information regarding strain type and culture media can be found online at https://www.dsmz.de.,Non-OADS,/arxiv_data1/oa_pdf/77/fc/ast.2014.1178.PMC4442567.pdf
1https://www.dsmz.de346 SCHWIETERMAN ET AL.,OADS,/arxiv_data1/oa_pdf/77/fc/ast.2014.1178.PMC4442567.pdf
2http://www.oceanoptics.comNONPHOTOSYNTHETIC PIGMENTS AS POTENTIAL BIOSIGNATURES 347,Non-OADS,/arxiv_data1/oa_pdf/77/fc/ast.2014.1178.PMC4442567.pdf
SeeSections 2.4.1 and 3.2 for a description of the 1-D synthetic spectra.3https://depts.washington.edu/naivpl/content/spectral-databases- and-tools352 SCHWIETERMAN ET AL.,OADS,/arxiv_data1/oa_pdf/77/fc/ast.2014.1178.PMC4442567.pdf
Insetswere generated with the Earth and Moon Viewer (http://www.fourmilab .ch/earthview).,Non-OADS,/arxiv_data1/oa_pdf/77/fc/ast.2014.1178.PMC4442567.pdf
Available online at http://speclab.cr .usgs.gov/spectral.lib06.,OADS,/arxiv_data1/oa_pdf/77/fc/ast.2014.1178.PMC4442567.pdf
http://www.ncbi.nlm.n ih.gov/pubmed/24097811 Neurology 2013;  81(19):1650-1.,Non-OADS,/arxiv_data1/oa_pdf/ce/b9/CNR-12-4.PMC4442621.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of thework, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/de/c9/civ174.PMC4442622.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2014.12.005 2352-5789/© 2014 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/42/b4/main.PMC4442643.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/42/b4/main.PMC4442643.pdf
Final pathology was FIGO Grade II Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2014.12.004 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f6/a5/main.PMC4442644.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f6/a5/main.PMC4442644.pdf
"There was an enlarged left inter- nal iliac lymph node measuring 1 × 2 cm, as well as enlarged lymph Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2014.12.001 2352-5789/© 2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dc/7d/main.PMC4442645.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/7d/main.PMC4442645.pdf
"Finally, removal of splenic implants can actually result in profound organ damage as the nodules parasitize the Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2015.01.004 2352-5789/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d6/c7/main.PMC4442646.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/c7/main.PMC4442646.pdf
http://dx.doi.org/10.1016/j.gore.2015.01.005 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/e2/main.PMC4442647.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/54/e2/main.PMC4442647.pdf
It will be of great interest to determine whether the POLE mutations we found in USC are of similar prognostic signi ﬁcance in the multiple additional types of human cancers recently found by the TCGA network to harbor POLE mutations ( https://tcga-data.nci.nih.,Non-OADS,/arxiv_data1/oa_pdf/54/e2/main.PMC4442647.pdf
The ﬁnal diagnosis read as mycosis Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2015.01.006 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/12/96/main.PMC4442648.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/96/main.PMC4442648.pdf
Given that Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2015.02.004 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/4c/main.PMC4442649.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d8/4c/main.PMC4442649.pdf
She was symptomatic with pain and underwent palliative radiation to Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2015.03.003 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d5/fb/main.PMC4442650.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/fb/main.PMC4442650.pdf
http://dx.doi.org/10.1016/j.gore.2015.01.008 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/cd/59/main.PMC4442651.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Introduction Germline mutations in the phosphatase and tensin homolog ( PTEN ) gene manifest in a spectrum of autosomal dominant disorders, the most common of which is Cowden syndrome (CS), but also include Bannayan –Riley –Ruvalcaba syndrome, adult Lhermitte –Duclos disease, macrocephaly, and autism spectrum disorders ( Pilarski et al., 2013 ).",Non-OADS,/arxiv_data1/oa_pdf/cd/59/main.PMC4442651.pdf
"Currently, there are approximately 1.5 million Vietnamese –Americans, with Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2015.02.003 2352-5789/© 2015 Published by Elsevier Inc.",Non-OADS,/arxiv_data1/oa_pdf/29/75/main.PMC4442652.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/29/75/main.PMC4442652.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cc/69/main.PMC4442653.pdf
http://dx.doi.org/10.1016/j.gore.2015.03.004 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/cc/69/main.PMC4442653.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cc/69/main.PMC4442653.pdf
"http://clinicaltrials.gov/ct2/show/record/NCT02050789 (Accessed June 6).Drolet, B.C., Whittle, S.B., Khokhar, M.T., Fischer, S.A., Pallant, A., Nov 2013.",Non-OADS,/arxiv_data1/oa_pdf/cc/69/main.PMC4442653.pdf
"Society of Gynecologic Oncology, 2014. http://www.sgo.org (Accessed January 23).",Non-OADS,/arxiv_data1/oa_pdf/cc/69/main.PMC4442653.pdf
"Then, the possibility of G-nas (exons 8 and 9) and KRAS Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2015.02.001 2352-5789/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ab/d7/main.PMC4442654.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/d7/main.PMC4442654.pdf
Ultrasound showed an 11 × 8 cm irregular hyper-echogenic complex mass with abundant blood ﬂow Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2015.03.005 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3a/a3/main.PMC4442655.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/a3/main.PMC4442655.pdf
"Acknowledgments We would like to thank the Small Cell Ovarian Cancer Foundation (http://smallcellovarian.org/ ), the Canadian Cancer Society Research Institute (702961) and the Fonds de Recherche du Québec —Santé for providing us with funding for this project.",Non-OADS,/arxiv_data1/oa_pdf/3a/a3/main.PMC4442655.pdf
Although in many tumors http://dx.doi.org/10.1016/j.gore.2015.02.002 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0c/f5/main.PMC4442656.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/f5/main.PMC4442656.pdf
Erythrocyte sedimentation rate and C-reactive Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2015.02.005 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/07/c6/main.PMC4442657.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/c6/main.PMC4442657.pdf
"The im- portant differentials for this tumor are the spindle cell tumors, tumors of neural origin, smooth muscle tumors, hemangiopericytoma (HPC), DFS, Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2015.03.002 2352-5789/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d7/8f/main.PMC4442658.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/8f/main.PMC4442658.pdf
Some Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2015.01.007 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/af/ff/main.PMC4442659.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/ff/main.PMC4442659.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2015.03.001 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/64/af/main.PMC4442660.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/64/af/main.PMC4442660.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2015.03.007 2352-5789/Crown Copyright © 2015 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/91/15/main.PMC4442663.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/91/15/main.PMC4442663.pdf
4 (Available from: http://www.nccn.org/ professionals/physician_gls/pdf/genetics_screening.pdf ).,Non-OADS,/arxiv_data1/oa_pdf/91/15/main.PMC4442663.pdf
"Nation- al Institute for Health and Care Excellence, London (Available from: http://www.nice.org.",Non-OADS,/arxiv_data1/oa_pdf/91/15/main.PMC4442663.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2015.03.008 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/68/4b/main.PMC4442664.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/4b/main.PMC4442664.pdf
"354, 34 –43.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/68/4b/main.PMC4442664.pdf
(1) http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/4b/main.PMC4442664.pdf
http://dx.doi.org/10.1530/ERC-12-0395 .,Non-OADS,/arxiv_data1/oa_pdf/68/4b/main.PMC4442664.pdf
http://dx.doi.org/10.1016/j.suc.2011.08.008 .,OADS,/arxiv_data1/oa_pdf/68/4b/main.PMC4442664.pdf
Her AFP was elevated at 146 μg/L but this was dif ﬁcult to interpret in Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2015.03.006 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/6c/main.PMC4442665.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/63/6c/main.PMC4442665.pdf
The ﬁnal Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2015.04.001 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/97/main.PMC4442666.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/97/main.PMC4442666.pdf
Research showed that subjects infected with vacA s1 or m1 isolates have an increased risk of peptic ulcer and/or New Microbe and New Infect 2015; 6:5–10 © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.02.005,Non-OADS,/arxiv_data1/oa_pdf/65/b9/main.PMC4442689.pdf
"The PCR conditions for vacA i region were as follows: the template mixtures were ampli ﬁed 35 cycles with primers VacF1 (50-GTTGGGATTGGGGGAATGCCG-30) and C1R (50- TTAATTTAACGCTGTTTGAAG-30) for i1 region and VacF16 New Microbes and New Infections , Volume 6 Number C, --- 2015 NMNI © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,6,5–10 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/65/b9/main.PMC4442689.pdf
"Relationship between dupA1 and clarithromycin resistance 7 © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,6,5–10 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/65/b9/main.PMC4442689.pdf
"No signi ﬁcant differences were found; * indicates outlier.8 New Microbes and New Infections , Volume 6 Number C, --- 2015 NMNI © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,6,5–10 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/65/b9/main.PMC4442689.pdf
"Relationship between dupA1 and clarithromycin resistance 9 © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,6,5–10 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/65/b9/main.PMC4442689.pdf
"J Clin Gastroenterol 2012;46(4):297 –301.10 New Microbes and New Infections , Volume 6 Number C, --- 2015 NMNI © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,6,5–10 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/65/b9/main.PMC4442689.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.02.006,Non-OADS,/arxiv_data1/oa_pdf/4b/6b/main.PMC4442690.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,6,1 1 –14 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/4b/6b/main.PMC4442690.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,6,1 1 –14 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/4b/6b/main.PMC4442690.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,6,1 1 –14 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/4b/6b/main.PMC4442690.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.04.003,Non-OADS,/arxiv_data1/oa_pdf/03/5d/main.PMC4442691.pdf
"Surveillance of SSI All consecutive patients undergoing heart surgery at the Uni- versity Hospital Zurich are included prospectively in the sur- veillance protocol of the Swissnoso Surgical Site Infection Surveillance Module ( http://www.swissnoso.ch/ ), which is based on the US Centers for Disease Control and Prevention de ﬁ- nitions [21].",Non-OADS,/arxiv_data1/oa_pdf/03/5d/main.PMC4442691.pdf
"As a modi ﬁcation to the latter, sternal osteitis is considered a deep incisional SSI even in the absence of concomitant mediastinitis ( http://www.swiss-noso.ch/wp- content/uploads/2009/05/2_-D-30-09-2013_D_ Teilnehmerhandbuch_VERSION-UPDATE_SEPTEMBER- 20132.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/03/5d/main.PMC4442691.pdf
Deep sternal wound infection was de ﬁned according to the Swissnoso Surgical Site Infection Surveillance Module de ﬁni- tions ( http://www.swiss-noso.ch/wp-content/uploads/2009/05/ 2_-D-30-09-2013_D_Teilnehmerhandbuch_VERSION- UPDATE_SEPTEMBER-20132.pdf ).,Non-OADS,/arxiv_data1/oa_pdf/03/5d/main.PMC4442691.pdf
"The disc diffusion method according to Kirby-Bauer was applied for susceptibility testing ( http://www.eucast.org/antimicrobial_ susceptibility_testing/disk_diffusion_methodology/ ) using discs from i2a (Montpellier, France).",OADS,/arxiv_data1/oa_pdf/03/5d/main.PMC4442691.pdf
"Inhibition zone diameters were determined and recorded in the automated Sirweb/Sirscansystem (i2a) and interpreted according to EUCAST 1.3 guide- lines from the European Committee on Antimicrobial Suscep- tibility Testing using their breakpoint tables for interpretation of minimum inhibitory concentrations and zone diameters, ver- sions 1.3 and 2.0 ( http://www.eucast.org/antimicrobial_ susceptibility_testing/previous_versions_of_tables/ ).16 New Microbes and New Infections , Volume 6 Number C, --- 2015 NMNI New Microbes and New Infections © 2015 The Authors.",OADS,/arxiv_data1/oa_pdf/03/5d/main.PMC4442691.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,6,1 5–21 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/03/5d/main.PMC4442691.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,6,1 5–21 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/03/5d/main.PMC4442691.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,6,1 5–21 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/03/5d/main.PMC4442691.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,6,1 5–21 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/03/5d/main.PMC4442691.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,6,1 5–21 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/03/5d/main.PMC4442691.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,6,1 5–21 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/03/5d/main.PMC4442691.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/a3/main.PMC4442692.pdf
"For simplicity, weContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.05.001 2213-2317/ &2015 The Authors.",OADS,/arxiv_data1/oa_pdf/e0/a3/main.PMC4442692.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: AUR, Amplex UltraRed; ME, malic enzyme (decarboxylating); NNT, nicotinamide nucleotide transhydrogenase; VC, the rate of H 2O2consumption; VappC, the apparent rate of H 2O2consumption; VP, the rate of H 2O2production; VappP, the apparent rate of H 2O2production nCorresponding author at: Department of Biological Sciences, University of Manitoba, 50 Sifton Road, Winnipeg, MB, Canada R3T 2N2.",Non-OADS,/arxiv_data1/oa_pdf/e0/a3/main.PMC4442692.pdf
"Popov, Scavenging of H 2O2by mouse brain mito- chondria, Journal of Bioenergetics and Biomembranes 46 (6) (2014) 471 –477, http://dx.doi.org/10.1007/s10863-014-9581-9 25248416 .",Non-OADS,/arxiv_data1/oa_pdf/e0/a3/main.PMC4442692.pdf
"Brown, V. Borutaite, There is no evidence that mitochondria are the main source of reactive oxygen species in mammalian cells, Mitochondrion 12 (1)(2012) 1 –4,http://dx.doi.org/10.1016/j.mito.2011.02.001 21303703 .Table 2 Summary of results and comparisons of nonlinear regression based determinationsof H 2O2metabolism by muscle mitochondria respiring on 5 mM succinate.",OADS,/arxiv_data1/oa_pdf/e0/a3/main.PMC4442692.pdf
"Palmeira, Diabetes and mitochondrial function: role of hyper- glycemia and oxidative stress, Toxicology and Applied Pharmacology 212 (2) (2006) 167 –178, http://dx.doi.org/10.1016/j.taap.2006.01.003 16490224 .",Non-OADS,/arxiv_data1/oa_pdf/e0/a3/main.PMC4442692.pdf
"Sharma, AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function, Journal of Clinical Investigation 123 (11) (2013) 4888 –4899, http://dx.doi.org/10.1172/JCI66218 24135141 .",Non-OADS,/arxiv_data1/oa_pdf/e0/a3/main.PMC4442692.pdf
"Rabinovitch, Mitochondrial oxidative stress in aging and healthspan, Longevity & Healthspan 3 (2014) 6, http://dx.doi.org/10.1186/2046-2395-3-6 24860647 .",Non-OADS,/arxiv_data1/oa_pdf/e0/a3/main.PMC4442692.pdf
"Day, Antioxidant therapeutics: Pandora's box, Free Radical Biology and Medicine 66 (2014) 58 –64,http://dx.doi.org/10.1016/j.free- radbiomed.2013.05.047 23856377 .",Non-OADS,/arxiv_data1/oa_pdf/e0/a3/main.PMC4442692.pdf
"[13] S. Mason, G.D. Wadley, Skeletal muscle reactive oxygen species: a target of good cop/bad cop for exercise and disease, Redox Report 19 (3) (2014) 97 –106, http://dx.doi.org/10.1179/1351000213Y.0000000077 24620937 .",Non-OADS,/arxiv_data1/oa_pdf/e0/a3/main.PMC4442692.pdf
"Patel, M. F. Beal, Mitochondrialα-ketoglutarate dehydrogenase complex generates reactive oxygen species, Journal of Neuroscience 24 (36) (2004) 7779 –7788, http://dx.doi.org/10.1523/JNEUROSCI.1899-04.2004 15356189 .",OADS,/arxiv_data1/oa_pdf/e0/a3/main.PMC4442692.pdf
"[15] L. Tretter, V. Adam-Vizi, Generation of reactive oxygen species in the reaction catalyzed by α-ketoglutarate dehydrogenase, Journal of Neuroscience 24 (36) (2004) 7771 –7778, http://dx.doi.org/10.1523/JNEUROSCI.1842-04.2004 15356188 .",Non-OADS,/arxiv_data1/oa_pdf/e0/a3/main.PMC4442692.pdf
"2) (2013) S1 –S8,http://dx.doi.org/10.1111/ bjd.12208 23786614 .",Non-OADS,/arxiv_data1/oa_pdf/e0/a3/main.PMC4442692.pdf
"[17] S.S. Liu, Generating, partitioning, targeting and functioning of superoxide in mitochondria, Bioscience Reports 17 (3) (1997) 259 –272, http://dx.doi.org/ 10.1023/A:1027328510931 9337481 .",OADS,/arxiv_data1/oa_pdf/e0/a3/main.PMC4442692.pdf
"[18] Y. Liu, G. Fiskum, D. Schubert, Generation of reactive oxygen species by the mitochondrial electron transport chain, Journal of Neurochemistry 80 (5)(2002) 780 –787, http://dx.doi.org/10.1046/j.0022-3042.2002.00744.x 11948241 .",Non-OADS,/arxiv_data1/oa_pdf/e0/a3/main.PMC4442692.pdf
"Lustgarten, A. Bhattacharya, Y. C. Jang, H. Van Remmen, High rates of superoxide production in skeletal- muscle mitochondria respiring on both complex I- and complex II-linked substrates, Biochemical Journal 409 (2) (2008) 491 –499, http://dx.doi.org/ 10.1042/BJ20071162 17916065 .",Non-OADS,/arxiv_data1/oa_pdf/e0/a3/main.PMC4442692.pdf
"Brand, Native rates of superoxide production from multiple sites in isolated mitochondria measured using endogenous reporters, Free Radical Biology and Medicine 53 (9) (2012) 1807 –1817, http://dx.doi.org/10.1016/j.freeradbiomed.2012.08.015 22940066 .",OADS,/arxiv_data1/oa_pdf/e0/a3/main.PMC4442692.pdf
"Brand, Sites of reactive oxygen species generation by mitochondria oxidizing differ- ent substrates, Redox Biology 1 (2013) 304 –312, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/e0/a3/main.PMC4442692.pdf
"Perevoshchikova, M. Hey-Mogensen, M. D. Brand, Sites of superoxide and hydrogen peroxide production by muscle mitochondria assessed ex vivo under conditions mimicking rest and exercise, Journal of Biological Chemistry 290 (1) (2015) 209 –227, http://dx.doi.org/ 10.1074/jbc.M114.619072 25389297 .",OADS,/arxiv_data1/oa_pdf/e0/a3/main.PMC4442692.pdf
"[25] F. Zoccarato, L. Cavallini, A. Alexandre, Respiration-dependent removal of exogenous H 2O2in brain mitochondria: inhibition by Ca2þ, Journal of Biolo- gical Chemistry 279 (6) (2004) 4166 –4174, http://dx.doi.org/10.1074/jbc.",Non-OADS,/arxiv_data1/oa_pdf/e0/a3/main.PMC4442692.pdf
"Brand, Inhibitors of the quinone-binding site allow rapid superoxide production from mitochondrial NADH:ubiquinone oxidoreductase (complex I), Journal of Biological Chemistry 279 (38) (2004) 39414 –39420, http://dx.doi.org/10.1074/jbc.M406576200 15262965 .",Non-OADS,/arxiv_data1/oa_pdf/e0/a3/main.PMC4442692.pdf
"Rigobello, A. Folda, G. Scutari, A. Bindoli, The modulation of thiol redox state affects the production and metabolism of hydrogen peroxide by heart mitochondria, Archives of Biochemistry and Biophysics 441 (2) (2005) 112 –122, http://dx.doi.org/10.1016/j.abb.2005.07.007 16111648 .",OADS,/arxiv_data1/oa_pdf/e0/a3/main.PMC4442692.pdf
"Drechsel, M. Patel, Respiration-dependent H 2O2removal in brain mito- chondria via the thioredoxin/Peroxiredoxin System, Journal of Biological Chemistry 285 (36) (2010) 27850 –27858, http://dx.doi.org/10.1074/jbc.",OADS,/arxiv_data1/oa_pdf/e0/a3/main.PMC4442692.pdf
"[29] S. Banh, J.R. Treberg, The pH sensitivity of H 2O2metabolism in skeletal muscle mitochondria, FEBS Letters 587 (12) (2013) 1799 –1804, http://dx.doi.org/ 10.1016/j.febslet.2013.04.035 23669366 .",Non-OADS,/arxiv_data1/oa_pdf/e0/a3/main.PMC4442692.pdf
"Turrens, Hydrogen peroxide metabolism in skeletal muscle mitochondria, Archives of Biochemistry and Biophysics 315 (2) (1994) 479 –482, http://dx.doi.org/10.1006/abbi.1994.1528 7986095 .",Non-OADS,/arxiv_data1/oa_pdf/e0/a3/main.PMC4442692.pdf
"[35] F. Taroni, C. Gellera, S. Di Donato, Evidence for two distinct mitochondrial malic enzymes in human skeletal muscle: puri ﬁcation and properties of the NAD(P)þ-dependent enzyme, Biochimica et Biophysica Acta 916 (3) (1987) 446 –454, http://dx.doi.org/10.1016/0167-4838(87)90191-9 3689803 .",Non-OADS,/arxiv_data1/oa_pdf/e0/a3/main.PMC4442692.pdf
"[36] L. Tretter, G. Horvath, A. Hölgyesi, F. Essek, V. Adam-Vizi, Enhanced hydrogen peroxide generation accompanies the bene ﬁcial bioenergetic effects of methylene blue in isolated brain mitochondria, Free Radical Biology and Medicine 77 (2014) 317 –330, http://dx.doi.org/10.1016/j.free- radbiomed.2014.09.024 25277417 .",Non-OADS,/arxiv_data1/oa_pdf/e0/a3/main.PMC4442692.pdf
"Role of thioredoxin reductase, Free Radical Research 39 (7) (2005) 687 –695, http://dx.doi.org/ 10.1080/10715760500135391 16036347 .",Non-OADS,/arxiv_data1/oa_pdf/e0/a3/main.PMC4442692.pdf
"Watson, M. A. Aon, N. Paolocci, Thioredoxin reductase-2 is essential for keeping low levels of H(2)O(2) emission from isolated heart mitochondria, Journal of BiologicalChemistry 286 (38) (2011) 33669 –33677, http://dx.doi.org/10.1074/jbc.",Non-OADS,/arxiv_data1/oa_pdf/e0/a3/main.PMC4442692.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/90/84/main.PMC4442693.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.05.002 2049-0801/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/84/main.PMC4442693.pdf
©2015TheAuthors.PublishedbyElsevierLtdonbehalf of AustralianSocietyforParasitology.Thisisan openaccessarticleundertheCCBY-NC-NDlicense( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f6/f1/main.PMC4442694.pdf
http://dx.doi.org/10.1016/j.ijpddr.2015.04.001 2211-3207/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f6/f1/main.PMC4442694.pdf
This is an open access article under the CC B Y-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).International Journal for Parasitology: Drugs and Drug Resistance 5 (2015) 58–64 Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.com/locate/ijpddr,Non-OADS,/arxiv_data1/oa_pdf/f6/f1/main.PMC4442694.pdf
This article is distributed under the terms of an Attribution–Noncom- mercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/a5/8a/JGP_201511411.PMC4442783.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/a5/8a/JGP_201511411.PMC4442783.pdf
"http://dx.doi .org/10.1113/jphysiol.1902.sp000911 Bezprozvanny, I., and R.W.",OADS,/arxiv_data1/oa_pdf/a5/8a/JGP_201511411.PMC4442783.pdf
"http://dx.doi.org/10.1101/csh - perspect.a003947 Dziegielewska, B., L.S.",Non-OADS,/arxiv_data1/oa_pdf/a5/8a/JGP_201511411.PMC4442783.pdf
"http://dx.doi.org/10.1007/s00424-014-1444-z Earley, S., T.J. Heppner, M.T.",Non-OADS,/arxiv_data1/oa_pdf/a5/8a/JGP_201511411.PMC4442783.pdf
"http://dx.doi.org/ 10.1161/01.RES.0000194321.60300.d6 Harraz, O.F., R.R.",Non-OADS,/arxiv_data1/oa_pdf/a5/8a/JGP_201511411.PMC4442783.pdf
"http://dx.doi.org/10.1085/jgp.201511361 Knot, H.J., and M.T.",OADS,/arxiv_data1/oa_pdf/a5/8a/JGP_201511411.PMC4442783.pdf
"http://dx.doi.org/ 10.1111/j.1469-7793.1998.199br.x Nelson, M.T., S.M.",OADS,/arxiv_data1/oa_pdf/a5/8a/JGP_201511411.PMC4442783.pdf
"http://dx.doi.org/10.2174/138161206777585184 Perez-Reyes, E. 2003.",Non-OADS,/arxiv_data1/oa_pdf/a5/8a/JGP_201511411.PMC4442783.pdf
"http://dx.doi .org/10.1152/physrev.00018.2002 Rubart, M., J.B. Patlak, and M.T.",OADS,/arxiv_data1/oa_pdf/a5/8a/JGP_201511411.PMC4442783.pdf
"http://dx.doi.org/ 10.1085/jgp.107.4.459 Stolberg, S.G. 1998.",OADS,/arxiv_data1/oa_pdf/a5/8a/JGP_201511411.PMC4442783.pdf
"Together with  TRPM6 and TRPM7, the TRPM2 channel has been clas- sified as a “chanzyme,” a channel with enzymatic activity  due to its capacity to cleave ADPR and convert it into  adenine monophosphate (AMP) and ribose-5-phosphate  (Sumoza-Toledo and Penner, 2011).Activators of TRPM2: Getting it right Tamara Rosenbaum Departamento de Neurodesarrollo y Fisiología, División Neurociencias, Instituto de Fisiología Celular,   Universidad Nacional Autónoma de México, 04510 México D.F., México © 2015 Rosenbaum  This article is distributed under the terms of an Attribution–Noncom- mercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/79/1e/JGP_201511405.PMC4442784.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/79/1e/JGP_201511405.PMC4442784.pdf
"http://dx.doi.org/10.1096/fj.05-5538fje Burzomato, V., M. Beato, P.J.",Non-OADS,/arxiv_data1/oa_pdf/79/1e/JGP_201511405.PMC4442784.pdf
"24:10924– 10940. http://dx.doi.org/10.1523/JNEUROSCI.3424-04.2004 Codina, J., A. Yatani, D. Grenet, A.M. Brown, and L. Birnbaumer.",OADS,/arxiv_data1/oa_pdf/79/1e/JGP_201511405.PMC4442784.pdf
"http://dx.doi .org/10.1126/science.2436299 Csanády, L., and B. Törocsik.",OADS,/arxiv_data1/oa_pdf/79/1e/JGP_201511405.PMC4442784.pdf
"http://dx.doi .org/10.1085/jgp.200810109 Ito, H., R.T. Tung, T. Sugimoto, I. Kobayashi, K. Takahashi, T. Katada,  M. Ui, and Y. Kurachi.",OADS,/arxiv_data1/oa_pdf/79/1e/JGP_201511405.PMC4442784.pdf
"http://dx.doi.org/10.1085/jgp.99.6.961 Kolisek, M., A. Beck, A. Fleig, and R. Penner.",OADS,/arxiv_data1/oa_pdf/79/1e/JGP_201511405.PMC4442784.pdf
"http://dx.doi .org/10.1016/j.molcel.2005.02.033 Kühn, F.J., and A. Lückhoff.",OADS,/arxiv_data1/oa_pdf/79/1e/JGP_201511405.PMC4442784.pdf
"http://dx.doi.org/10.1074/jbc.M407263200Lange, I., R. Penner, A. Fleig, and A. Beck.",OADS,/arxiv_data1/oa_pdf/79/1e/JGP_201511405.PMC4442784.pdf
"http://dx.doi.org/10.1073/ pnas.85.16.5814 Mei, Z.Z., and L.H.",OADS,/arxiv_data1/oa_pdf/79/1e/JGP_201511405.PMC4442784.pdf
"http://dx.doi.org/10.1007/s00232-009-9190-4 Nagamine, K., J. Kudoh, S. Minoshima, K. Kawasaki, S. Asakawa, F.  Ito, and N. Shimizu.",OADS,/arxiv_data1/oa_pdf/79/1e/JGP_201511405.PMC4442784.pdf
"http://dx.doi.org/10.1006/geno.1998.5551 Naziroğlu, M., and A. Lückhoff.",Non-OADS,/arxiv_data1/oa_pdf/79/1e/JGP_201511405.PMC4442784.pdf
"http://dx.doi.org/10.1007/s11064-007-9577-5 Perraud, A.L., A. Fleig, C.A.",OADS,/arxiv_data1/oa_pdf/79/1e/JGP_201511405.PMC4442784.pdf
"http://dx.doi .org/10.1038/370143a0 Sumoza-Toledo, A., and R. Penner.",Non-OADS,/arxiv_data1/oa_pdf/79/1e/JGP_201511405.PMC4442784.pdf
"http://dx.doi.org/10.1113/jphysiol.2010.201855 Tóth, B., and L. Csanády.",OADS,/arxiv_data1/oa_pdf/79/1e/JGP_201511405.PMC4442784.pdf
http://dx.doi.org/10.1126/science.2457252,Non-OADS,/arxiv_data1/oa_pdf/79/1e/JGP_201511405.PMC4442784.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/4d/34/JGP_201511356.PMC4442785.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/4d/34/JGP_201511356.PMC4442785.pdf
"http://dx.doi.org/10.1124/mol.111.075234 Brenner, R., T.J. Jegla, A. Wickenden, Y. Liu, and R.W.",OADS,/arxiv_data1/oa_pdf/4d/34/JGP_201511356.PMC4442785.pdf
"http://dx.doi.org/ 10.1161/CIRCRESAHA.115.303407 Gessner, G., K. Schönherr, M. Soom, A. Hansel, M. Asim, A.  Baniahmad, C. Derst, T. Hoshi, and S.H.",Non-OADS,/arxiv_data1/oa_pdf/4d/34/JGP_201511356.PMC4442785.pdf
"http://dx.doi .org/10.1007/s00232-005-0830-z Gonzalez-Perez, V., X.M.",Non-OADS,/arxiv_data1/oa_pdf/4d/34/JGP_201511356.PMC4442785.pdf
"http://dx.doi.org/10.1073/ pnas.1322123111 Gribkoff, V.K., J.E.",OADS,/arxiv_data1/oa_pdf/4d/34/JGP_201511356.PMC4442785.pdf
"http://dx.doi.org/10.1177/107385840100700211 Gurnett, C.A., and K.P.",OADS,/arxiv_data1/oa_pdf/4d/34/JGP_201511356.PMC4442785.pdf
"http://dx.doi.org/10.1074/jbc.271.45.27975 Horrigan, F.T., and R.W.",OADS,/arxiv_data1/oa_pdf/4d/34/JGP_201511356.PMC4442785.pdf
"http://dx.doi.org/10.1085/jgp.20028605 Manzanares, D., M. Srinivasan, S.T.",OADS,/arxiv_data1/oa_pdf/4d/34/JGP_201511356.PMC4442785.pdf
"http://dx.doi.org/10.1152/ajplung.00247 .2013 Meera, P., M. Wallner, and L. Toro.",OADS,/arxiv_data1/oa_pdf/4d/34/JGP_201511356.PMC4442785.pdf
"http://dx.doi.org/10.1126/science .283.5399.215 Savalli, N., A. Kondratiev, S.B.",Non-OADS,/arxiv_data1/oa_pdf/4d/34/JGP_201511356.PMC4442785.pdf
"http://dx.doi.org/10.1085/ jgp.200709803 Sun, X., M.A.",OADS,/arxiv_data1/oa_pdf/4d/34/JGP_201511356.PMC4442785.pdf
"3:63. http://dx.doi.org/10.3389/fphar.2012 .00063 Wallner, M., P. Meera, and L. Toro.",OADS,/arxiv_data1/oa_pdf/4d/34/JGP_201511356.PMC4442785.pdf
"http://dx.doi .org/10.1113/jphysiol.2011.213868 Yan, J., and R.W.",OADS,/arxiv_data1/oa_pdf/4d/34/JGP_201511356.PMC4442785.pdf
"http://dx.doi.org/10.1038/nature09162 Yan, J., and R.W.",OADS,/arxiv_data1/oa_pdf/4d/34/JGP_201511356.PMC4442785.pdf
"http://dx.doi.org/10.1073/ pnas.1111104108 Zeng, X.H., X.M.",OADS,/arxiv_data1/oa_pdf/4d/34/JGP_201511356.PMC4442785.pdf
5:401. http://dx.doi.org/10.3389/ fphys.2014.00401,Non-OADS,/arxiv_data1/oa_pdf/4d/34/JGP_201511356.PMC4442785.pdf
This article is distributed under the terms of an Attribution–Noncommercial–  Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/10.1113/ jphysiol.2002.018515 DiNitto, J.P., T.C.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/10.1023/ B:JOBB.0000008026.37790.5a Ertel, E.A., K.P.",Non-OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/10.1016/S0896-6273(00) 81057-0 Frank, C.A.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/10.1126/science.1222483 Heneghan, J.F., T. Mitra-Ganguli, L.F. Stanish, L. Liu, R. Zhao, and  A.R.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/ 10.1085/jgp.200910203 Horowitz, L.F., W. Hirdes, B.C.",Non-OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/10.1085/jgp.200509309 Hurley, J.H., A.L.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/10.1038/nmeth763 Keum, D., C. Baek, D.I.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/10.1085/jgp.201411245 Korzeniowski, M.K., M.A.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/10.1074/ jbc.M109.012252 Liang, H., C.D.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/ 10.1016/S0896-6273(03)00560-9 Link, S., M. Meissner, B.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/10.1074/jbc.M109.045583 Lipscombe, D., T.D.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi .org/10.1152/jn.00486.2004 Ludwig, A., V. Flockerzi, and F. Hofmann.",Non-OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/10 .1152/physrev.00028.2012 Bichet, D., V. Cornet, S. Geib, E. Carlier, S. Volsen, T. Hoshi, Y.  Mori, and M. De Waard.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi .org/10.1016/S0896-6273(00)80881-8 Buraei, Z., and J. Yang.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/10.1152/ physrev.00057.2009 Catterall, W.A.",Non-OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/ 10.1146/annurev.cellbio.16.1.521 Catterall, W.A., and A.P.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/10 .1016/j.neuron.2008.09.005 Chan, A.W., S. Owens, C. Tung, and E.F. Stanley.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/10.1016/j.ceca.2007.04.009 Chien, A.J., K.M.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/10.1074/jbc.271.43.26465 Chien, A.J., T. Gao, E. Perez-Reyes, and M.M.",Non-OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"273:23590– 23597. http://dx.doi.org/10.1074/jbc.273.36.23590 Cho, W., and R.V.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/10.1146/annurev .biophys.33.110502.133337 Colecraft, H.M., B. Alseikhan, S.X.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi .org/10.1523/JNEUROSCI.5637-12.2013 Massa, E., K.M.",Non-OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/10.1038/nature04398 Miranda-Laferte, E., D. Ewers, R.E.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/10.1074/jbc.M113.507244 Mulgrew-Nesbitt, A., K. Diraviyam, J. Wang, S. Singh, P. Murray, Z.  Li, L. Rogers, N. Mirkovic, and D. Murray.",Non-OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/10.1016/j.bbalip.2006.07.002 Nalefski, E.A., and J.J. Falke.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/10.1074/jbc.M109.044271 Qin, N., D. Platano, R. Olcese, J.L.",Non-OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/10.1016/j.tins.2003.10.003 Roberts-Crowley, M.L., T. Mitra-Ganguli, L. Liu, and A.R.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/10.1016/j.ceca.2009.03.015 Rosenhouse-Dantsker, A., and D.E.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/10.1007/s00424-007-0291-6 Roy, A., and T.P.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/ 10.1074/jbc.M401583200 Schlick, B., B.E.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi .org/10.1016/j.neuroscience.2010.02.037Simms, B.A., and G.W.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/10.1016/j.neuron.2014.03.016 Suh, B.C., and B. Hille.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/10.1016/ j.neuron.2010.07.001 Suh, B.C., D.I.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/10.1016/S0006-3495(03)70027-7 Vacher, H., D.P.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi .org/10.1152/physrev.00002.2008 van Meer, G., D.R.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/10.1038/nrm2330 Waithe, D., L. Ferron, K.M.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"286:9598– 9611. http://dx.doi.org/10.1074/jbc.M110.195909 Webb, Y., L. Hermida-Matsumoto, and M.D.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"http://dx.doi.org/10.1074/jbc.275.1.261 Wykes, R.C., C.S.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"27:5236– 5248. http://dx.doi.org/10.1523/JNEUROSCI.3545-06.2007 Xie, M., X. Li, J. Han, D.L.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
"178:489– 502. http://dx.doi.org/10.1083/jcb.200702072 Yeung, T., G.E.",OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
http://dx.doi.org/ 10.1126/science.1152066,Non-OADS,/arxiv_data1/oa_pdf/bc/5e/JGP_201411349.PMC4442786.pdf
This article is distributed under the terms of an Attribution–Noncom- mercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/df/41/JGP_201511365.PMC4442788.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/df/41/JGP_201511365.PMC4442788.pdf
"http://dx.doi.org/10.1016/j.sbi.2009.06.002 Adair, G.S., A.V.",OADS,/arxiv_data1/oa_pdf/df/41/JGP_201511365.PMC4442788.pdf
"http://dx.doi .org/10.1529/biophysj.108.139741 Dahlquist, F.W.",OADS,/arxiv_data1/oa_pdf/df/41/JGP_201511365.PMC4442788.pdf
"http://dx.doi.org/10.1016/S0076- 6879(78)48015-2 Dai, G., O.",OADS,/arxiv_data1/oa_pdf/df/41/JGP_201511365.PMC4442788.pdf
"http://dx.doi.org/10.1038/379458a0 De la Vieja, A., C.S.",Non-OADS,/arxiv_data1/oa_pdf/df/41/JGP_201511365.PMC4442788.pdf
"http://dx.doi.org/10.1242/ jcs.00898 De la Vieja, A., C.S.",Non-OADS,/arxiv_data1/oa_pdf/df/41/JGP_201511365.PMC4442788.pdf
"http://dx.doi.org/10.1210/me.2005-0162 De la Vieja, A., M.D.",Non-OADS,/arxiv_data1/oa_pdf/df/41/JGP_201511365.PMC4442788.pdf
"http://dx.doi .org/10.1074/jbc.M700147200 Dohán, O., M.V.",Non-OADS,/arxiv_data1/oa_pdf/df/41/JGP_201511365.PMC4442788.pdf
"16:1893– 1902. http://dx.doi.org/10.1210/me.2002-0071 Eskandari, S., D.D.",Non-OADS,/arxiv_data1/oa_pdf/df/41/JGP_201511365.PMC4442788.pdf
"http://dx.doi.org/10 .1074/jbc.272.43.27230 Fotiadis, D., Y. Kanai, and M. Palacín.",OADS,/arxiv_data1/oa_pdf/df/41/JGP_201511365.PMC4442788.pdf
"http://dx.doi.org/10.1016/j.mam.2012.10.007 Goutelle, S., M. Maurin, F. Rougier, X. Barbaut, L. Bourguignon,  M. Ducher, and P. Maire.",OADS,/arxiv_data1/oa_pdf/df/41/JGP_201511365.PMC4442788.pdf
"http://dx.doi.org/10.1111/j.1472-8206.2008.00633.x Harder, D., and D. Fotiadis.",OADS,/arxiv_data1/oa_pdf/df/41/JGP_201511365.PMC4442788.pdf
"http://dx.doi .org/10.1038/nprot.2012.090 Hill, A.V.",Non-OADS,/arxiv_data1/oa_pdf/df/41/JGP_201511365.PMC4442788.pdf
"http://dx.doi.org/10.1113/jphysiol.1910.sp001386other methods, Ka,A and Ka,B can be obtained as the two  roots of a quadratic equation (Eq.",OADS,/arxiv_data1/oa_pdf/df/41/JGP_201511365.PMC4442788.pdf
"http://dx.doi .org/10.1085/jgp.201311116 Ho, A.L., R.K. Grewal, R. Leboeuf, E.J.",OADS,/arxiv_data1/oa_pdf/df/41/JGP_201511365.PMC4442788.pdf
"http://dx.doi.org/ 10.1056/NEJMoa1209288 Khafizov, K., C. Perez, C. Koshy, M. Quick, K. Fendler, C. Ziegler,  and L.R.",Non-OADS,/arxiv_data1/oa_pdf/df/41/JGP_201511365.PMC4442788.pdf
"http://dx.doi.org/10.1073/ pnas.1209039109 Klutz, K., M.J. Willhauck, N. Wunderlich, C. Zach, M. Anton, R.  Senekowitsch-Schmidtke, B. Göke, and C. Spitzweg.",OADS,/arxiv_data1/oa_pdf/df/41/JGP_201511365.PMC4442788.pdf
"http://dx.doi.org/10.1089/hum.2010.158 Levy, O., C.S.",Non-OADS,/arxiv_data1/oa_pdf/df/41/JGP_201511365.PMC4442788.pdf
"http://dx.doi.org/10.1096/fj.13-229138 Nicola, J.P., N. Carrasco, and L.M.",Non-OADS,/arxiv_data1/oa_pdf/df/41/JGP_201511365.PMC4442788.pdf
"5:3948. http://dx.doi.org/10.1038/ ncomms4948 Paroder, V., J.P. Nicola, C.S.",Non-OADS,/arxiv_data1/oa_pdf/df/41/JGP_201511365.PMC4442788.pdf
"http://dx.doi.org/10 .1242/jcs.120246Paroder-Belenitsky, M., M.J. Maestas, O. Dohán, J.P. Nicola, A.  Reyna-Neyra, A. Follenzi, E. Dadachova, S. Eskandari, L.M.",Non-OADS,/arxiv_data1/oa_pdf/df/41/JGP_201511365.PMC4442788.pdf
"http://dx.doi .org/10.1074/jbc.M111008200 Portulano, C., M. Paroder-Belenitsky, and N. Carrasco.",Non-OADS,/arxiv_data1/oa_pdf/df/41/JGP_201511365.PMC4442788.pdf
"http://dx.doi.org/10.1210/er.2012-1036 Quick, M., and J.A.",OADS,/arxiv_data1/oa_pdf/df/41/JGP_201511365.PMC4442788.pdf
"20:634– 640. http://dx.doi.org/10.1038/nsmb.2548 Shi, L., M. Quick, Y. Zhao, H. Weinstein, and J.A.",Non-OADS,/arxiv_data1/oa_pdf/df/41/JGP_201511365.PMC4442788.pdf
"http://dx.doi.org/10.1016/j .molcel.2008.05.008 Weiss, J.N.",OADS,/arxiv_data1/oa_pdf/df/41/JGP_201511365.PMC4442788.pdf
"http://dx.doi.org/10.1016/j.mam.2012.11.002 Yamashita, A., S.K.",OADS,/arxiv_data1/oa_pdf/df/41/JGP_201511365.PMC4442788.pdf
"http://dx.doi .org/10.1038/nature03978 Zhou, X., E.J.",OADS,/arxiv_data1/oa_pdf/df/41/JGP_201511365.PMC4442788.pdf
http://dx.doi.org/10.1038/nature12811,Non-OADS,/arxiv_data1/oa_pdf/df/41/JGP_201511365.PMC4442788.pdf
© 2015 Lolkema and Slotboom  This article is distributed under the terms of an Attribu- tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the  publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/a4/4f/JGP_201411332.PMC4442790.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/a4/4f/JGP_201411332.PMC4442790.pdf
"http://dx.doi.org/10.1038/nature12265 Akyuz, N., E.R.",Non-OADS,/arxiv_data1/oa_pdf/a4/4f/JGP_201411332.PMC4442790.pdf
"http://dx.doi.org/10 .1038/nature14158 Bezanilla, F. 2000.",Non-OADS,/arxiv_data1/oa_pdf/a4/4f/JGP_201411332.PMC4442790.pdf
"http://dx.doi.org/10.1038/nature05455 Erkens, G.B., I. Hänelt, J.M.H.",OADS,/arxiv_data1/oa_pdf/a4/4f/JGP_201411332.PMC4442790.pdf
"502:119– 123. http://dx.doi.org/10.1038/nature12538 Ewers, D., T. Becher, J.-P. Machtens, I. Weyand, and C. Fahlke.",OADS,/arxiv_data1/oa_pdf/a4/4f/JGP_201411332.PMC4442790.pdf
"http://dx.doi.org/10.1016/j.str.2013.03.002 Focke, P.J., A.W.",OADS,/arxiv_data1/oa_pdf/a4/4f/JGP_201411332.PMC4442790.pdf
"http://dx.doi.org/10.1021/ bi501477y Groeneveld, M., and D.J.",OADS,/arxiv_data1/oa_pdf/a4/4f/JGP_201411332.PMC4442790.pdf
"http://dx.doi.org/10.1021/bi100430s Hänelt, I., D. Wunnicke, E. Bordignon, H.-J.",OADS,/arxiv_data1/oa_pdf/a4/4f/JGP_201411332.PMC4442790.pdf
"http://dx.doi .org/10.1038/nsmb.2471 Hill, A.V.",Non-OADS,/arxiv_data1/oa_pdf/a4/4f/JGP_201411332.PMC4442790.pdf
"http://dx.doi.org/10.1038/nsmb.2663 Koshland, D.E., Jr., G. Némethy, and D. Filmer.",OADS,/arxiv_data1/oa_pdf/a4/4f/JGP_201411332.PMC4442790.pdf
"http://dx.doi .org/10.1021/bi00865a047 Kuriyan, J., B. Konforti, and D. Wemmer.",OADS,/arxiv_data1/oa_pdf/a4/4f/JGP_201411332.PMC4442790.pdf
"http://dx.doi.org/10.1111/ j.1432-1033.1994.tb18645.xbinding experiments for Glt Ph, only the binding of as- partate and not the binding of Na+ was detected, as  binding of Na+ alone did not generate a measurable  fluorescence change nor a detectable heat release.",OADS,/arxiv_data1/oa_pdf/a4/4f/JGP_201411332.PMC4442790.pdf
The online supple-mental material is available at http://www.jgp.org/cgi/content/full/jgp.201411332/DC1.,Non-OADS,/arxiv_data1/oa_pdf/a4/4f/JGP_201411332.PMC4442790.pdf
"http://dx.doi .org/10.1016/j.cell.2014.12.035 Monod, J., J. Wyman, and J.P. Changeux.",OADS,/arxiv_data1/oa_pdf/a4/4f/JGP_201411332.PMC4442790.pdf
"http://dx.doi.org/10.1016/S0022-2836(65)80285-6 Mulligan, C., and J.A.",OADS,/arxiv_data1/oa_pdf/a4/4f/JGP_201411332.PMC4442790.pdf
"288:35266– 35276. http://dx.doi.org/10.1074/jbc.M113.508408 Perutz, M.F.",Non-OADS,/arxiv_data1/oa_pdf/a4/4f/JGP_201411332.PMC4442790.pdf
"http://dx.doi.org/ 10.1017/S0033583500003826 Reyes, N., C. Ginter, and O. Boudker.",Non-OADS,/arxiv_data1/oa_pdf/a4/4f/JGP_201411332.PMC4442790.pdf
"http://dx.doi.org/10.1038/nature08616 Reyes, N., S. Oh, and O. Boudker.",OADS,/arxiv_data1/oa_pdf/a4/4f/JGP_201411332.PMC4442790.pdf
"20:634– 640. http://dx.doi.org/10.1038/nsmb.2548 Ryan, R.M., and J.A.",OADS,/arxiv_data1/oa_pdf/a4/4f/JGP_201411332.PMC4442790.pdf
"http://dx.doi.org/10.1038/nsmb1230 Ryan, R.M., E.L.R.",Non-OADS,/arxiv_data1/oa_pdf/a4/4f/JGP_201411332.PMC4442790.pdf
"http://dx.doi.org/10.1017/S0033583500002894 Slotboom, D.J., W.N.",Non-OADS,/arxiv_data1/oa_pdf/a4/4f/JGP_201411332.PMC4442790.pdf
"http://dx.doi.org/10.7554/ eLife.02283 Weiss, J.N.",Non-OADS,/arxiv_data1/oa_pdf/a4/4f/JGP_201411332.PMC4442790.pdf
"http://dx.doi.org/10.1038/nature03018 Yifrach, O.",Non-OADS,/arxiv_data1/oa_pdf/a4/4f/JGP_201411332.PMC4442790.pdf
http://dx.doi.org/10.1085/jgp.103.2.321,OADS,/arxiv_data1/oa_pdf/a4/4f/JGP_201411332.PMC4442790.pdf
This article is distributed under the terms of an Attribution–Noncom- mercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1161/CIRCRESAHA.115.303897 Avila, G., and R.T. Dirksen.",Non-OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi .org/10.1085/jgp.118.3.277 Avila, G., K.M.S.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1085/jgp .200308791 Baddeley, D., I.D.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10 .1073/pnas.0908971106 Canato, M., M. Scorzeto, M. Giacomello, F. Protasi, C. Reggiani,  and G.J.M.",Non-OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1085/ jgp.201311022 Chen, W., R. Wang, B. Chen, X. Zhong, H. Kong, Y. Bai, Q. Zhou, C.  Xie, J. Zhang, A. Guo, et al.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1038/nm.3440 Cheng, H., W.J.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1126/ science.8235594 Collier, M.L., G. Ji, Y. Wang, and M.I.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1085/jgp.115.5.653 Csernoch, L., L. Kovács, and G. Szücs.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi .org/10.1113/jphysiol.1987.sp016695 De Crescenzo, V., R. ZhuGe, C. Velázquez-Marrero, L.M.",Non-OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"24:1226– 1235. http://dx.doi.org/10.1523/JNEUROSCI.4286-03.2004 Diaz-Sylvester, P.L., M. Porta, and J.A.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1074/jbc.M305016200 Andronache, Z., S.L.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1196/annals.1341 .007 Friel, D.D., and R.W.",Non-OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi .org/10.1113/jphysiol.1992.sp019125 Gallant, E.M., N.S.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1016/j.yjmcc.2013.01.011 Gómez, A.M., H.H.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1126/science.276.5313.800 González, A., and E. Ríos.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1085/jgp.102.3.373 Gouadon, E., R.P.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi .org/10.1113/jphysiol.2005.104406 Györke, S., S.C.W.",Non-OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10 .1016/j.molmed.2012.09.006 Jiang, D., R. Wang, B. Xiao, H. Kong, D.J.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10 .1161/01.RES.0000192146.85173.4b Jiang, D., W. Chen, R. Wang, L. Zhang, and S.R.W.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1073/ pnas.0706573104 Jones, L.R., Y.J.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1172/JCI1362 Kirsch, W.G., D. Uttenweiler, and R.H. Fink.",Non-OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi .org/10.1111/j.1469-7793.2001.00379.x Kohl, T., and S.E.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1093/cvr/cvt058 Kraeva, N., E. Zvaritch, W. Frodis, O. Sizova, A. Kraev, D.H. MacLennan,  and S. Riazi.",Non-OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1152/ajpcell.90642.2007 Dietze, B., J. Henke, H.M. Eichinger, F. Lehmann-Horn, and W. Melzer.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1111/j.1469-7793 .2000.t01-1-00507.x Divet, A., S. Paesante, C. Grasso, D. Cavagna, C. Tiveron, C. Paolini,  F. Protasi, C. Huchet-Cadiou, S. Treves, and F. Zorzato.",Non-OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"213:464– 474. http://dx.doi.org/10.1002/jcp.21121 Dowling, J.J., M.W.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"11:773– 785. http://dx.doi.org/10.1007/s13311-014-0300-3 Duke, A.M., P.M. Hopkins, S.C. Calaghan, J.P. Halsall, and D.S.",Non-OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"285:25645– 25653. http://dx.doi.org/10.1074/jbc.M110.104976 Dulhunty, A., L. Wei, and N. Beard.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1113/jphysiol.2009 .171959 Durham, W.J., X.H.T.",Non-OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/  10.1007/978-1-4020-6191-2_10 Eltit, J.M., W. Feng, J.R. Lopez, I.T.",Non-OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"285:38453– 38462. http://dx.doi.org/10.1074/jbc.M110.164525 Eltit, J.M., T. Yang, H. Li, T.F.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1074/jbc.M110.107300 Eltit, J.M., H. Li, C.W.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1152/physrev.00040 .2008 Faggioni, M., and B.C.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1074/jbc.M305931200 Feldmeyer, D., W. Melzer, B. Pohl, and P. Zöllner.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1113/ jphysiol.1990.sp018107 Fénelon, K., C.R.H.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"140:403– 419. http://dx.doi.org/10.1085/jgp.201110730 Franzini-Armstrong, C., F. Protasi, and V. Ramesh.",Non-OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
http://dx.doi.org/ 10.1016/S0006-3495(99)77000-1,OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1113/ jphysiol.2009.171892 Maxwell, J.T., T.L.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1152/ajpheart.00936.2011 Meissner, G., and J.S.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/ 10.1086/515454 Monnier, N., R. Krivosic-Horber, J.-F. Payen, G. Kozak-Ribbens, Y.  Nivoche, P. Adnet, H. Reyford, and J. Lunardi.",Non-OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1097/00000542-200211000-00007 Monod, J., J. Wyman, and J.P. Changeux.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1016/S0022-2836(65)80285-6 Mosca, B., O. Delbono, M. Laura Messi, L. Bergamelli, Z.-M.   Wang, M. Vukcevic, R. Lopez, S. Treves, M. Nishi, H. Takeshima, et al.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"4:1541. http://dx.doi.org/10.1038/ ncomms2496 Nakai, J., R.T. Dirksen, H.T.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1038/380072a0 Oddoux, S., J. Brocard, A. Schweitzer, P. Szentesi, B. Giannesini,  J. Brocard, J. Fauré, K. Pernet-Gallay, D. Bendahan, J. Lunardi,   et al.",Non-OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10 .1074/jbc.M109.022442 Olojo, R.O., A.P.",Non-OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi .org/10.1371/journal.pone.0027036 Paolini, C., M. Quarta, A. Nori, S. Boncompagni, M. Canato, P. Volpe,  P.D.",Non-OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10 .1113/jphysiol.2007.138024 Pape, P.C., D.S.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1111/j.1365-2044.2004.03658.x Lännergren, J., J.D.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi .org/10.1111/j.1469-7793.2000.00597.x Lännergren, J., H. Westerblad, and J.D.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"26:911– 920. http://dx.doi.org/10.1006/cbir.2002.0941 Launikonis, B.S., J. Zhou, L. Royer, T.R.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1111/j.1440-1681.2007.04708.x Laver, D.R., C.H.T.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1016/j.cell.2005.07.030 Lopez, J.R., L.A. Alamo, D.E.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10 .1016/S0006-3495(83)84346-X Ma, J., K. Anderson, R. Shirokov, R. Levis, A. González, M. Karhanek,  M.M.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10 .1085/jgp.102.3.423 MacLennan, D.H., and S.R.W.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"587:3113– 3115. http://dx.doi.org/10.1113/jphysiol.2009.172155 MacLennan, D.H., and E. Zvaritch.",Non-OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/ 10.1016/j.bbamcr.2010.11.009 Marks, T.N., and S.W.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
http://dx.doi.org/10.1085/jgp.99.3.367,OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi .org/10.1074/jbc.M705702200 Shirokova, N., R. Shirokov, D. Rossi, A. González, W.G.",Non-OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"521:483– 495. http://dx.doi.org/10.1111/j.1469-7793.1999.00483.x Sigworth, F.J. 1994.",Non-OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1017/S0033583500002894 Srikanth, S., M. Jew, K.-D. Kim, M.-K. Yee, J. Abramson, and Y. Gwack.",Non-OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1085/jgp.110.4.415 Stern, M.D., L.S.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1085/jgp.113.3.469 Szentesi, P., C. Collet, S. Sárközi, C. Szegedi, I. Jona, V. Jacquemond,  L. Kovács, and L. Csernoch.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1085/ jgp.118.4.355 Sztretye, M., J. Yi, L. Figueroa, J. Zhou, L. Royer, P. Allen, G. Brum,  and E. Ríos.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1085/jgp .201010592 Tijskens, P., L.R.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1016/ S0022-2828(03)00181-0 Timerman, A.P., T. Jayaraman, G. Wiederrecht, H. Onoue, A.R.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1006/bbrc.1994.1101 Toppin, P.J., T.T.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1007/s12630- 010-9314-4 Treves, S., H. Jungbluth, F. Muntoni, and F. Zorzato.",Non-OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
"http://dx.doi.org/10.1016/j.coph.2008.01.005 Treves, S., M. Vukcevic, M. Maj, R. Thurnheer, B. Mosca, and F.  Zorzato.",OADS,/arxiv_data1/oa_pdf/62/c8/JGP_201411321.PMC4442791.pdf
